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Abstract 
Clostridium difficile is a Gram-positive, obligate anaerobe and a leading cause of hospital-
acquired diarrhoea in humans. Under conditions that are not favourable for growth, C. difficile 
triggers sporulation, producing metabolically dormant endospores through asymmetric cell division. 
These are regarded as the principal infective stage in the C. difficile life cycle, but must germinate to 
allow for vegetative cell growth and toxin production, representing an attractive target for 
intervention. A detailed understanding of sporulation and germination could thus have direct 
applications for disease prevention. While sporulation and germination in the model sporeformer 
Bacillus subtilis is well understood, little is known about these events in C. difficile. Therefore, the 
primary aim of this project was to provide a genome-wide overview of sporulation and germination 
in C. difficile and to identify genes that are essential in these processes using a combination of 
molecular microbiology, microscopy, transcriptomics and next-generation sequencing. 
The first part of this thesis is devoted to the characterisation of C. difficile sporulation and 
germination dynamics, and is followed by a transcriptional analysis of temporal gene expression in 
germinating spores. A functional analysis of the 511 genes identified as differentially regulated 
during germination is provided and the results validated for a number of selected genes. One gene in 
particular, encoding a membrane associated cell wall protein Cwp7, is examined in more detail. In 
the second part of this thesis I describe the construction of the first comprehensive transposon 
mutant library which is then used to identify genes that are essential for sporulation and/or 
germination using Transposon-Directed Insertion Site Sequncing (TraDIS). The results of this study 
are validated by constructing in-frame deletions in four selected genes followed by a thorough 
analysis of the resulting phenotypes. Two genes: CD0125 encoding a homologue of B. subtilis SpoIIQ 
and CD3567 encoding a putative cell wall hydrolase are shown to be involved in spore formation 
while CD0106 encoding a homologues of B. subtilis CwlD is shown to be involved in germination. 
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Chapter I 
Introduction 
1.1. Clostridium difficile as a human pathogen 
Clostridium difficile is a Gram-positive, spore-forming, obligate anaerobe and a leading 
cause of antibiotic-associated diarrhoea in humans. First isolated in 1935 from an infant's stool 
sample and initially named Bacillus difficilis to reflect the difficulties in culturing the organism (Hall 
and O'Toole, 1935), it was not until 1978 that the pathogen was discovered as the agent responsible 
for pseudomembraneus colitis (PMC), the most severe form of C. difficile infection (CDI) (George et 
al., 1978, Bartlett et al., 1978b, Bartlett et al., 1978c). Since then, the organism has continued to 
evolve into an adaptable, aggressive, ‘hypervirulent’ strain placing considerable economic pressure 
on healthcare systems worldwide (Dubberke and Olsen, 2012). 
1.1.1. Epidemiology 
For nearly 30 years, CDI has been a common complication of antibiotic use and, with the 
exception of occasional institutional outbreaks and the problem of relapsing disease following 
treatment, has been relatively easy to manage. However, the last decade has brought an 
unexpected change in C. difficile epidemiology, particularly in some locations, where C. difficile–
associated disease (CDAD) has become more frequent, more serious, and more refractory to 
standard therapy. 
1.1.1.1. The new epidemic 
Alarming increases in CDI rates initially reported in Canada and the United States in 
2002 were shortly followed by reports of similar outbreaks in Europe (Kuijper et al., 2006, Warny et 
al., 2005, Pepin et al., 2004), raising  the possibility of a new strain of C. difficile, with unique 
properties accounting for enhanced virulence. Indeed, the increase in CDI severity and frequency 
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was shortly correlated with the emergence of a previously uncommon but more virulent strain 
known as C. difficile BI/NAP1, or ribotype 027 (McDonald et al., 2005, Warny et al., 2005). This trend 
continued during the following years, culminating in 2007 when more than 55,000 CDI cases were 
reported in England alone, resulting in 8,324 deaths, compared to 1,517 deaths caused by MRSA, a 
major nosocomial pathogen implicated in a number of high-profile outbreaks during that period 
(www.statistics.gov.uk). In response to public health needs, enhanced surveillance of CDI was 
implemented and mandatory reduction targets for CDI were established across the UK to help battle 
the escalating infection (Wilcox et al., 2012). As a result, CDI numbers have been falling steadily since 
2008 with only 1,646 deaths reported in England and Wales in 2012 (www.statistics.gov.uk) (Figure 
1.1). 
  
Figure 1.1. Mortality rates for deaths involving C. difficile registered in England and Wales between 2002 and 2012 
(Office for National Statistics, 22 August 2013; http://www.ons.gov.uk/ons/dcp171778_323989.pdf). 
16 
Chapter I. Introduction 
 
 
1.1.1.2. Hospital-acquired infection 
CDI typically occurs among elderly, hospitalized patients, whose natural intestinal 
microflora has been disrupted by prolonged treatment with broad-spectrum antibiotics, allowing the 
pathogen to colonize the compromised gastro-intestinal tract. While it remains unclear why C. 
difficile is particularly effective at colonising this niche compared to other organisms, it is estimated 
that 20-30% of cases of antibiotic-associated diarrhoea are caused by C. difficile making it the most 
common cause of the disease (McFarland, 2008). Many antibiotics have been linked to CDI, but 
some carry a higher risk than others including clindamycin, cephalosporins and fluoroquinolones 
(Johnson et al., 1999, Pepin et al., 2005). While the use of clindamycin and cephalosporins, to which 
virtually all C. difficile strains are resistant, has been implicated as a CDI risk factor in hospitals for 
several decades (Johnson et al., 1999), the rise in fluoroquinolone-associated risk is more recent, 
and has been attributed to the rising incidence of C. difficile ribotype 027 and other strains that carry 
high-level fluoroquinolone resistance (Pepin et al., 2005). Hospitalisation remains the primary cause 
of CDI however, as it brings together multiple risks factors, including exposure to antibiotics, a spore-
contaminated environment, poor hygiene among health care workers and a highly susceptible 
elderly population of patients, unable to mount an effective immune response upon infection 
(reviewed in Rupnik et al., 2009). 
1.1.1.3. Community-acquired infection 
It is estimated that approx. 1 - 3% of the healthy adult population and 40 – 60% of 
neonates carry C. difficile as a commensal bacterium (Kuipers and Surawicz, 2008, McFarland et al., 
2000). However, community-acquired CDI has always been thought to be rare, leading researchers 
to focus on hospital settings as the primary backdrop for C. difficile-associated disease. Nevertheless, 
while elderly, hospitalized patients receiving antibiotics are still considered the main group at risk of 
infection, recent studies revealed an increase in CDI among populations with no previous contact 
either with the hospital environment or with antibiotics, including children (Kim et al., 2008) and 
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pregnant women (Rouphael et al., 2008). The paradigm of a hospital-acquired infection has been 
further challenged by Eyre et al., (2013) who used whole-genome sequencing to illustrate the 
genetic diversity of C. difficile isolates, suggesting a considerable, community-driven reservoir of the 
pathogen and forcing researcher to consider the role of non-symptomatic carriers in spreading CDI.  
1.1.2. Pathogenesis 
CDI is a toxin-mediated, intestinal disease with clinical outcomes ranging from 
asymptomatic colonisation through mild, self-limiting diarrhoea to more severe disease syndromes, 
including abdominal pain, severe diarrhoea, fever and leukocytosis. Fulminant CDI is characterized 
by inflammatory lesions and the formation of pseudomembranes in the colon (typical for the 
aforementioned PMC) (Figure 1.2) which can progress to toxic megacolon and sepsis syndrome 
causing significant morbidity and mortality (reviewed in Rupnik et al., 2009). 
  
Figure 1.2. Endoscopic visualisation of pseudomembranous colitis. (A) Image of a healthy colon. (B) Image from a CDAD 
patient. Classic pseudomembranes are visible as raised yellow plaques, which range from 2-10 mm in diameter and are 
scattered over the colorectal mucosa. Adapted from Yassin et al. (2009). 
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1.1.2.1. C. difficile toxins 
It is widely accepted that symptoms of CDI are caused by the action of enterotoxins, as 
most can be reproduced in animal models by purified toxins alone. Early studies with Clostridium 
sordellii antitoxin showed neutralisation of the C. difficile toxins in cell rounding assays (Chang et al., 
1978, Willey and Bartlett, 1979) and alleviation of CDI symptoms in hamsters, with a reduction in 
mortality by 75% and reduction in toxicity in faecal filtrates (Allo et al., 1979). Two major toxins have 
been implicated in C. difficile pathogenicity: the enterotoxin TcdA and cytotoxin TcdB. 
TcdA (308 kDa) and TcdB (269 kDa) are among the largest bacterial toxins known to date and 
belong to a group of large clostridial toxins (LCTs) that includes the Clostridium sordellii lethal toxin 
(TcsL) and hemorrhagic toxin (TcsH), Clostridium novyi alpha toxin (Tcnα) and two types of 
Clostridium perfringens toxin (TcpL). Both TcdA and TcdB are single-chain proteins with similar 
activity conferred by three main functional regions: an C-terminal binding domain with characteristic 
repeats, a N-terminal catalytic domain and a putative translocation domain (reviewed in Popoff and 
Bouvet, 2009) (Figure 1.3A). They enter the cell by receptor-mediated endocytosis and require an 
acidified endosome for translocation. While TcdA has been shown to bind cell-surface carbohydrates 
including Gal-α1,3-Gal-β1,4-GlcNAc, the receptor for TcdB has been more elusive. Upon 
translocation, the N-terminal catalytic domains are released into the cytosol where they glycosylate 
small GTPases of the Rho and Ras families, rendering them inactive and leading to disruption of the 
actin cytoskeleton and tight junctions. This results in decreased transepithelial resistance, fluid 
accumulation and eventual destruction of the intestinal epithelium (reviewed in Jank et al., 2007). 
Both TcdA and TcdB are expressed from genes located within a 19.6 kb pathogenicity locus 
(PaLoc) which also contains three other genes important in regulation of toxin activity: tcdR, tcdE 
and tcdC (Figure 1.3A). Due to its homology to DNA-binding proteins, TcdR is predicted to be a 
positive regulator of toxin expression, with its presence enhancing toxin promoter activity in E. coli 
(Moncrief et al., 1997). TcdE is speculated to be a holin-like protein involved in toxin secretion 
(Govind and Dupuy, 2012). The tcdC gene shows high expression during exponential phase, and a 
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decrease in transcription when the rest of the PaLoc is up-regulated, suggesting it to be a negative 
regulator of toxin production (Carter et al., 2011, Hundsberger et al., 1997, Saujet et al., 2011). 
Mutation of tcdC in some ribotype 027 strains was believed to cause constitutive expression of 
toxins, resulting in ‘hypervirulence’ (Curry et al., 2007). However, this view has been recently 
challenged, as no link between tcdC mutations and toxin production was observed following 
restoration of the WT tcdC allele in a ribotype 027 strain (Cartman et al., 2012). 
Not all strains produce both toxins and the exact role of each protein has long been disputed. 
Early experiments indicated that TcdA alone had enterotoxic effects and was able to evoke the 
symptoms of C. difficile infection in hamsters, while toxin B was unable to do so unless mixed with 
sub-lethal concentrations of TcdA (Lyerly et al., 1985). In a later study, a different group 
demonstrated the importance of both toxins by creating isogenic toxin mutants, both of which 
showed cytotoxic activity in vivo and in vitro, as well as a toxin null-mutant which was found to be 
avirulent (Kuehne et al., 2010). In contrast, a study by Lyras et al. (2009) indicated that TcdB is 
essential for C. difficile virulence and that a strain producing TcdA alone was avirulent, consistent 
with experiments on human colonic tissue in which TcdB was shown to be more potent than TcdA in 
causing mucosal necrosis (Riegler et al., 1995). To date, a consensus on the role of each individual 
protein has not been reached. 
In addition to the TcdA and TcdB, some strains also produce the so called binary toxin CTD 
(Stubbs et al., 2000), a homologue of actin-specific ADP-ribosyltransferases found in other clostridial 
species (Figure 1.3B). Binary toxin genes, ctdA and ctdB are located away from PaLoc on the 
chromosome and toxin production is controlled by ctdR (Carter et al., 2007). The exact function of 
binary toxin remains to be elucidated, although some studies have found a positive correlation with 
the severity of diarrhoea (Bacci et al., 2011, Barbut et al., 2005) and at least one study suggests that 
CTD might be involved in modulating the epithelial layer to allow for increased colonisation of the 
gut (Schwan et al., 2009). 
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Figure 1.3. Toxins produced by C. difficile. (A) Toxin A and toxin B (TcdA and TcdB), are single chain proteins, with several 
functional domains and motifs (TcdB shown in detail). The genes are located within the pathogenicity locus (PaLoc), which 
apart from tcdA and tcdB contains three genes involved in regulation of toxin expression and secretion: tcdC, tcdE and 
tcdR. In non-toxigenic strains, this region is replaced by a short 115 bp sequence. (B) A third toxin, the binary toxin or CDT, 
is encoded within a separate region of the chromosome (CdtLoc) and comprises three genes. Two of these encode the 
binary toxin, composed of two unlinked proteins, CdtB and CdtA. CdtB has a binding function and CdtA is the enzymatic 
component. The third gene, encoding CtdR is involved in regulation of toxin expression. (C) Mechanism of toxin action. 
The toxin binds with its C terminus to the cell surface receptor, resulting in endocytosis of the toxin–receptor complex. 
The low pH of endosomes results in a structural change in the toxin, allowing membrane insertion. After translocation of 
the glucosyltransferase and protease domains into the cytosol, the cysteine protease domain is activated. The protease 
domain autocatalytically cleaves the toxin and releases the glucosyltransferase domain into the cytosol, where RHO-family 
proteins are then glucosylated. Adapted from Rupnik et al. (2009). 
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1.1.3. Diagnosis 
Rapid and accurate diagnosis of CDI is critical in successful management of the disease, 
improving patient outcome and ensuring that correct infection control measures are put in place to 
reduce the chances of horizontal transmission in health care facilities. An early indication of CDI is 
diarrhoea with a characteristic, foul-smelling odour (Bartlett and Gerding, 2008). While not sufficient 
for a definitive diagnosis, odour assessment can be a useful tool when determining priority for 
isolation in settings where isolation capacity is limited, particularly when rapid laboratory diagnostics 
are not available. All patients with diarrhoea that are at risk of CDI should be further tested. 
Historically, detection of toxin in stool has been the gold standard in C. difficile diagnostics and a 
number of such methods have been developed over the years, including the cell culture cytotoxicity 
neutralisation assay, first described in 1978, shortly after the association between C. difficile and 
PMC was made (Bartlett et al., 1978a). In this assay the patient’s stool filtrate is inoculated onto a 
monolayer of a particular cell line and tested for toxin-mediated cytopathic effect (CPE). Once CPE is 
observed, the result is validated by neutralisation with an antiserum. While being highly specific, the 
CPE test does have certain limitations as it requires 24-48h to carry out and is both costly and 
labour-intensive (Ticehurst et al., 2006). Furthermore, recent comparisons with toxigenic culture 
tests, in which the pathogen is first cultured form a patients stool sample and then tested for toxin 
production, as well as with PCR-based assays, have shown the CPE test to have unacceptably low 
sensitivity (Stamper et al., 2009), forcing health care professionals to re-evaluate its usefulness as a 
reference method in CDI diagnostics (Crobach et al., 2009). Some of these issues have been solved 
with the introduction of enzyme immunoassays (EIAs) which are now commonly used by most 
laboratories to detect toxin A or both toxins A and toxin B. These are particularly attractive because 
they do not require cell culture and are technically easier to carry out with a turnaround time of 
approx. two hours. Several studies have shown however, that EIAs are less sensitive than tissue 
culture assays, which combined with a poor positive predictive value, particularly in low-prevalence 
populations, makes them suboptimal for diagnosis of CDI (reviewed in Planche et al., 2008). Finally, 
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indirect detection of toxin is also possible using PCR-based assays specific for conserved regions of 
tcdB, or PaLoc itself. In general PCR-based testing is rapidly replacing other methods in clinical 
microbiology laboratories, particularly where the required instrumentation is already in place. 
However, these new technologies are yet to be endorsed by professional society guidelines (Cohen 
et al., 2010, Crobach et al., 2009). 
Alternative diagnostic methods rely on detection of the pathogen by culture, by PCR or by 
testing for conserved antigens such as glutamate dehydrogenase (GDH) (Riley et al., 1995, Ticehurst 
et al., 2006, van den Berg et al., 2006), although all of these suffer from high frequency of false-
positive results as 10 - 30% of hospitalised patients are non-symptomatic carriers. Many laboratories 
have now adopted a two-step approach in which a high negative predictive values test such as the 
GDH assay is performed first, and if negative, no further testing is required. If the GDH test is 
positive, a toxin test follows. Due to its high sensitivity (>90%), this two-step method is currently 
recommended by professional societies in both Europe and America (Cohen et al., 2010, Crobach et 
al., 2009). 
1.1.4. Treatment 
Prior to the emergence of hypevirulent C. difficile strains and the corresponding increase in 
CDI frequency and severity there was little interest in developing new treatments against the 
pathogen. In most patients, CDI responded to antibiotic therapy, severe complicated cases of CDI 
were infrequent and while recurrent disease was common, it was also more easily managed. During 
the past decade, the limitations of current treatment options have become more apparent urging 
researcher to revisit this once-forgotten problem and develop new methods for battling C. difficile. 
1.1.4.1. Standard therapy 
Since their introduction in the early 1980’s, metronidazole and vancomycin have 
remained the first-line treatment for CDI (Silva et al., 1981, Teasley et al., 1983). Metroniodazole is 
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primarily used in mild to moderate cases while vancomycin is reserved for more severe and 
recurrent CDI as the emergence of vancomycin-resistant enterococci has prompted the reduction of 
vancomycin usage. While both antibiotics are effective at killing C. difficile, between 20 and 30% of 
patients suffer from recurring infection (Johnson et al., 1989). Such Individuals typically respond to 
further treatment but their symptoms resume within days to weeks after the treatment has 
stopped. Patients who have one recurrence have up to a 40% chance of a second recurrence, and 
after their seconds recurrence, up to 65% of patients will suffer a third (Huebner and Surawicz, 
2006). Approx. 60% of recurrent infections are classified as relapses caused by the same strain of C. 
difficile, suggesting that antibiotic treatment fails to eradicate the pathogen. The remaining cases 
represent new infections, caused by a different strain of C. difficile (O'Neill et al., 1991). There are no 
effective means to deal with these multiple recurrences, and most are treated with prolonged 
tapering and pulse dosing of vancomycin given every other or every third day in the hope of keeping 
C. difficile from re-growing while the normal flora recovers. Similarly, there is currently no effective 
treatment for severe complicated CDI and if antibiotic therapy fails, surgical removal of the colon 
can be the only remaining life-saving measure (Lamontagne et al., 2007).  
Better agents for treatment of multiple relapsing and fulminant CDI are desperately 
needed, and several approaches are currently under investigation. Alternative antibiotics are being 
developed to deal with the threat of resistance to vancomycin and metronidazole. Possibly the most 
prominent of these is fidaxomicin, a macrocyclic antibiotic with potent in vitro activity against C. 
difficile and limited activity against the normal gut flora (Louie et al., 2011). When compared to oral 
vancomycin, fidaxomicin is equally effective in treating acute CDI, while being associated with 
significantly lower risk of recurrent infection (Mullane et al., 2011). Such promising results led the 
FDA to approve the drug in 2011 as a routine treatment for CDAD. 
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1.1.4.2. Faecal transplant therapy 
Possibly the most interesting method of treatment that is currently under investigation 
is the restoration of normal gut flora through faecal transplant therapy. It is now widely accepted 
that disruption of the indigenous gut flora is a major risk for both primary CDI and recurrent disease. 
Restoration of the gut flora using stool from a healthy donor has thus been long considered as a 
viable therapeutic strategy. While the method has been successfully used in the treatment of PMC 
as early as 1958 (Eiseman et al., 1958), it has not gained public attention until recently, when several 
studies were published showing the therapeutic potential of faecal microbiota in treating fulminant 
and recurring CDI (Chang et al., 2008, Grehan et al., 2010, Khoruts et al., 2010). Although current 
literature on the effectiveness of faecal transplant therapy is limited, in all studies published to date 
approx. 92% of patients that underwent treatment recovered from recurrent CDI (reviewed in 
Gough et al., 2011). The only long-term multicentre follow-up study reported a cure rate of 98% 
(Brandt et al., 2012). 
Despite its effectiveness, availability of faecal transplant therapy is still limited and a number 
of issues need to be addressed before it can be accepted as a standard therapy. The logistics of the 
treatment are relatively complex, particularly with regard to donor selection and screening as there 
is a significant risk of donor infection transmission. The timing of collection and preparation of the 
specimen as well as the route and means of administration are also critical and need to be 
standardised (reviewed in Smits et al., 2013). Finally, the unusual nature of the treatment is met 
with an understandable reluctance among the general public. In order to overcome these problems 
research has begun in defining the bacterial species necessary for recovery, to produce a more 
palatable treatment. In a recent study, six phylogenetically distinct bacterial species were shown to 
be sufficient to regain microbial diversity and clear an established C. difficile infection in mice 
(Lawley et al., 2012). This approach was further validated in humans when a stool substitute 
preparation, containing just 33 species of bacteria isolated from a healthy donor, was used to 
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restore normal bowel patterns in two patients suffering from recurrent CDI (Petrof et al., 2013), 
providing an attractive alternative to standard faecal transplant therapy. 
1.2. The bacterial cell wall 
While toxin-mediated pathogenicity has been extensively studied in C. difficile, and its 
contribution to CDAD has been well characterised, relatively little is known about the early stages of 
infection, critical in the establishment of the pathogen’s niche. Successful colonisation of the human 
gut is largely dependent on the interactions that occur at the host-pathogen interface, typically 
mediated by surface-exposed, cell wall-associated virulence factors, facilitating adhesion, micro-
colony formation and evasion of the host’s immune responses. This is why increasingly more 
attention is now being paid to the C. difficile cell wall and its surface structures, as key factors in CDI 
pathogenesis. 
The cell wall is of central importance in bacterial physiology, providing protection from 
stresses, determining the cell shape and forming an interface for communication with the 
environment. In pathogenic bacteria it can also play a key role during the course of infection, 
facilitating invasion, immune evasion, and acting as a platform for anchoring virulence factors such 
as adhesins and toxins (reviewed in Silhavy et al., 2010). The cell walls of Gram-positive and Gram-
negative bacteria can be clearly distinguished by their thickness and the presence or absence of an 
outer membrane. Yet  the chemical structure of their primary component, the peptidoglycan layer, is 
largely conserved (Vollmer, 2008), consisting of linear chains of alternating N-acetylglucosamine 
(NAG) and N-acetylmuramic acid (NAM) residues, cross-linked by peptides attached to the lactate 
residue of NAM (Liu and Gotschlich, 1967, Wheat and Ghuysen, 1971, Young, 1966). While this 
architecture is preserved in C. difficile, a recent study by Peltier et al. found that 96% of NAG 
residues within the C. difficile peptidoglycan are de-acetylated, accounting for its resistance to 
lysozyme. In addition to peptidoglycan, the Gram-positive cell wall can contain secondary cell wall 
polymers such as peptidoglycan-bound wall teichoic and teichuronic acids (WTA) and membrane-
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bound lipoteichoic acids (LTA) (Coley et al., 1975, Hancock and Baddiley, 1976, Lambert et al., 1977). 
These can make up between 10 – 60% of the cell wall structure and play an important role in 
maintaining cell wall integrity, attaching the peptidoglycan layer to the membrane and anchoring 
additional structures that provide important functional properties to the surface of the cell 
(reviewed in Schaffer and Messner, 2005, Weidenmaier and Peschel, 2008). 
 
1.2.1. The C. difficile S-layer 
The most prominent cell wall-associated surface structures in prokaryotes are surface 
layers (S-layers), formed by one or more glycoproteins, that self-assemble into a two-dimensional 
crystalline array covering the entire surface of the cell (Sleytr and Messner, 1983). These are 
ubiquitous among both Gram-positive and Gram-negative bacteria (Sleytr and Beveridge, 1999) as 
well as Archaea (Albers and Meyer, 2011), and have been extensively studied in numerous species 
since their initial discovery in the 1950’s. S-layer proteins are believed to be anchored to the cell 
surface through non-covalent interactions with cell surface structures, most commonly with LPS in 
Gram-negative bacteria and with cell wall polysaccharides in Gram-positive bacteria. To date, two 
conserved Gram-positive S-layer anchoring modules have been identified, utilizing either the S-layer 
homology (SLH) domain, typically found in Bacillus species, or the cell wall-binding (CWB2) domain, 
more common among Clostridia (Mesnage et al., 2000, Fagan et al., 2011). S-layer biogenesis 
consumes considerable metabolic resources and therefore must confer a significant advantage to 
the cell. It is thus not surprising that, as a major structure of the cell, a variety of functions have been 
proposed for the S-layer, acting as a scaffold for enzyme display, forming a permeability barrier, and 
playing important roles in host-pathogen interactions (Fagan and Fairweather, 2014).  
To date, the best studied examples of S-layers in Gram-positive bacteria are those found in 
Bacillus anthracis and C. difficile. In the latter, the S-layer is composed primarily of the major cell wall 
protein, SlpA (Calabi et al., 2001). Following SecA2-mediated export (Fagan and Fairweather, 2011) 
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SlpA undergoes post-translational cleavage by a specific, surface layer-associated cysteine protease 
Cwp84 (Kirby et al., 2009), forming two proteins: the high and low molecular weight S-layer proteins 
(HMW SLP and LMW SLP). Together these form a non-covalent, heterodimeric complex that 
assembles into a two-dimensional array completely surrounding the bacterial cell (Fagan et al., 
2009), most likely in a Ca2+-dependent manner (Takumi et al., 1992) (Figure 1.4A). Both proteins are 
highly variable across different strains of C. difficile, show little cross-reactivity and often produce 
different band patterns when separated via SDS-PAGE (Calabi and Fairweather, 2002, McCoubrey 
and Poxton, 2001). In addition to HMW SLP and LMW SLP, C. difficile encodes an 'arsenal' of minor 
SLP homologues forming a family of cell wall proteins (CWPs), scattered throughout the C. difficile S-
layer. Each member of this family contains a conserved CWB2 motif (Pfam 04122) and many contain 
additional domains that may specify a functional property (Figure 1.4B) (Emerson and Fairweather, 
2009). As is the case with the major SLPs, many CWPs show significant sequence diversity (Reynolds 
et al., 2011). Transcriptomic and proteomic studies have shown several of these proteins to be 
expressed in vitro (Emerson et al., 2008, Wright et al., 2005) while CWP-specific antibodies found in 
the serum of CDAD patients suggest that at least some of the CWPs are also expressed in vivo during 
infection being recognised by the host’s immune system (Wright et al., 2008). A number of CWPs 
have now been characterised. The cysteine protease Cwp84 has been shown to be involved in SlpA 
processing while its paralog Cwp13 appears to have a role in Cwp84 processing, although it is not 
essential for its activity  (de la Riva et al., 2011, Janoir et al., 2007, Kirby et al., 2009). Cwp66 has 
been shown to be expressed on the cell surface, and has been implicated in adhesion to the 
epithelial lining of the gut as antibodies raised against recombinant Cwp66 were shown to inhibit 
adhesion of C. difficile to a mammalian cell line (Waligora et al., 2001). This was further confirmed in 
the mouse model of CDI using a Cwp66 knock-out strain (Dr Zoë Seager, unpublished results). The 
largest member of the CWP family, CwpV, was shown to be surface expressed in a phase-variable 
manner (Emerson et al., 2009), and to be post-translational cleaved via enzyme-independent 
intramolecular autoproteolysis into two fragments, forming a stable, non-covalently associated 
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complex (Dembek et al., 2011, Reynolds et al., 2011). The protein has been implicated in cell 
aggregation as its overexpression results in severe cell clumping (Emerson et al., 2009). Finally, the 
highly conserved, immunodominant protein Cwp2 has attracted a lot of attention from 
vaccinologists and has been recently implicated in flagellar motility (Dr Aaron Dale, unpublished 
results).  
Figure 1.4. The C. difficile cell wall and S-layer. (A) Schematic cross section through the C. difficile cell wall and the S-layer 
structure. The major S-layer proteins HMW SLP and LMW SLP form heterodimeric complexes (white-blue) that self-
assemble into a hexagonal crystalline array on the surface of the cell wall peptidoglycan (purple). Minor cell wall proteins 
scattered throughout the S-layer are indicated as hexagons of varying colours.  (B) C. difficile CWP family. Each protein 
contains 3 putative cell wall binding motifs (blue: Pfam 04122) and many contain a unique domain that specifies the 
proteins function. Adapted from Fagan and Fairweather (2014). 
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1.3. Role of endospores in C. difficile infection 
Many bacterial species, including important human pathogens belonging to the Bacillus 
and Clostridium genera, have evolved to form specialised, differentiated cells known as endospores 
(henceforth referred to as spores for simplicity) as a means of surviving in unfavourable conditions, 
non-conducive for vegetative growth. Due to their robust characteristics, spores are resistant to 
extreme chemical and physical insult and provide the mechanism by which sporeformers can evade 
the potentially fatal consequences of exposure to heat, oxygen, alcohol, and certain disinfectants 
(reviewed in Setlow, 2006, Setlow, 2007). This makes spores extremely difficult to eradicate, 
allowing them to persist in the environment for extended periods of time. As a consequence, spores 
produced by pathogenic bacteria are now widely recognised as the primary infectious agent in 
diseases such as anthrax, tetanus, botulism and CDAD (Deakin et al., 2012, Wells and Wilkins, 1996, 
LaForce et al., 1969). 
The importance of spores in CDI has been highlighted in a number of recent studies. C. 
difficile spores can be frequently found in hospital settings, mostly in rooms of patients suffering 
from CDI (Dubberke et al., 2007), leading to infection or re-infection of individuals through 
inadvertent ingestion of contaminated material (Gerding et al., 2008, Riggs et al., 2007). Once in the 
anaerobic environment of the gut, spores germinate to form toxin-producing vegetative cells and, in 
susceptible individuals, diarrhoeal disease. C. difficile spores have been shown to be highly infectious 
in animal models with as few as seven spores per cm2 cage floor area deemed sufficient to establish 
a persistent infection among exposed, antibiotic-treated mice (Lawley et al., 2009b). Interestingly, 
non-infectious mice asymptomatically colonised with C. difficile treated with antibiotics enter a 
highly contagious ‘supershedder’ state whereby large numbers of spores are shed in faeces, 
infecting non-colonised, cohabiting mice (Lawley et al., 2009a). Furthermore, disruption of spo0A, 
the master response regulator initially identified in Bacillus subtilis as essential in sporulation 
(Olmedo et al., 1990), results in mutants that are not only defective in sporulation (Underwood et 
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al., 2009), but also unable to persist in mice and transmit between animals, suggesting an essential 
role of sporulation in infection, transmission and recurrence of C. difficile (Deakin et al., 2012).  
1.3.1. Mechanism of sporulation 
The process of sporulation has been the subject of continuous microbiological investigation 
since the seminal 19th century reports of Robert Koch (Koch, 1876) and Ferdinand Cohn (Cohn, 
1877). Its basic principle is based on an ancient bacterial cell differentiation programme of 
temporally and spatially-controlled gene expression that is largely conserved among Baciliales and 
Clostridiales (Figure 1.5) (reviewed in Paredes et al., 2005). The most widely studied spore-forming 
organism is B. subtilis, and the molecular mechanisms that underpin its sporulation have been 
extensively studied, becoming a useful paradigm for spore research carried out in other systems 
(reviewed in Sonenshein, 2000). 
  
Figure 1.5. Schematic representation of B. subtilis life cycle. When stressed, B. subtilis exits vegetative growth and triggers 
asymmetric cell division. Two compartments are formed, the smaller forespore and the larger mother cell compartment which 
eventually engulfs the former so that a ‘cell-within-a-cell’ structure is formed. Gene expression is spatially and temporarily 
controlled by a cascade of sporulation specific RNA polymerase sigma factors: σF and σG in the forespore and σE and σK in the 
mother cell compartment. Following maturation, the endospore is released into the environment where it can persist for 
extended periods of time without loss of viability. Under conditions favourable for growth, the spore initiates germination, 
followed by outgrowth of a fully developed vegetative cell. Adapted from Errington (2003). 
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1.3.1.1. Entry into sporulation 
Initiation of sporulation is governed by phosphorylation of Spo0A, a transcriptional 
factor that plays a central role in phenotypic differentiation and adaptation to changing 
environmental conditions. The spo0A gene itself is expressed from two different promoters: Pv 
which is active throughout vegetative growth and Ps, a sporulation-specific promoter activated by 
the RNA polymerase sigma factor σH, the product of spo0H (Siranosian and Grossman, 1994). Both 
the level of Spo0A phosphorylation and its abundance can affect the physiological outcome of its 
activation, which can result in biofilm formation and cannibalism when Spo0A is phosphorylated at 
low levels (Gonzalez-Pastor et al., 2003, Hamon and Lazazzera, 2001) or spore formation when 
Spo0A is phosphorylated at higher levels (Fujita and Losick, 2005). 
Spo0A phosphorylation in B. subtilis is facilitated by a complex phosphorelay (Burbulys et al., 
1991) comprised of several sensor kinases (KinA-E) that respond to external signals by 
autophosphorylating and subsequently transferring phosphate either directly to Spo0A or via 
intermediary proteins Spo0F and Spo0B (Jiang et al., 2000). Kinase activity is antagonised by a 
number of regulatory factors that add an additional level of regulation, protecting the cell from 
premature sporulation. These include KipI (Wang et al., 1997) and Sda (Burkholder et al., 2001), both 
of which bind KinA, the major kinase involved in initiation of sporulation, preventing its 
autophosphorylation, as well as a family of protein-aspartate phosphatases (RapA, RapB, RapE and 
RapH) that dephosphorylate Spo0F thus reducing the level of Spo0A~P (Figure 1.6) (Perego et al., 
1994).  
A number of environmental and cell cycle-related signals have been shown to induce 
sporulation, either by acting upon elements of the phosphorelay or by independent signal 
transduction pathways. One such stimulus is nutrient limitation (Schaeffer et al., 1965) and the 
corresponding drop in intracellular GTP concentration, the primary indicator of nutrient availability. 
It has been suggested that a number of GTP-binding proteins such as CodY, a global repressor of 
stationary phase genes, loose their ability to repress target genes as the intracellular GTP levels 
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drop, thus allowing for initiation of sporulation (Handke et al., 2008, Ratnayake-Lecamwasam et al., 
2001). Culture density has also been shown to affect spore formation via a mechanism involving 
phrA, phrC and phrE. Proteins encoded by these genes are exported out of the cell and cleaved into 
pentapeptides that accumulate in the culture supernatant during growth, inhibiting the activity of 
their respective Rap phosphatases and allowing for initiation of sporulation when the culture density 
reaches a certain threshold (Pottathil and Lazazzera, 2003). Finally, the state of chromosomal DNA is 
an important factor in committing to sporulation and a number of proteins that monitor DNA 
replication and chromosome integrity are known to prevent spore formation under conditions that 
could compromise DNA replication. These include DisA, a cyclic diadenosine monophosphate (c-di-
AMP) synthase that couples chromosome integrity with progression of sporulation (Bejerano-Sagie 
et al., 2006) and the previously mentioned Sda protein which inhibits sporulation while the cell 
contains actively replicating chromosomes (Burkholder et al., 2001). A corresponding mechanism 
regulating chromosome replication during sporulation involves the sporulation-specific SirA protein 
that prevents new rounds of replication during sporulation (Figure 1.6) (Rahn-Lee et al., 2009, 
Wagner et al., 2009). 
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Figure 1.6. Entry into sporulation in B. subtilis. Phosphorylation of Spo0A is controlled by a phosphorelay comprised of 
several kinases and a number of intermediaries. Interactions that work against Spo0A phosphorylation are presented in 
red while those that stimulate Spo0A phosphorylation are presented in green. The phosphorelay is initiated when KinA 
and KinB respond to external signals by autophosphorylating and subsequently transferring phosphate to Spo0F. Spo0F 
phosphorylates Spo0B, which passes phosphate onto Spo0A. A third kinase, KinC, bypasses the phosphorelay and acts 
directly on Spo0A. A number of phosphatases and kinase inhibitors act at various steps in the pathway to directly 
antagonize Spo0A phosphorylation. These inhibitors are subject to their own regulation. KinD has been shown to inhibit 
Spo0A phosphorylation, although the exact mechanism has not been described. Adapted from Higgins and Dworkin 
(2012). 
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1.3.1.2. Asymmetric cell division 
Once phosphorylated, Spo0A acts to repress abrB, a negative regulator of stationary 
phase genes, some of which are required for sporulation (Perego et al., 1988), and activates 
transcription from the spoIIA, spoIIE and spoIIG loci which encode key developmental regulators. 
This triggers asymmetric cell division leading to the formation of two cell compartments, the smaller 
forespore and the larger mother cell compartment. During this process the nucleoid is remodelled 
into a filament of chromatin that spans the length of the cell, attached to the cell pole through the 
action of RecA (Ben-Yehuda et al., 2003), while elements of the cell cytoskeleton, including the 
essential tubulin homologues FtsZ are re-localized to sites near the cell pole via a σH mediated 
mechanism. As the cell septum expands, only the origin-proximal one-third of a chromosome is 
present in the forespore. The remainder is then transported through the septum by the DNA 
translocase SpoIIIE (Wu and Errington, 1994). Soon after the division, distinct programmes of gene 
expression are initiated, driven by cell compartment-specific action of a series of RNA polymerase 
sigma subunits, σF in the forespore and σE in the mother cell, replaced by σG and σK respectively 
during the later stages of sporulation. However, events that follow do not occur in isolation as inter-
cellular communication between the forespore and the mother cell is maintained throughout 
sporulation. Activation of σF in the forespore is necessary for the expression of SpoIIR, a secreted 
protein that crosses into the space between the septal membranes and mediates processing of the 
σE precursor into its active form. Later on, σE is required for σG activation in the forespore, which, in 
turn, leads to σK activation in the mother cell (reviewed in Hilbert and Piggot, 2004). In order to 
explain this cross-talk, the ‘feeding tube’ model has been proposed in which the signalling between 
the mother cell and the forespore is facilitated by a channel linking the two compartments (Meisner 
et al., 2008). This channel is formed primarily by two proteins: SpoIIQ and SpoIIIAH. The former 
localizes to the septum in the forespore membrane (Rubio and Pogliano, 2004, Rodrigues et al., 
2013, Fredlund et al., 2013) where it interacts with the mother cell proteins encoded by the spoIIIA 
locus, several of which show homology to type III and type IV secretion systems (Camp and Losick, 
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2008). One of these, SpoIIIAH, directly interacts with SpoIIQ (Doan et al., 2005, Blaylock et al., 2004) 
forming a channel that spans the inter-membrane space ensuring communication between the two 
compartments of the sporulating cell (Meisner et al., 2008, Doan et al., 2009, Camp and Losick, 
2009). 
1.3.1.3. Engulfment 
Following asymmetric cell division and DNA translocation, the membrane of the mother 
cell continues to develop, eventually engulfing the forespore so that a 'cell-within-a-cell' structure is 
formed. Once initiated, the process is irreversible, committing the cell to sporulation even if nutrient 
levels are restored (Dworkin and Losick, 2005). Three partially redundant mechanisms of engulfment 
have been proposed. The first involves the so-called ‘DPM machine’, an enzyme complex owing its 
name to three peptidoglycan hydrolases located within the outer forespore membrane: SpoIID, 
SpoIIP and SpoIIM (Chastanet and Losick, 2007). These act at the junction of the septum and the cell 
wall, hydrolysing peptidoglycan located between the two membranes and moving the mother cell 
membrane around the forespore. The DPM machine is tracked by sites of active peptidoglycan 
synthesis, which form the second mechanisms, providing the motive force for membrane movement 
until the mother cell membrane fuses at the cell pole releasing the forespore into the cytosol (Meyer 
et al., 2010). The third and final mechanism that facilitates membrane movement during engulfment 
involves the previously mentioned SpoIIQ and SpoIIIAH. These track the mother cell membrane as it 
moves around the forespore, irreversibly driving engulfment via a ratchet-like mechanisms (Broder 
and Pogliano, 2006). While being partially redundant, it remains unclear whether the three 
mechanisms overlap spatially and temporally or participate in distinct stages of engulfment (Figure 
1.7). 
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Figure 1.7. Mechanism of engulfment. Three partially redundant molecular mechanisms are responsible for the membrane 
movement that occurs during engulfment. Firstly, the ‘DMP’ machine (orange) is responsible for membrane migration by 
hydrolyzing the peptidoglycan between the inner and outer membranes, thereby moving the outer membrane around the 
forespore. Secondly, the SpoIIQ-SpoIIIAH zipper (blue) acts as a ratchet to irreversibly drive engulfment. Finally, 
peptidoglycan synthesis (purple) of the germ cell wall provides a motive force for membrane movement during early 
engulfment as well as the final step of forespore detachment. Adapted from Sogaard-Andersen (2013). 
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1.3.1.4. Spore morphogenesis 
On completion of forespore engulfment, σF and σE activity falls, while two new subunits 
become active, σG in the forespore and σK in the mother cell compartment. This 
compartmentalisation of gene expression is coupled to spore morphogenesis as the sequential 
activation of these four sporulation-specific sigma factors governs assembly of the three principal 
layers that comprise the spore: the core compartment which contains the chromosome, and two 
protective layers of different properties: the cortex peptidoglycan and the proteinaceous coat 
(Figure 1.8). 
 
  
Figure 1.8. Spore ultrastructure. The innermost layer, the core, contains genomic DNA, RNA, densely packed ribosomes 
and enzymes critical in re-establishment of cell metabolism following a phase of dormancy. The low water content of 
the core, its high levels of Ca2+-DPA and the saturation of DNA with SASPs contribute to the resistance properties of the 
spore, particularly against high temperatures and UV irradiation. Surrounding the core is a significantly compressed 
inner membrane, in which the lipids are largely immobile. This membrane has low permeability to small molecules, 
which is likely to protect the spore core from DNA damaging chemicals. Surrounding the inner membrane is the 
primordial cell wall, and the cortex composed of modified peptidoglycan containing muramic-δ-lactam (MAL). The MAL 
residues appear to be the recognition element for spore cortex-lytic enzymes (SCLEs), which hydrolyze the cortex but 
not the cell wall during spore germination. The cortex is surrounded by the outer membrane, which in turn is 
surrounded by the proteinaceous coat, composed of approx. 80 spore-specific proteins, protecting the spore from 
reactive chemicals and lytic enzymes. Four major layers of the coat can be distinguished: The amorphic basal layer, the 
lamellar inner coat, the electron-dense outer coat and the crust. In some species, the coat is the outermost layer of the 
spore. In others, including C. difficile, an additional glycoprotein layer called the exosporium is loosely attached to the 
coat. Adapted from McKenney et al. (2013). 
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1.3.1.4.1. Spore core 
Following engulfment, the forespore protoplast undergoes a number of 
modifications in order to protect the genetic material stored within. This leads to the formation of 
the core, the innermost layer of the spore containing genomic DNA, ribosomes, tRNA and most of 
the spore enzymes, the minimal set of components required to re-establish metabolism following a 
phase of dormancy. During this process the water content of the forespore drops to 25-50% of dry 
weight as most of the water is replaced with pyridine-2,6-dicarboxylic acid [dipicolinic acid (DPA)] 
(Murrell, 1967). DPA is produced in the mother cell and then transported into the forespore 
compartment where it forms a 1:1 chelate with divalent cations, predominantly Ca2+ (Daniel and 
Errington, 1993). The high content of Ca2+-DPA within the spore (20% dry weight) contributes to DNA 
resistance to dry and wet heat, desiccation and hydrogen peroxide (reviewed in Setlow, 2006). The 
core components that gives DNA the most protection however are α/β-type small acid-soluble 
proteins (SASP), expressed in the forespore compartment from monocistronic genes in a σG-
dependent manner. SASPs make up 5-10% of total core protein and saturate the bacterial 
chromosome, changing its topology (Nicholson et al., 1990) and protecting it from DNA-damaging 
agents such as wet and dry heat, UV radiation, desiccation and genotoxic chemicals including nitrous 
acid, hydrogen peroxide and formaldehyde (reviewed in Setlow, 2007). Finally, surrounding the core 
is a significantly compressed inner membrane, in which the lipids are largely immobile (Cowan et al., 
2004). This membrane has low permeability to small molecules, which is likely to protect the spore 
core from DNA damaging chemicals (Setlow, 2006). 
1.3.1.4.2. Spore cortex 
Following the completion of engulfment, the forespore protoplast is surrounded by 
two membranes of opposite polarity: the inner and outer membrane. Two types of peptidoglycans 
are then layered between the two membranes. The surface of the inner spore membrane is the site 
of assembly of a thin layer of peptidoglycan called the primordial germ cell wall, similar in 
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composition to the vegetative cell wall that serves as the initial wall of the newly formed vegetative 
cell following spore germination (Tipper and Linnett, 1976). The outer forespore membrane is the 
site of assembly of a second, thicker, and chemically distinct layer of peptidoglycan called the spore 
cortex, which is essential for the maintenance of protoplast dehydration and spore mineralization, 
both key factors in spore resistance to wet and dry heat (Lewis et al., 1960), and the corresponding 
metabolic dormancy. In contrast to vegetative cell peptidoglycan, where each NAM residue carries a 
peptide side chain, approximately half of the NAM residues in the cortex peptidoglycan carry no side 
chains and instead are cyclized to form muramic-δ-lactam (MAL) (Warth and Strominger, 1969, 
Warth and Strominger, 1972) (Figure 1.9). These lactam residues are distributed regularly, 
alternating with NAM residues within the glycan strands, and are thought to act as the recognition 
element for cortex-lytic enzymes (CLEs), which hydrolyze the cortex but not the cell wall during 
spore germination (Makino and Moriyama, 2002). In B. subtilis, formation of MAL residues in 
catalysed by an N-acetylmnoramoyl-L-alanine amidase encoded by cwlD and its disruption results in 
spores with a severe germination defect (Popham et al., 1996, Sekiguchi et al., 1995). In addition to 
MAL formation, 25% of NAM residues only carry a single L-alanine. The peptides on the remaining 
NAM residues are cross-linked at a frequency of 13–19% (Popham et al., 1996, Warth and 
Strominger, 1969, Warth and Strominger, 1972). The outer membrane of the spore surrounds the 
cortex, and although this membrane might not act as a permeability barrier in the dormant spore, it 
is essential for spore formation. 
  
Figure 1.9. Structure of B. subtilis cortex spore peptidoglycan. Approx. 50% of N-acetylmuramic acid (NAM) residues are 
cyclized to form muramic-δ-lactam (MAL). The glycan chains are cross-linked via the peptide side chains on N-
acetylglucosamine (NAG) residues. Adapted from Popham et al. (1996). 
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1.3.1.4.3. Spore coat 
The cortex peptidoglycan is surrounded by a proteinaceous coat comprising of an 
amorphic basal layer, a lamellar inner coat and an electron-dense, striated outer coat (reviewed in 
McKenney et al., 2013). Recently, a fourth layer called the crust has been identified in Bacillus 
subtilis (McKenney et al., 2010). The spore coat consists of approx. 80 proteins synthesized in the 
mother cell compartment and then targeted to the outer surface of the forespore. The protein 
composition of the spore coat differs significantly between species. Analysis of existing genome 
sequences suggest that only half of the known B. subtilis coat proteins have recognizable 
orthologues in other Bacillus species. In Clostridium species, conservation is even more limited 
(Henriques and Moran, 2007, Permpoonpattana et al., 2011). Considering that the spore surface 
represents the interface between spores and the environment, diversity in coat composition may 
have a crucial role in defining the ecological niches of spore-forming bacteria. 
The primary function of the spore coat is to protect the bacterial genome from 
environmental stresses, both passively, by forming a barrier that blocks access to the spore core, and 
actively, through the action of enzymes contained within the coat layers. It provides protection from 
oxidizing agents, detoxifying them before they reach sensitive targets in the spore inner layers. One 
of the coat components involved in this is CotA, a copper-dependent laccase involved in protection 
against hydrogen peroxide (Riesenman and Nicholson, 2000). Interestingly, CotA is also thought to 
enhance the spores’ resistance to UV radiation by generating a pigment structurally similar to 
melanin (Hullo et al., 2001, Riesenman and Nicholson, 2000). The spores resistance to lysozyme and 
other peptidoglycan-hydrolysing enzymes is thought to be mediated by CotE, conferring protection 
form predation by a variety of bacteriovores including as the protozoan Tetrahymena thermophila 
and the nematode Caenorhabditis elegans (Klobutcher et al., 2006, Laaberki and Dworkin, 2008). 
While the exact molecular mechanism of this protection is unknown it has been proposed that the 
coat may have an important role in limiting access of peptidoglycan hydrolases to the peptidoglycan-
containing cortex. Finally, the coat also plays an important role in modulating spore responses to 
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germinants such as sugars, amino acids, peptidoglycan fragments and ions. While this effect is 
primarily passive, acting as a molecular sieve that allows small molecule germinants to reach their 
respective receptors and preventing larger molecules such as lysozyme from entry, active 
mechanism involving enzymes immobilized within the spore coat have also been proposed. These 
include alanine racemase which has been shown to be important in preventing premature 
germination in B. anthracis (Chesnokova et al., 2009) and peptidoglycan hydrolases CwlJ and SleL, 
both essential in cortex degradation during germination (Chirakkal et al., 2002).  
Coat assembly is a highly dynamic process, precisely coordinated with spore development, 
and is governed by a set of key morphogenetic proteins: SafA, CotE and SpoIVA. Each of these 
interacts with a subset of coat polypeptides forming three independent modules: the SafA-
dependent protein sub-network involved in inner coat assembly, the CotE-dependent protein sub-
network involved in outer coat assembly and a third module consisting of proteins that are 
independent of both SafA and CotE, and interact with SpoIVA, the primary component of the coat 
basal layer. A fourth module, controlled by CotX, CotY and CotZ has been recently identified and 
implicated in crust assembly (McKenney et al., 2010). During the first phase of coat morphogenesis, 
SafA, CotE, SpoIVA and CotX/Y/X are involved in targeting spore coat proteins to their respective 
layers in a σE-dependent manner, forming the so-called scaffold cap on the mother cell proximal pole 
of the newly formed forespore. The cap is then extended through successive waves of a σE and a σK-
dependent gene expression in the encasement phase of coat assembly to form a full spherical shell. 
During the process of assembly, coat proteins undergo extensive modifications including, 
proteolysis, cross-linking and glycosylation all of which play an important role in forming the 
functional characteristics of the coat (reviewed in McKenney et al., 2013).  
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1.3.1.4.4. The exosporium 
In B. subtilis, the coat is the outermost layer of the spore. In others, including C. 
difficile, an additional glycoprotein layer called the exosporium is loosely attached to the coat. The 
structure and composition of the exosporium is highly diverse and can vary significantly between 
species and even strains within a species. It is also highly dynamic, being smooth in the dormant 
state but developing numerous filamentous projections that attach to the host tissue during 
germination (Panessa-Warren et al., 2007). The exosporium may confer resistance to chemical and 
enzymatic treatments, and provides a hydrophobic surface that enhances the spore’s adhesive 
properties. It also contains several enzymes with roles in spore germination, at least some of which 
localize to specific regions of the structure. The exosporium is also the first point of contact of the 
spore with cells of the immune system and as such forms an important interface in host-pathogen 
interactions. To date, the best studied exosporium is that of B. anthracis, consisting of a 
paracrystalline basal layer covered by a hair-like nap. The filaments of the hair-like nap appear to be 
formed mainly by a single collagen-like protein called BclA. This immunodominant protein has been 
show to affect spore germination, interaction with extracellular matrix proteins and host immune 
responses and thus plays an important role in B. anthracis pathogenesis. Three homologues of BclA 
have been identified in C. difficile 630 genome, designated BclA1, BclA2 and BclA3 and are likely 
candidates for the main components of the C. difficile exosporium (Henriques and Moran, 2007). 
1.3.2. Germination and outgrowth 
Spore germination is defined as the irreversible loss of spore-specific properties allowing 
the bacterium to resume vegetative growth following a phase of dormancy. In Bacillus, it is typically 
initiated by one or more members of the GerA family of germination receptors (GRs) encoded by the 
homologous tricistronic gerA, gerB and gerK operons, expressed in the forespore late in sporulation. 
All GRs are most likely membrane proteins, and at least some of them (GerAA, GerAC, GerA) are 
localized in the spore’s inner membrane (Hudson et al., 2001). They are synthesized in relatively 
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small amounts with only tens of molecules per spore for individual GRs (Paidhungat and Setlow, 
2001). According to the simplest model, each GR is composed of three proteins encoded by its 
cognate operon homolog. However, the topology of these proteins in the membrane, the 
stoichiometry of proteins in the receptor, and the possible physical interaction between different 
germinant receptors and with additional proteins is not clear (reviewed in Setlow, 2003). 
 All GRs monitor the spore’s environment for specific signals (germinants) indicating 
favourable growth conditions. A wide range of germinants have been identified and include 
nutrients (amino acids, carbohydrates, purine nucleosides) as well as other, non-nutrient chemical 
and physical agents: lysozyme, salts, high pressure, cationic surfactants, peptidoglycan fragments 
and Ca2+-DPA, although the latter are most likely non-physiological. While mutant B. subtilis spores 
lacking all germinant receptors do not germinate with nutrients (Paidhungat and Setlow, 2000) they 
do exhibit a slow constant rate of spontaneous germination, the mechanism of which is not 
understood. These ‘receptorless’ spores do, however, germinate normally with non-nutrient 
germinants (Paidhungat and Setlow, 2000, Setlow et al., 2003). 
 Upon binding of germinants, GRs initiate a series of irreversible biophysical events that 
cannot be stopped even after the removal of stimulus, although the mechanism of commitment 
remains unknown. Firstly, monovalent cations (H+, Na+ and K+) and Zn2+ are released from the spore 
core, elevating its pH from approx. 6.5 to 7.7. This is essential for spore metabolism as it ensures 
optimal conditions for enzyme activity in later stages of germination. Secondly, a large depot of DPA 
is released together with its associated divalent cations, predominantly Ca2+. Both steps are 
facilitated by one or more ion/DPA channels within the spore inner membrane (Paidhungat et al., 
2001). Simultaneously, DPA is replaced by water resulting in an increase in core hydration and 
lowering the spore’s resistance to wet heat. This is followed by hydrolysis of cortex PG by 
germination-specific SCLEs. In B. subtilis two enzymes, CwlJ and SleB, play redundant roles in the 
degradation of the spore’s peptidoglycan cortex during germination (Chirakkal et al., 2002) and both 
require MAL residues for PG cleavage. Degradation of the PG cortex is essential for completion of 
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spore germination as it removes a physical constraint to spore core expansion, and allows further 
water uptake into the core to the levels found in vegetative cells. Full core hydration then enables 
protein mobility, enzyme activity and initiation of spore outgrowth (reviewed in Setlow, 2003). 
Once the constraints of spore outer layers are lifted, the cell enters a period of longitudinal 
growth, accompanied by re-establishment of cell metabolism during which DNA, RNA and protein 
synthesis resume. This period is termed outgrowth and is often not distinguished in literature from 
the more general term: germination. Although the two processes normally form a continuum, 
outgrowth is distinguished by its sensitivity to inhibitors of macromolecular synthesis and strictly 
depends on the completion of germination. 
 Most of the pioneering work on cell metabolism during sporulation, germination and 
outgrowth was done in Bacillus spp. in a series of biochemical studies conducted by Arthur Kornberg 
and colleagues and published over a period of four years in the late 60's and early 70's. This 
combined effort comprising twenty-three research papers covers everything from nucleic acid and 
protein synthesis to energy metabolism and patterns of enzymatic activity, summarising the state of 
knowledge on the subject at that time. While it is beyond the scope of this thesis to report on each 
of those finding, the most important aspects of cell metabolism during outgrowth are listed below. 
Macromolecular synthesis, essential for the re-establishment of biochemical pathways, nutrient 
uptake, and replication, can only be initiated upon the production of ATP. In the first stage of 
outgrowth, ATP is generated through conversion of 3-phosphoglyceric acid stored in the spore core. 
Only later does the outgrowing spore switch to the use of extracellular nutrients. The enzymes 
required for energy metabolism are previously formed and found present in the dormant spore 
(Setlow and Kornberg, 1970b, Singh and Setlow, 1979). Phosphate metabolism is highly active in 
germination. Inorganic phosphate (Pi) is generated from both endogenous and exogenous sources 
and is incorporated into RNA, glucose-6P, fructose diphosphate, ATP and L-α-glycerophosphate 
(Nelson and Kornberg, 1970). The level of fatty acids and phospholipids increases during germination 
and outgrowth, most likely reflecting the necessity of rebuilding the membrane during cell 
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expansion. The newly produced fatty acids are predominantly branch-chained pentadecanoates and 
their distribution, by the time vegetative cell development is complete, resembles that observed in 
an exponentially growing culture (Scandella and Kornberg, 1969). RNA synthesis is underway early 
on in germination. During the first 10 min it can proceed in the absence of exogenous nutrients at 
the expense of previously existing RNA. Salvage pathways for bases, nucleosides, and nucleotides 
are operative during this period and utilize enzymes which are previously formed in the dormant 
spore (Setlow and Kornberg, 1970a). Biosynthesis of purines and pyrimidines de novo begins 
approximately 15 to 20 min after the onset of germination. The increase in nucleotide pools sustains 
an increase in the rate of RNA synthesis (Setlow and Kornberg, 1970a). Chromosomal replication is 
initiated after approximately 30 min (Garrick-Silversmith and Torriani, 1973). Protein synthesis in the 
outgrowing spore is dependent on de novo transcription and is initiated in the first minutes of 
germination (Setlow, 1975, Setlow and Primus, 1975). Distinct patterns of protein production have 
been revealed, suggesting the existence of an ordered process (Hirano et al., 1991, Huang et al., 
2004). Amino acids generated by proteolysis are sufficient for synthesis of proteins required early on 
in germination, however exogenous carbon and energy sources must be supplied (Setlow and 
Kornberg, 1970a). 
1.3.3. Comparison of sporulation and germination in Clostridiales 
and Baciliales 
Sporulation is an ancient bacterial cell differentiation programme that has emerged some 
2.5 billion years ago at the base of the Firmicutes phylum and is largely conserved among 
Clostridiales and Baciliales, particularly with regard to the key regulatory components: Spo0A and 
the sporulation-specific sigma factors (reviewed in Paredes et al., 2005). However, recent studies 
have highlighted several notable differences in the sporulation programmes of Bacillus and 
Clostridium species. While both Spo0A and σH are present and required for sporulation in C. difficile 
and other Clostridia (Saujet et al., 2011, Underwood et al., 2009), the complex phosphorelay that 
46 
Chapter I. Introduction 
 
 
modulates Spo0A activity in B. subtilis is replaced with a simple two-component system, as 
phosphorylation of Spo0A is mediated directly by Spo0A-assocaited kinases (Paredes et al., 2005, 
Steiner et al., 2011). Furthermore, studies carried out in C. perfringens and C. acetobutilicum have 
shown than in contrast to B. subtilis, σE and σF are active prior to asymmetric cell division. This is also 
true for σK, which in B. subtilis controls late stages of morphogenesis in the mother cell. In C. difficile, 
the main periods of activity of the four cell type-specific sigma factors are more conserved when 
compared to the B. subtilis model, with σF and σE controlling early stages of development and σG and 
σK governing late developmental events. However, the temporal segregation between the activities 
of the early and late-stage sigma factors is less stringent and the cross-talk between the forespore 
and the mother cell seems to be weaker, as the activity of σE is partially independent of σF, and 
activation of σG and σK does not require σE and σG, respectively (Pereira et al., 2013, Saujet et al., 
2013). The C. difficile σE, σF, σG and σK regulons have now been identified (Saujet et al., 2013), each 
containing key representatives of the homologous regulons previously identified in B. subtilis (de 
Hoon et al., 2010). Containing 228 genes, this core set of C. difficile sporulation genes corresponds to 
about half the number of genes under the control of cell type-specific sigma factors of B. subtilis 
(Steil et al., 2005). While this could be attributed to the experimental design of the study in question, 
it could also be a reflection of the more ancestral mechanism of sporulation proposed for Clostridia 
(Galperin et al., 2012, Paredes et al., 2005). 
Similarly, while many of the components of the germination machinery are conserved 
between spore forming members of the Bacillales and Clostridiales orders, recent studies have 
revealed significant differences both in the proteins and in the signal transduction pathways 
involved (Figure 1.10) (reviewed in Paredes-Sabja et al., 2010). Bioinformatic analysis of C. difficile 
genome has failed to reveal genes encoding known GR subunits (Sebaihia et al., 2007, Sebaihia et al., 
2006) even though a number of such genes were identified in other Clostridia. Furthermore, while 
the C. difficile 630 spore proteome has recently been identified (Lawley et al., 2009b), little 
homology has been shown between C. difficile spore proteins and those found in other Clostridia 
47 
Chapter I. Introduction 
 
and Bacilli. Possibly, C. difficile GRs are too divergent from those of other sporulating bacteria. 
Alternatively, C. difficile may use a different set of proteins as GRs. 
It is well established that bile salts: cholate, taurocholate, glycocholate and deoxycholate 
stimulate C. difficile spore germination (Wilson et al., 1982, Wilson, 1983), while more recent studies 
revealed that glycine and histidine act as a co-germinants with these cholate derivatives (Sorg and 
Sonenshein, 2008, Wheeldon et al., 2011, Wheeldon et al., 2008). Even though neither of these 
compounds has been previously described as a germinant for spores of Bacillus or Clostridium 
species, supporting the notion of a novel mode of germinant recognition, kinetic studies have 
suggested that there are distinct germination receptors for taurocholate and glycine in C. difficile 
(Ramirez et al., 2010). Furthermore, chenodeoxycholate, another bile salt, has been shown to inhibit 
C. difficile spore germination (Sorg and Sonenshein, 2009), although a recent study has pointed to 
substantial diversity among different clinical isolates in their response to bile salts (Heeg et al., 
2012). This adds a new level of regulation to the model of C. difficile colonisation of the gut. While 
chenodeoxycholate and taurocholate have been shown to have antagonistic effects, spores of C. 
difficile are suggested to have a higher affinity for chenodeoxycholate than for taurocholate (Sorg 
and Sonenshein, 2010). Therefore, in equal concentrations both compounds may compete for 
binding to putative C. difficile GRs and germination may be inhibited. However, as the rate of 
absorption of chenodeoxycholate by the colon is ten times that of cholate (Mekhjian et al., 1979), 
spores reaching the large intestine encounter a higher concentration of cholate derivatives, such as 
taurocholate. This suggests that germination may be inhibited until C. difficile spores reach the 
anaerobic environment of the large bowel, where conditions are suitable for vegetative cell growth. 
Furthermore, in a normal, healthy host, the colonic microflora dehydroxylates chenodeoxycholate to 
lithocholate, also an inhibitor of germination. In an antibiotic-treated host, chenodeoxycholate is not 
dehydroxylated and is absorbed by the colonic epithelium at a rate 10 times higher than that of 
cholate (Mekhjian et al., 1979). Thus, in an antibiotic-treated individual, the ratio of cholate to 
chenodeoxycholate derivatives would favour germination. This generated the hypothesis that the 
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metabolism of bile salts by the normal gut flora is one mechanism by which it can protect against C. 
difficile infection, and experiments with antibiotic-treated and untreated mice cecal extracts support 
this hypothesis (Giel et al., 2010). 
While the chemical signals that promote the initiation of germination in C. difficile have been 
well characterised over the years, it was not until 2013 that the first germination receptor has been 
described in the form of CspC, a germination-specific, subtilisin-like serine protease responsible for 
triggering germination upon stimulation with bile salts (Francis et al., 2013). In C. perfringens, the 
Csp family of proteins (CspA, CspB and CspC) has been previously implicated in germination as being 
responsible for cleaving the cortex hydrolase precursor pro-SleC to an active form (Shimamoto et al., 
2001) thus initiating cortex degradation. While all three proteins contain an active catalytic triad, 
only CspB has been shown to be essential in germination (Paredes-Sabja et al., 2009), although the 
signals that stimulate this proteolysis have not been elucidated. In C. difficile, the cspA and cspB 
coding sequences are fused, and only CspB contains an active catalytic triad necessary to activate 
SleC, suggesting that it might play a similar role to that observed in C. perfringens. Indeed, a recent 
study by Adams et al. (2013) has shown that CspBA undergoes auto-processing to generate CspB, 
which can cleave the cortex hydrolase precursor pro-SleC to an active form. It has also been 
suggested that  the stimulus required for activation of CspB might come from CspC which changes its 
conformation upon binding of bile salts (Francis et al., 2013). 
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Figure 1.10. Tentative models of germination signalling pathways in B. subtilis, C. perfringens and C. difficile. In B. 
subtilis, spore germination is triggered by L-alanine, which acts through the GerA receptor, and a mixture of L-asparagine, 
fructose, glucose and KCl (AGFK) acting through the GerB and GerK receptors. High hydrostatic pressures (HHPs) of 200–
400 MPa also trigger germination through the GerA, GerB and GerK receptors. The germination signals from the GRs are 
transduced and amplified, possibly via GerD, and lead to ion and Ca2+-DPA release, which in turn activates CwlJ. The 
resulting changes in cortex structure activate SleB. These two redundant CLEs degrade the PG cortex, allowing 
completion of germination and initiation of spore outgrowth. In C. perfringens, germinants such as L-asparagine and KCl 
or the co-germinants NaPi and sodium ions act primarily through the GerKA–GerKC receptor proteins, while GerKB and 
GerAA, play auxiliary roles. Exogenous Ca2+–DPA does not trigger C. perfringens spore germination through a CLE, but 
acts through GerKA–GerKC, In the absence of a GerD homolog, germinant–GR binding is presumed to directly trigger 
Ca+2–DPA release, allowing partial core hydration and perhaps some cortex deformation. However, Ca2+–DPA release has 
no role in activation of the C. perfringens CLE, SleC. Instead, the serine protease, CspB, is activated through an unknown 
mechanism, and cleaves and activates pro-SleC. Mature SleC then hydrolyzes the PG cortex, allowing entry into spore 
outgrowth, and the action of SleC and thus of CspB increase rates of DPA release. In C. difficile germination is triggered by 
bile salt and the co germinants glycine and histidine, acting upon CspC. This results in Ca+2–DPA release and partial core 
rehydration as well as CspB mediated activation of SleC, the major CLE present in C. difficile, allowing completion of 
germination and initiation of spore outgrowth. Adapted from Parades-Sabja et al. (2010). 
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1.4. Overview of genetic tools for studying C. difficile 
The rapid increase in prevalence and severity of C. difficile infections seen since 2001 has 
attracted attention from the scientific community, driving the development of new diagnostics, 
treatments and prevention regimes. Despite its importance in human disease, progress in 
understanding the molecular basis of C. difficile pathogenicity has been slow, hindered by the 
scarcity of established methods suitable for studying CDI, particularly with regard to genetic studies. 
While the organism has been genetically tractable since 2006, when the complete genome sequence 
of C. difficile strain 630 was published (Sebaihia et al., 2006), the genetic tools necessary to exploit 
this information have been lacking. Recent advancements in the field and the introduction of new 
methods for both forward and reverse genetic studies have helped overcome these issues, bridging 
the gap between C. difficile research and that carried out in better-characterised organisms. 
1.4.1. Clostridial vector systems 
The first attempts at delivering DNA into C. difficile were based on conjugative transposons 
such as Tn916 that may be conjugated from B. subtilis donors using a filter mating technique 
(Mullany et al., 1991). While this method has been successfully used to transfer heterologous DNA 
through co-integration of a replication-deficient plasmid, the relatively low transfer frequency (10-8 
per donor) combined with preferential integration into a single site within the recipient’s genome 
drastically limit its usability (Mullany et al., 1994). Further advances in the field came with the use of 
E. coli – C. difficile shuttle vectors for the episomal expression of native or exogeneous genes. These 
were largely based on pMTL960 plasmids developed by Purdy et al. (2002) which utilised the Gram-
positive replicon from the C. difficile native plasmid pCD6, the E. coli origin of replication ColE1 and 
the conjugative transfer origin oriT allowing for efficient conjugation into C. difficile from E. coli 
donor strains. The catP gene from C. perfringens encoding resistance to chloramphenicol (in E. coli) 
and thaimphenicol (in C. difficile) was included as a selectable marker. This has been further refined 
with the introduction of the pMTL8000 modular vector family, in which both Gram-positive and 
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Gram-negative replicons as well as the selection markers can be swapped, allowing for higher 
flexibility in experimental design (Heap et al., 2009). Over the years a number of variations of the 
original system have been developed. Native, well-characterised C. difficile promoters such as the 
cwp2 promoter have been successfully used to express or over-express C. difficile genes in 
expression studies. These included the study of the C. difficile cell wall protein CwpV (Dembek et al., 
2011, Emerson et al., 2009, Reynolds et al., 2011), and the cell wall-associated cysteine protease 
Cwp84 (de la Riva et al., 2011). More recently, an inducible promoter system has been developed by 
introducing a tetracycline inducible promoter from Staphylococcus aureus into pMTL960 (Fagan and 
Fairweather, 2011). The system has been successfully used to express genes in  a controlled, dose-
dependent manner as well as in knock-down studies, to temporarily disrupt the expression of a 
particular gene using antisense RNA (Fagan and Fairweather, 2011). Finally, a variant of the inducible 
promoter plasmid lacking a transcriptional terminator directly downstream of the tetracycline 
repressor gene tetR, has been shown to be segregationally-unstable due to transcriptional read-
through from the inducible promoter. Upon induction, the plasmid is rapidly lost from the 
population and can thus be used as a conditional replicon, the first conditional replicon for use in C. 
difficile (Dr Robert Fagan, unpublished results). 
1.4.2. Genomic mutations in C. difficile 
1.4.2.1. ClosTron insertional mutagenesis 
The introduction of ClosTron technology in 2007 (Heap et al., 2007) was an important 
milestone in Clostridial research allowing for the creation of genetically stable mutants by targeted 
disruption of selected genes within the genome. The system makes use of group II introns, genetic 
elements widespread in both eukaryotic and bacterial genomes that insert into specific DNA target 
sites by a unique mechanism in which the intron RNA reverse splices directly into double-stranded 
DNA and is then reverse transcribed by the intron-encoded reverse transcriptase. The rules that 
govern group II intron mobility were first characterised by Mohr et al. (2000) who elucidated the 
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mechanism of replication of a group II intron found in the ltrB gene of Lactococcus lactis, and 
demonstrated that by changing the intron sequence, its target specificity could be altered to allow 
for disruption of almost any gene of interest. It was also noted that the intron-encoded protein (IEP) 
that confers intron mobility can be provided in trans without affecting its function, preventing 
further mobility after the desired insertion has been achieved. In order to facilitate rapid selection of 
genetically stable mutants, re-targeted introns were equipped with retrotransposition-activated 
markers (RAM) carrying a nested group I intron (Zhong et al., 2003). Upon transcription, the group I 
intron is spliced out and the complete group II intron carrying a functional selection marker is 
integrated into the desired site within the genome, disrupting gene expression (Figure 1.11). The 
system has been further refined in 2010 (Heap et al., 2010) becoming the gold standard in genetic 
manipulation of C. difficile, successfully used in a wide range of studies (de la Riva et al., 2011, 
Deakin et al., 2012, Emerson et al., 2009, Kirby et al., 2009, Reynolds et al., 2011).  
 
  
Figure 1.11. Schematic representation of ClosTron insertional mutagenesis. pMTL007-based plasmid carrying a retargeted 
group II intron is conjugated into C. difficile. Following transcription, the group I intron disrupting ermR undergoes splicing 
and the active group II intron integrates into the target site within a gene, disrupting its expression. ClosTron mutants are 
selected through erythromycin resistance. 
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1.4.2.2. Homologous recombination techniques 
While the ClosTron system provides a fast, reliable and reproducible method for 
targeted disruption of genes, insertional mutagenesis does impose certain limitations. Polar effects 
are common as insertion of the group II intron can disrupt the expression of neighbouring genes. 
Multiple insertions, while rare, have been reported necessitating the use of time consuming 
screening techniques. While double mutants have been successfully created by introducing a second 
selectable marker (Kuehne et al., 2010), the limited availability of such markers makes creating 
multiple gene deletions difficult. Finally, as in situ complementation of a disrupted gene is not 
possible, plasmid-based in trans complementation has to be used, often resulting in unwanted gene 
dosage effects.  
In order to overcome these problems and to allow for more refined genetic manipulations 
required for robust functional analyses, methods involving homologous recombination were 
investigated. Early attempts at creating unmarked mutations within the C. difficile genome involved 
single crossovers that were largely unstable, often reverting to wild-type (O'Connor et al., 2006). At 
this early stage, all attempts to generate stable double crossover were unsuccessful. It was not until 
2012 that this became possible with the introduction of two independent methods for homologous 
recombination in C. difficile. 
The first method utilises codA from E. coli which encodes for cytosine deaminase (EC 3.5.4.1), 
an enzyme that converts the innocuous 5-fluorocytosine (FC) into toxic 5-fluorouracil (FU). A plasmid 
carrying the codA gene and a mutated allele containing 500 bp-long upstream and downstream 
homology regions is transferred into C. difficile through conjugation. Single crossover mutants 
carrying the entire plasmid are selected for using catP-mediated thiamphenicol resistance and are 
further confirmed by PCR. Isolated mutants are then plated onto minimal medium supplemented 
with FC, to select for the rare, double crossover event resulting in excision of the plasmid backbone 
carrying codA and replacement of the original allele with the plasmid-encoded copy. Standard PCR 
techniques are used to differentiate between allele exchange and reversion to wild-type. As a proof-
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of-principle this system has been successfully used in C. difficile R20291 to correct point mutations in 
tcdC and to study their role in regulation of toxin production (Cartman et al., 2012). 
The second system was developed in parallel as a method for introducing heterologous DNA 
fragments of any size or complexity into the C. difficile genome without the need for a counter-
selection marker and is based on the native pyrE gene involved in uracil biosynthesis. Strains carrying 
a functioning copy of pyrE can grow in the absence of uracil but are sensitive to 5-fluoroorotic acid 
(FOA). This is exploited to select for double crossover events that allow for integration of DNA 
fragments directly downstream of the pyrE. Briefly, homology regions of varying lengths are used to 
target the plasmid-encoded DNA cargo to the pyrE locus such that a single cross-over event, which 
does not interrupt the gene, occurs first. These thiamphenicol resistant, FOA-sensitive clones are 
then plated onto minimal medium supplemented with FOA to select for double crossover events. 
Upon excision of the plasmid backbone the pyrE allele is replaced with a truncated copy, rendering 
the cells sensitive to thiamphenicol and resistant to FOA. This defective pyrE allele can be returned 
to WT by homologous recombination, selected for by growth in the absence of uracil. In an elegant 
study by Heap et al., (2012) this method, dubbed Allele-Coupled Exchange (ACE), was successfully 
used to deliver a 40 kb fragment of lambda DNA into the chromosome of C. acetobutilicum using a 
multi-step approach. The system was further exploited by Ng et al. (2013) who used pyrE mutants to 
deliver DNA anywhere in the genome by integrating constructs carrying the DNA cargo alongside a 
functional pyrE allele. The resulting mutants were then returned to uracil prototrophy as described 
above or simultaneously complemented by introducing a WT copy of the disrupted gene under the 
control of a native or heterogeneous promoter directly downstream of the pyrE allele (Figure 1.12). 
Both systems are now considered the gold standard for precise genetic manipulation of C. difficile 
and have contributed greatly towards understanding this, once genetically intractable, organisms. 
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  Figure 1.12. Schematic representation of Allele Coupled Exchange (ACE) mutagenesis. (A) A pMTL-YN3-based plasmid 
carrying a mutated allele of the targeted gene (green) together with upstream and downstream homology regions (teal 
and red) as well as a WT copy of pyrE (dark blue) is conjugated into ΔpyrE background. Single cross-over mutants are 
selected through plasmid-encoded thiamphenicol resistance. These are then plated onto minimal medium 
supplemented with FOA to select for double cross-over events. (B) Mutants are restored to uracil prototrophy by 
introduction of a WT pyrE allele via homologous recombination, (C) and can be complemented by concomitant 
introduction of the WT allele of the targeted gene between the pyr E and hydA loci. 
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1.4.2.3. Transposon mutagenesis and sequencing 
Since their discovery in the 1950s (McClintock, 1950), transposons have become a 
valuable component of the ‘molecular toolbox’, allowing for the precise manipulation of genes in 
virtually any genetically tractable organisms. Originally identified as factors controlling gene 
expression in maize, these mobile genetic elements have since been found in every kingdom of life, 
playing important roles in the evolution of speciation and antibiotic resistance in microorganisms 
(reviewed in Kidwell and Lisch, 2001, Alekshun and Levy, 2007). Their remarkable characteristics 
have been exploited in molecular biology, primarily in the creation of random mutant libraries via 
insertional mutagenesis, allowing for large-scale analyses of gene function. Such studies have 
benefited greatly from the recent advances in microbial genome sequencing, which have enabled 
researchers to directly link an observed phenotype to a particular genotype. With the advent of 
high-throughput sequencing and the introduction of signature-tagged mutagenesis methodologies 
(Hensel et al., 1995) it is now possible to sequence comprehensive libraries of mutants 
simultaneously, thus allowing for genome-wide, genotype-phenotype analyses. These have already 
led to the identification of thousands of virulence genes in a number of clinically-relevant bacteria, 
including Salmonella enterica subsp. enterica serovar Typhimurium (Hensel et al., 1995), 
Staphylococcus aureus (Mei et al., 1997), Vibrio cholerae (Chiang and Mekalanos, 1998), 
Streptococcus agalactiae (Jones et al., 2000), Listeria monocytogenes (Autret et al., 2001) and 
Streptococcus pneumoniae (Polissi et al., 1998). Further advancements in the field and the 
introduction of massively parallel sequencing (MPS) have led to the development of transposon 
sequencing methods in which a comprehensive mutant library, containing insertions in all but the 
essential genes is passaged under permissive or non-permissive conditions in order to determine the 
minimal set of genes necessary for survival (reviewed in Barquist et al., 2013). In these methods, 
genomic DNA extracted from the entire mutant pool is either sheered or digested into small 
fragments which are ligated to adapter DNA. Primers specific to the transposon inverted repeats and 
the adapter, are then used to PCR-amplify across the insertion junction and the resulting PCR 
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products are sequenced. The differences in the number of sequence reads for each junction can be 
then analysed to assess the fitness contribution of each gene under a particular set of conditions. 
One such method, dubbed transposon-directed insertion site sequencing (TraDIS) has recently been 
used in S. typhi to identify genes essential for growth in rich medium as well as those involved in 
tolerance to bile, a substance the pathogen encounters when colonizing the gall bladder (Langridge 
et al., 2009). 
To date, the undeniable success of transposon mutagenesis has not been translated into C. 
difficile research. While in vitro transposon mutagenesis systems have been successfully used in the 
closely related C. perfringens (Vidal et al., 2009, Lanckriet et al., 2009), their reliance on 
transformation as a way of introducing DNA into the cell, makes them unsuitable for use in C. 
difficile. An alternative approach was introduced by Cartman et al. (2010) who attempted to 
generate random libraries of C. difficile mutants in vivo, by introducing mariner-based transposons 
via segregationally unstable, ‘pseudo-suicide’ vectors (Cartman and Minton, 2010). The mariner-
transposable element Himar1 has been previously shown to insert randomly into TA target sites in 
genomes of many bacterial species via a cut-and-paste mechanism mediated by the Himar1 
transposase (Lampe et al., 1996, Lampe et al., 1998), a useful characteristic considering the low GC-
content found in the C. difficile genome. While the experiment provided good evidence that a 
mariner-based transposon could be an effective tool for generating random mutants in C. difficile, 
and a number of stable mutants carrying single insertions were identified, the lack of a well-defined 
conditional replicon meant that the system provided little control over the transposition event and 
was not suitable for the creation of large scale libraries. 
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1.5. Project aims 
Sporulation and germination play a pivotal role in CDI transmission, allowing the otherwise 
strictly anaerobic organism to survive outside of the host and being responsible for recurrence of 
disease when therapy is stopped. While the molecular basis of sporulation and germination has been 
extensively studied in B. subtilis, and more recently in other clostridia, our current understanding of 
these events in C. difficile remains rudimentary at best. A detailed understanding of the mechanisms 
behind sporulation and germination could have direct implications in infection control and the 
development of new therapeutics. 
Two complementary approaches were taken in order to provide a more complete image of 
sporulation and germination in C. difficile. Firstly, a transcriptomic analysis of temporal gene 
expression patterns during germination was performed to illustrate how the germinating cell re-
establishes its metabolism following a phase of dormancy. Secondly, transposon mutagenesis 
combined with next-generation sequencing was used to identify genes essential in sporulation 
and/or germination. These results could be validated thanks to the recent development of robust 
systems for genetic manipulation of Clostridia, facilitating a more in-depth characterisation of genes 
of interest.  
The major aims for this project were: 
I. To perform a genome-wide analysis of sporulation and germination in C. difficile 
II. To identify sporulation and germination core gene set 
III. To characterise selected genes and identify their role in sporulation and/or germination 
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Materials and Methods 
2.1. Bacterial strains and growth conditions 
Plated cultures of C. difficile strains were routinely grown on blood agar base II (Oxoid) 
supplemented with 7% horse blood (TCS Biosciences), brain-heart infusion (BHI) agar (Oxoid), BHIS 
agar (BHI agar supplemented with 0.1% L-cysteine and 5 mg/ml yeast extract (Bacto)) or Clostridium 
difficile Defined Medium (CDMM) (Karasawa et al., 1995). 
Table 2.1. Composition of Clostridium difficile Defined Medium. 
 Stock concentration [mg/ml] Final concentration [mg/ml] 
Amino acids (5x)   
Casamino acids 50 10 
L-Tryptophan 2.5 0.5 
L-Cysteine 2.5 0.5 
   
Salts (10X)   
Na2HPO4 50 5 
NaHCO3 50 5 
KH2PO4 9 0.9 
NaCl 9 0.9 
   
Glucose (20X)   
D-Glucose 200 10 
   
Trace salts (50X)   
(NH4)2SO4 2.0 0.04 
CaCl2 · 2H2O 1.3 0.026 
MgCl2 · 6H2O 1.0 0.02 
MnCl2 · 4H2O 0.5 0.01 
CoCl2 · 6H2O 0.05 0.001 
   
Iron (100X)   
FeSO4 · 7H2O 0.4 0.004 
   
Vitamins    
D-Biotin (1000X) 1 0.001 
Calcium-D-panthothenate 
(1000X) 
1 0.001 
Pyridoxine (1000X) 1 0.001 
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Liquid cultures were grown in BHI broth (Oxoid), BHIS broth or TY broth (3% tryptose, 2% 
yeast extract (Bacto)). All cultures were supplemented where appropriate with antibiotics: 
thiamphenicol (15 µg/ml), cycloserine (250 µg/ml) or erythromycin (5 µg/ml). Unless stated 
otherwise, liquid cultures were grown statically overnight (O/N) in an anaerobic cabinet (Don 
Whitley Scientific), at 37°C, in an atmosphere of 10% CO2, 10% H2 and 80% N2. All media were pre-
reduced in the anaerobic cabinet before inoculation. 
Plated cultures of E. coli strains were routinely grown on LB agar (VWR). Liquid cultures were 
grown in LB broth (VWR). For inducible protein expression, strains were grown in Overnight Express 
Instant TB medium (Merck) supplemented with 1% (v/v) glycerol. All media were supplemented 
where appropriate with antibiotics: kanamycin (50 µg/ml) or chloramphenicol (15 µg/ml). E. coli 
NovaBlue (Merck) or NEB5α (NEB) were used as the recipient strains in all cloning procedures. E. coli 
CA434 was used as the donor strain for conjugation of plasmids into C. difficile. E. coli Rosetta 
(Novagen) and BL21(DE3) were used as expression strains for protein production. Unless stated 
otherwise, cultures were grown O/N with agitation (225 rpm) at 37°C. 
All strains were stored at -80°C in 20% glycerol. A detailed list of strains used and created 
throughout this project is provided in Appendix A, Table A1. 
2.2. Production of chemically-competent E. coli CA434 
An O/N culture of E. coli CA434 in LB broth was sub-cultured 1:100 and grown to exponential 
phase [optical density at 600nm (OD600) 0.4 – 0.6]. The culture was harvested by centrifugation (10 
min at 3,400 x g at 4°C), resuspended in 5 ml of ice-cold 100 mM CaCl2 and incubated on ice for 15 
min. Cells were harvested as above, resuspended in 1 ml ice-cold CaCl2 with 15% (v/v) glycerol and 
incubated on ice for 2h before aliquoting and freezing at -80°C. All steps except centrifugation were 
carried out at 4°C. 
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2.3. C. difficile sporulation and spore purification 
C. difficile sporulation was induced as described previously (Permpoonpattana et al., 2011). 
Briefly, 10 ml of TGY broth (3% tryptic soy broth; 2% glucose; 1% yeast extract; 0.1% L-cysteine) was 
inoculated with a single colony of C. difficile grown on BHIS agar. Following O/N static incubation, 
bacteria were sub-cultured 1:10 in sporulation medium (SM) broth (9% Bacto peptone, 0.5% 
proteose peptone, 0.15% Tris base, 0.1% ammonium sulphate), grown to OD600 of 0.6 and 200 µl 
aliquots were spread out on SM agar plates. The number of plates used depended on the required 
yield and ranged from 6 to 48 plates. After 7 days of anaerobic incubation at 37°C, spores were 
harvested in 2ml of ice-cold sterile water per plate.  
Crude spore suspensions were washed five times with 1 ml of ice-cold sterile water and 
vortexed for 10 min in between washes. Pellets from four plates were pooled, re-suspended in 500 
µl of 20% HistoDenz (Sigma) and layered over 1 ml of 50% HistoDenz in a 1.5 ml tube. Tubes were 
centrifuged at 14,000 x g for 15 min. The spore pellet was recovered and washed three times with 
ice-cold sterile water to remove residual HistoDenz. Spore purity was assessed via phase contrast 
microscopy. Spore yields in individual preparations were estimated by counting colony-forming units 
(CFU) on BHI agar plates supplemented with 0.1% sodium taurocholate (Tch). Purified spores were 
stored in water at 4°C until further analysis. 
2.4. DNA manipulation 
2.4.1. Genomic DNA extraction 
C. difficile genomic DNA (gDNA) was isolated via phenol:chloroform extraction as described 
previously (Wren et al., 1987). 10 ml O/N cultures were harvested by centrifugation (10 min at 5,000 
x g). Bacterial pellets were resuspended in 2 ml lysis buffer (200mM NaCl, 50mM EDTA, 20mM Tris-
HCl pH 8.0) supplemented with 2mg/ml lysozyme and incubated at 37°C for 1 h. The resulting 
suspension was treated with 0.5 mg/ml pronase (1 h at 37°C), 2% N-lauroylsarcosine (1 h at 55°) and 
0.1 mg/ml RNase (1 h at 37°C). Following lysis, gDNA was extracted twice with 
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phenol:chloroform:isoamyl alcohol (25:24:1) and twice with chloroform:isoamyl alcohol in 15 ml 
phase lock gel (PLG) tubes (VWR), followed by O/N precipitation with 2.5 volumes of absolute EtOH 
at -20°C. gDNA pellets were re-suspended in nuclease-free water do a desired volume. gDNA 
quantity and quality was assessed on a NanoDrop instrument (Thermo Scientific) by measuring total 
concentration as well as A260/A280 and A260/A230 ratios. gDNA integrity was assessed via standard 
agarose gel electrophoresis. 
2.4.2. Chelex DNA preparations 
DNA preparations for routine colony screening were extracted using 5% (w/v) Chelex 100 
resin (Bio-Rad) in nuclease-free water. Single colonies were suspended in 100 µl 5% Chelex, boiled 
for 10 min at 100°C and pelleted at 10,000 x g for 1 min. Supernatants containing DNA were 
transferred to a fresh tube for further analysis. 
2.4.3. Plasmid DNA extraction 
Plasmid DNA was extracted from E. coli using the QIAprep spin kit (Qiagen) according to 
manufacturer’s protocols. Briefly, 5 ml O/N cultures were centrifuged (10 min at 5,000 x g) and the 
resulting pellets were re-suspended in 250 μl of buffer P1. An equal volume of buffer P2 was added, 
the sample was mixed gently and incubated for 5 min. 350 μl of buffer N3 was added, the sample 
was mixed once more and centrifuged at 10,000 x g for 10 min. The supernatant was applied to a 
QIAprep column and centrifuged at 10,000 x g for 1 min. The column was washed with 700 μl of 
buffer PE. Residual buffer was removed by centrifuging a second time at 10,000 x g for 1 min. DNA 
was eluted by adding 30-50 μl of nuclease-free water, incubating for 1 min at room temperature (RT) 
and centrifuging at 10,000 x g for 1 min. A complete list of plasmids used or created throughout this 
study is provided in Appendix A, Table A2. Plasmid maps are provided in Appendix A, Figure A1. 
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2.4.4. Polymerase chain reaction (PCR) 
Routine screening PCR and colony PCR were carried out using Taq polymerase (Sigma) 
according to manufacturer’s guidelines in a total volume of 20 µl (1x PCR buffer, 2.5 mM MgCl2, 0.2 
mM dNTPs, 0.1 µM forward and reverse primers, 0.2 U Taq). Initial denaturation was at 94°C for 3 
min followed by thirty cycles of denaturation at 94°C for 30 s, annealing at 1°C below primers Tm for 
1 min and extension at 72°C for 1 min per kb. A final extension at 72°C for 10 min was included to 
ensure completion of DNA synthesis. 
Reactions requiring higher stringency (amplification of gDNA fragments for cloning purposes 
and inverse PCR) were carried out using KOD Hot Start polymerase (Merck) according to 
manufacturer’s guidelines in a total volume of 50 µl (1x PCR buffer, 1 mM MgSO4, 0.2 mM dNTPs, 
0.3 µM forward and reverse primers, 0.02 U KOD). Initial denaturation was at 95°C for 2 min 
followed by thirty cycles of denaturation at 95°C for 20 s, annealing at 1°C below primers Tm for 30 s 
and extension at 72°C for 15 s per kb. A final extension at 72°C for 10 min was included to ensure 
completion of DNA synthesis. All reactions were carried out using a G-Storm GS2 thermal cycler. 
Primers used throughout this study were synthesised by either Euorfins or Sigma-Aldrich and are 
listed in Appendix A, Table A3. 
2.4.5. Purification of PCR reactions 
PCR-amplified DNA fragments were purified using the QIAquick PCR purification kit 
according to manufacturer’s guidelines. 
2.4.6. Restriction endonuclease digestion of DNA 
All restriction endonuclease digest were carried out using enzymes provided by New 
England Biolabs (NEB) according to manufacturer’s guidelines. Unless stated otherwise, PCR 
products and plasmid DNA were digested at 37°C for 1h while gDNA was digested O/N. 
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2.4.7. Agarose gel electrophoresis 
Agarose gels were prepared by melting 0.6 - 3% (w/v) agarose powder (Invitrogen) in 1 x 
TAE (40mM TrisAcetate, 2mM Na2EDTA pH 8.3) in a microwave oven. When sufficiently cool, 
1/10,000 volume SybrSafe DNA stain was added and the gel was cast on a horizontal perspex plate. 
When fully set, gels were placed in a tank containing 1 x TAE. DNA samples were mixed with 0.25 
volumes DNA loading buffer and then loaded into the gel wells. Electrophoresis was performed at 
approximately 10V/cm. DNA was visualised on a UV transilluminator at 312 nm, and images 
recorded on an InGenius gel documentation system (Syngene). 
2.4.8. Extraction of DNA from agarose gels 
DNA was extracted from agarose gels using the QIAquick Gel Extraction kit according to 
manufacturer’s guidelines. Briefly, bands were excised using a scalpel, weighed and mixed with 3 
volumes of buffer QG (100 µg ~ 100 µl). Following 10 min incubation at 50°C 1 volume of 
isopropanol was added and the resulting samples were applied onto a QIAquick column and 
centrifuged at 10,000 x g for 1 min. The column was washed with 500 µl of buffer QG and 750 µl of 
buffer PE (10,000 x g for 1 min). DNA was eluted by adding 30-50 μl of nuclease-free water, 
incubating for 1 min at RT and centrifuging at 10,000 x g for 1 min. 
2.4.9. DNA Ligation 
Ligation reactions were carried out for 15 min at RT using QuickStick ligase (Bioline) 
according to manufacturer’s guidelines in a total volume of 20 μl (50 ng of DNA in nuclease-free 
water, 5 μl 4x Quick Stick ligase buffer, 1 μl QuickStick ligase). For routine cloning a 3:1 insert:vector 
molar ratio was used. Blunt-ended products obtained via inverse PCR, were phosphorylated using T4 
polynucleotide kinase (NEB; 30 min at 37°C) prior to ligation. 
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2.4.10. Transformation 
25 µl aliquots of chemically competent E. coli cells were transformed with 1 µl of ligation 
reaction and incubated on ice (5 min for NEB5α, Top10 and NovaBlue cells; 30 min for CA434 cells). 
Following a 30 s heat-shock at 42°C cells were incubated on ice for 2 min, resuspended in 125 µl of 
sterile S.O.C. medium, incubated for 1 h at 37°C with agitation and plated onto LB agar 
supplemented with the appropriate antibiotic. 
2.4.11. DNA sequencing 
Routine Sanger sequencing was carried out by GATC Biotech (Konstanz, Germany) on 
previously purified plasmid DNA or PCR-amplified DNA fragments. Sequencing primers were 
provided at 10 pmol/µl or synthesised directly by GATC. 
2.4.12. E. coli – C. difficile conjugation 
pMTL960-based shuttle plasmids were transformed into E. coli CA434 and conjugated into 
C. difficile as described previously (Purdy et al., 2002). Briefly, 1 ml of O/N E. coli culture (donor) was 
spun down (1 min at 3,000 x g), washed gently with sterile phosphate-buffered saline (PBS) and 
mixed with 200 µl of O/N C. difficile culture (recipient). The resulting mixture was spotted onto non-
selective BHIS agar and incubated anaerobically for 8h. The resulting growth was resuspended in 1 
ml of sterile PBS and spread out onto BHIS agar supplemented with thiamphenicol (15 µg/ml) to 
select for pMTL960-based plasmids and cycloserine (250 µg/ml) to counterselect against E. coli. 
2.4.13. ClosTron insertional mutagenesis 
All C. difficile ClosTron mutants were generated in C. difficile 630Δerm (Hussain et al., 2005) 
by insertion of a bacterial group II intron containing a retrotransposition-activated marker (RAM) 
conferring erythromycin resistance (Zhong et al., 2003) using the ClosTron clostridial gene knockout 
system (Heap et al., 2007). 45bp intron target sites were identified within the respective genes using 
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the Perutka algorith (http://www.clostron.com). Plasmids were synthesised (DNA 2.0) and 
transferred into C. difficile 630Δerm by conjugation from previously transformed E. coli CA434. 
Transconjugants were restreaked twice onto Brazier’s agar (BioConnections) supplemented with 
thiamphenicol (15 µg/ml), cefoxitin (8 µg/ml) and cycloserine (250 µg/ml). Potential Ll.ltrB insertions 
were selected by plating bacteria on Brazier’s agar supplemented with erythromycin (5 µg/ml). 
Putative mutants were screened by colony PCR using (i) primers specific for genes of interest 
flanking the intron insertion site, (ii) gene specific primers in combination with a primer internal to 
the group II intron (iii) and RAM specific primers flanking the group I intron. 
2.4.14. Allele-Coupled Exchange (ACE) mutagenesis 
ACE mutants were generated in C. difficile 630ΔermΔpyrE as described by Ng et al. (2013). 
Briefly, mutated alleles carrying in-frame deletions were generated by cloning PCR-amplified 750 bp 
upstream and downstream homology regions into pMTL-YN3 using Gibson Assembly according to 
manufacturer’s instructions. The resulting plasmids were conjugated into 630ΔermΔpyrE as 
described above. Following two passages on BHIS agar supplemented with 5 µg/ml uracil, 15 µg/ml 
thiamphenicol and 250 µg/ml cycloserine, colonies that were noticeably larger (indicative of plasmid 
integration) were screened by colony PCR to identify single-crossover mutants using (i) primers 
flanking the upstream and downstream homology regions and (ii) one of these primers in 
conjunction with a plasmid-specific primer to amplify across the integration junction. Pure, single 
crossover mutants were streaked onto C. difficile minimal medium (CDMM) supplemented with 5 
µg/ml uracil and 2 mg/ml 5-fluoroorotic acid (FOA) to select for plasmid excision. The isolated FOA-
resistant colonies were screened by PCR. Double-crossover mutants in which the mutated allele was 
successfully integrated yielded products smaller than those seen in WT revertants. 
In order to restore the pyrE+ phenotype, plasmid pMTL-YN1 carrying the WT pyrE allele was 
conjugated into the isolated double-crossover mutants. The resulting colonies were restreaked onto 
non-supplemented CDMM agar to select for uracil prototrophy indicating successful allele exchange. 
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Restoration of the pyrE allele was further confirmed by colony PCR using primers flanking the pyrE 
locus followed by Sanger sequencing of the amplified product. 
In order to complement the mutants, WT alleles including their Ribosome Binding Site (RBS) 
and a 200bp 5’ non-coding region containing the putative promoter signals as identified by BPROM 
(SoftBerry) were cloned into pMTL-YN1C using SacI and BamHI sites. The resulting plasmids were 
conjugated into the isolated double-crossover mutants. Following 96h of incubation individual 
transconjugantes were re-streaked onto non-supplemented CDMM agar to select for uracil 
prototrophy indicating successful allele exchange and the introduction of the WT allele immediately 
downstream of the concomitantly restored pyrE locus. Complementation was confirmed by colony 
PCR using primers flanking the pyrE locus followed by Sanger sequencing of the amplified product. 
2.4.15. Southern blotting 
5 µg gDNA was digested O/N with 20u AseI in a total volume of 30 µl and then separated 
O/N on a 1% agarose gel at 20V. The gel was incubated in denaturing buffer (1.5 M NaCl; 0.5 M 
NaOH) for 45 min, rinsed briefly with water, incubated in neutralising buffer (1.5 M NaCl; 1 M Tris-
HCl, pH 7.4) for 45 min and rinsed once more. The capillary blotting stack was assembles as follows. 
Two gel-sized pieces of Whatman 3MM filter paper soaked in 20x SSC buffer (3 M NaCl; 300mM 
sodium citrate, pH 7.0) were placed on a plastic support tray immersed in 20x SSC buffer, followed 
by the gel, a gel-sized piece of Biodyne B nylon membrane and two pieces of Whatman 3MM filter 
paper soaked in 20x SSC buffer. A 5 cm stack of tissue paper was placed on top of the filter paper 
and weighed down. The stack was left to transfer O/N. The following day the transfer stack was 
disassembled, the membrane was allowed to dry and was then cross-linked in a UV Stratalinker 
(Strategene). The membrane was rolled into a glass hybridization bottle and immersed in 10 ml pre-
warmed hybridization solution containing the probe, a PCR product complementary to the ClosTron 
group II intron labelled using the AlkPhos Direct Labelling and Detection System (Pierce) according to 
manufacturer’s instructions. Hybridization was carried out O/N at in a hybridization oven at 55°C 
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with rotation. The following day, the membrane was washed twice with wash buffer 1 (2 M urea; 
0.1% SDS; 150mM NaCl; 0.2% blocking reagent; 1 mM MgCl2; 50 mM Na2HPO4) (10 min at 55°C) and 
twice with wash buffer 2 (100 mM NaCl, 2 mM MgCl2; 500 mM Tris base) (10 min at RT). The 
membrane was developed by adding 5 ml 1x CDP-Star detection reagent (Roche) and incubating for 
5 min at RT prior to imaging on a LAS 4000 imager (Fuji). 
2.5. RNA manipulation 
2.5.1. Total RNA extraction 
RNA was extracted using the FastRNA Pro Blue Kit (MP Biosciences) according to 
manufacturer’s guidelines. Briefly, 10 ml vegetative cell cultures or 5 ml cultures containing 5 x 109 
endospores (OD600 10) at various stages of germination were mixed with 2 volumes of RNA Protect 
(Qiagen) and incubated for 5 min at RT. Samples were centrifuged (10 min at 5,000 x g at 4°C), 
resuspended in 1 ml of RNA Pro solution and transferred to a lysing matrix tube containing 0.1 mm 
silica beads. Tubes were processed in a FastPrep-24 instrument (MP Biosciences) (45 s at 6.5 m/s). 
For vegetative cells, 1 cycle was used. For spores, 3 cycles were used with 2 min of cooling on ice 
between cycles. The efficiency of spore rupture was evaluated via phase contrast microscopy as well 
as by plating spore samples prior to and post processing onto BHIS agar supplemented with 0.1% Tch. 
Following disruption, samples were centrifuged to remove spore debris and silica beads from 
suspension (16,000 x g; 10 min; 4°C). Approx. 700 µl of liquid was transferred to an RNase-free tube 
and incubated at RT for 5 min. 300 µl of chloroform was added. The sample was vortexed for 10s 
and centrifuged (16,000 x g; 15 min; 4°C) to separate the phases. The aqueous phase was 
transferred to a fresh tube containing 200 µl of 95% EtOH and placed on ice. The mixture was 
transferred to a spin column assembly (SV Total RNA isolation system; Promega) and centrifuged (1 
min at 16,000 x g). Columns were washed twice with 600 µl and 250 µl of RNA wash solution. RNA 
was eluted in 45 µl of RNase-free water. DNase treatment was carried out using the Turbo DNase kit 
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(Ambion) according to manufacturer’s protocol. The enzymatic reaction was cleaned-up using the 
RNeasy Mini Kit (Qiagen).  
2.5.2. RNA quality control 
RNA purity and quantity was determined by nanodrop UV spectroscopy. RNA integrity was 
confirmed on a RNA 6000 nano lab-Chip using a Bioanalyzer 2100 instrument (Agilent). Samples 
were stored at -80°C until further analysis. 
2.6. Expression and purification of recombinant proteins 
2.6.1. Growth and induction 
5 ml starter cultures of E. coli Rosetta strains carrying expression plasmids based on pET28a 
were used to inoculate 100 ml of Overnight Express Instant TB medium (Merck). Cultures were 
grown for approx. 24 h at 37°C with agitation (225 rpm). Cells were harvested (5,000 x g; 10 min; 
4°C) and frozen at -80°C. 
2.6.2. Inclusion body purification 
Frozen pellets were resuspended in 10 ml of Tris-buffered saline (TBS) pH 7.2 
supplemented with 5 µg of lysozyme and 400 µg of DNase I. Suspensions were lysed on a French 
press (3 cycles at 1,500 psi) and spun down (25,000 x g; 10 min; 4°C) to separate the soluble and 
insoluble fractions. Pellets were washed in TBS containing 10% BugBuster (Novagen) until the 
supernatant was clear. 
2.6.3. On-column protein refolding 
Isolated inclusion bodies were resolubilized in buffer A1 (20 mM Tris-HCl pH 7.7; 500 mM 
NaCl; 8 M urea) and incubated O/N on a rotating wheel at 4°C. The following day, the supernatant 
was harvested and applied onto a His-Trap FF column (GE Healthcare). Proteins of interest were 
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purified on an ACTA Prime (GE Healthcare) by sequential washes in buffer A2 (20 mM Tris-HCl pH 
7.7; 500 mM NaCl; 0.1% Triton-X-100), buffer A3 (20 mM Tris-HCl pH 7.7; 150 mM NaCl; 5 mM ß-
cyclodextrin), buffer A4 (20 mM Tris-HCl pH 7.7; 150 mM NaCl; 20 mM imidazole) and eluted in 
buffer B (20 mM Tris-HCl pH 7; 150 mM NaCl; 250 mM imidazole). 
2.6.4. Dialysis of purified proteins 
Following purification, fractions containing the desired protein were pooled and injected 
into a Slide-A-Lyzer Dialysis Cassette (Thermo Scientific). Cassettes were allowed to equilibrate in 2 
litres pre-chilled buffer (10mM Tris-HCl pH 7.7; 150 mM NaCl) for 6h. Three buffer changes were 
performed. The resulting samples were concentrated if needed on an Amicon Centrifugal Spin Filter 
(Millipore) with an appropriate MWCO and analysed via SDS-PAGE to assess purity and stability. 
2.6.5. BCA assay 
Protein concentration was determined using a BCA assay kit (Pierce) according to 
manufacturer’s guidelines. Briefly, BSA standards of known concentrations and purified protein 
samples were diluted in HBS. Reagents A and B were mixed in a 50:1 ratio, with 180 µl reagent 
added to 20 µl sample in a 96 well plate. The reaction was incubated at 37°C for 30 minutes and the 
absorbance read at 595 nm using a Benchmark microplate reader (Bio-Rad). Sample concentration 
was estimated form the BSA standard curve. 
2.7. Protein characterisation assays 
2.7.1. S-layer extraction 
S-layer extracts were prepared using low pH glycine incubation as described by Wright et al. 
(2005). Briefly, 50 ml overnight cultures of C. difficile (OD600 1) were harvested by centrifugation 
(5,000 x g; 10 min; 4°C). Pellets were washed once with 5 ml sterile PBS, centrifuged as above, 
resuspended in 0.5 ml of 0.2 M glycine–HCl pH 2.2 and incubated at RT with rotation for 30 min. 
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Preparations were then centrifuged at 10,000 x g rpm for 15 min at 4 °C. Supernatants were 
recovered and pH adjusted to pH 6 – 8 with 2 M Tris-HCl. The volume ratios were altered accordingly, 
depending on the starting volume and optical density of overnight culture. 
2.7.2. TCA protein precipitation 
C. difficile culture supernatants were harvested by centrifugation (4,000 x g; 10 min; 4°C). 
Trichloroacetic acid (TCA) was added to a final concentration of 10%. Samples were vortexed briefly, 
incubated on ice for 30 min and precipitated twice with ice-cold 90% acetone. Protein pellets were 
incubated at 50°C for 5 min to evaporate any residual liquid and re-suspended to OD600 20 in PBS. 
2.7.3. Membrane fractionation 
C. difficile was grown O/N, harvested by centrifugation (5,000 x g; 10 min; 4°C) and frozen 
down at -80°C. Frozen bacterial pellets were re-suspended in PBS containing 1.4 mg/ml lysozyme 
and 0.12 µg/ml DNaseI to an OD600 of 20 and incubated at 37°C for 1 h. Membranes were harvested 
by centrifugation at 25,000 x g for 10 min at 4°C. The supernatant, containing the soluble 
cytoplasmic proteins, was removed and mixed with an equal volume of 2 x Laemmli sample buffer 
(4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125M Tris-HCl, pH 6.8). 
The harvested membranes were washed twice with 500 µl PBS, re-suspended in PBS and solubilised 
with 1% SDS to a final equivalent OD600 of 20 and mixed with an equal volume of 2 x Laemmli sample 
buffer. 
2.7.4. Protein cross-linking 
200 ml of exponentially growing C. difficile cultures was pelleted (5,000 x g; 10 min), 
washed with 10 ml of PBS and re-suspended in 10 ml PBS containing 0.1% - 1% formaldehyde. The 
cross-linking reaction was carried out at 37°C for 10 – 60 min and was then quenched by adding 2 ml 
of 1 M glycine and incubating for 10 min at RT. Cultures were pelleted (5,000 x g; 10 min), freeze-
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thawed thrice and re-suspended in 5 mL 1× SMM buffer [0.5 M sucrose; 20 mM MgCl2; 20 mM 
morpholineethanesulfonic acid (Mes), pH 6.5] supplemented with lysozyme (1.4 mg/ml), amidase (3 
µg/ml) and protease inhibitor mixture (1 tablet of cOmplete Mini, EDTA-free (Roche) per 10 ml of 
buffer). Following 1 h of incubation at 37°C, cultures were pelleted and resuspended in 5 ml buffer H 
(200 mM NaCl; 1 mM DTT; 100 nM MgCl2; 100 nM CaCl2; 20 mM Hepes, pH 8) supplemented with 5 
µg/ml DNase I (Sigma) and 10 µg/ml pre-boiled RNase (Roche). Following 1 h of incubation on ice, 
the insoluble fraction was pelleted (16,000 x g; 30 min; 4°C) and re-suspended in 2 ml CoIP lysis 
buffer (50 mM Tris-HCl; pH 7.4, 150 mM NaCl; 1 mM EDTA; 1% (v/v) Triton X-100) and incubated for 
30 min on ice. The membrane suspension was cleared of insoluble cell debris via centrifugation 
(16,000 x g; 10 min; 4°C), mixed with 80 µl of anti-FLAG M2 affinity gel (Sigma), pre-equilibrated by 
in CoIP wash buffer (50 mM Tris-HCl; pH 7.4, 150 mM NaCl; 1 mM EDTA) and incubated O/N at 4°C 
with agitation. The following day, the samples were applied to a 5 ml gravity flow column (Bio-Rad) 
and washed thrice with 1 ml CoIP lysis buffer. Flag-tagged protein was eluted with 200 µl FLAG 
elution buffer (CoIP wash buffer containing 3x FLAG peptide at 150 µg/ml). Residual protein was 
eluted by washing the column twice with 200 µl CoIP wash buffer. The resulting protein sample was 
concentrated on an Amicon Ultra Centrifugal Filter Unit (10,000 kDa MWCO) to a volume of 40 µl 
according to manufacturer’s instructions. Concentrated samples were split evenly into two samples, 
and each sample was mixed with 20 μl 2× Laemmli sample buffer containing 5% (v/v) β-
mercaptoethanol. One sample was heated at 90°C for 1 h to break the cross-links, while the other 
sample was stored on ice. Samples were separated by SDS-PAGE as described below. 
2.7.5. SDS-PAGE and Coomassie staining 
Protein samples were analysed by electrophoresis under denaturing conditions using 
polyacrylamide gels in the presence of SDS. 0.75 mm gels were prepared using an 
acrylamide:bisacrylamide ratio of 29:1 according to standard protocols. Gel percentage was adjusted 
depending on the size of analysed proteins. Samples were mixed with an equal volume of 2x 
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Laemmli sample buffer and boiled for 5 min before loading onto the gel. Electrophoresis was carried 
out in a vertical Mini Protean II apparatus (Bio-Rad) at constant voltage (200 V), until the dye front 
reached the bottom of the gel. Proteins were stained with Coomassie Blue R-250 (1 h at RT), 
followed by destaining overnight (40% methanol (v/v), 10% acetic acid (v/v) overnight. Gels were 
scanned using an Epson Perfection V750 Pro scanner running SilverFast software. 
2.7.6. Semi-dry transfer 
Following SDS-PAGE, proteins were transferred onto PVDF membranes by semi-dry 
transfer. The transfer stack was assembled as follows. Two pieces of Whatman 3MM filter paper 
soaked in Anode buffer I (300 mM Tris-HCl in 10% methanol, pH 10.4), followed by one piece of filter 
paper soaked in Anode buffer II (25 mM Tris-HCl in 10% methanol, pH 9.4), followed by PVDF 
membrane wet with methanol, washed with water and soaked in Anode buffer II, followed by the 
gel soaked in Cathode buffer 40 mM glycine; 25 mM Tris-HCl in 10% Methanol, pH 9.4) followed by 
three pieces of filter paper soaked in Cathode buffer. Transfer was carried out for 15 min at a 
constant voltage of 15V. Following transfer, membranes were stained (0.1% Ponceau S (w/v) in 5% 
acetic acid) to visualise the molecular weight marker, destained in water and dried. 
2.7.7. Western blotting 
Following protein transfer, membranes were incubated with primary antibodies in 3% 
skimmed milk in PBS for 1h at RT. After washing the membrane with PBS, HRP-conjugated secondary 
antibodies were applied in 3% milk in PBS and incubated as above. The membranes were washed 
with PBS once more and developed using SuperSignal West Pico chemiluminescence substrate. 
Signal was detected using a Las 4000 imager (Fuji). A complete list of primary and secondary 
antibodies used throughout this study is provided in Appendix A, Table A4. 
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2.7.8. Peptide mass fingerprinting 
Peptide mass fingerprinting was carried out in its entirety by Dr Len Packman at the Protein 
and Nucleic Acid Chemistry Facility, University of Cambridge. Following destaining, gels were fixed in 
10% MeOH. Gel bands were excised and treated as follows (30 min per step at 20oC in 200 μl 100 
mM ammonium bicarbonate/50% acetonitrile). Firstly, samples were reduced with 5 mM tris(2-
carboxyethyl)phosphine. Secondly, samples were alkylated by addition of iodoacetamide (25 mM 
final concentration). Finally, excess liquid was removed and the bands were washed.  Gel pieces 
were dried in vacuo for 10min and 25 μl 100 mM ammonium bicarbonate containing 10 μg/ml 
modified trypsin (Promega). Digestion was carried out for 17h at 32oC. Peptides were recovered and 
desalted using μC18 ZipTip (MIllipore) and eluted to a MALDI target plate using 2 μl alpha-cyano-4-
hydroxycinnamic acid matrix (Sigma) in 50% acetonitrile, 0.1% trifluoroacetic acid. Peptide mass was 
determined using a MALDI micro MX mass spectrometer (Waters) in reflectron mode and analysed 
with Masslynx software. Database searches of the mass fingerprint data were performed using 
Mascot (http://www.matrixscience.com). For tandem MS/MS analysis, desalted peptides in 70% 
MeOH, 0.2% formic acid were delivered to a ThermoFinnigan LCQ Classic ion-trap mass 
spectrometer using a static nanospray needle (Thermo Proxeon). Peptide masses of interest were 
manually selected for fragmentation using manufacturer-recommended settings. Fragment ions 
were matched to possible sequence interpretations using MS-Product and/or MS-Tag 
(http://prospector.ucsf.edu/). 
 
2.8. Microscopy 
2.8.1. Phase contrast and immunofluorescence microscopy 
1 ml of sample was centrifuged at 5,000 x g for 10 min at 4°C, washed with 1 ml of PBS and 
fixed with 0.5 ml 3.7% formaldehyde in PBS for 15 min at RT. Following fixation, samples were 
washed with PBS, incubated in 0.5 ml 20mM NH4Cl for 15 min, washed with PBS once more and 
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dried onto glass slides. For immunofluorescence microscopy, samples were incubated with primary 
antibodies (1:20 dilution) in 10% donkey serum for 45 min, rinsed with PBS and incubated with 
secondary antibodies (1:200 dilution) in 10% donkey serum for another 45 min in the dark. Following 
a final rinse with PBS, slides were mounted in 3 µl of ProLong Gold Anti-fade reagent (Invitrogen). 
DNA staining was carried out by adding Hoechst 33258 dye to the mounting medium to a final 
concentration of 20µg/ml. Images were captured using an Eclipse E600 microscope (Nikon) with a 
100x oil immersion lens and a Retiga-400R Charge Coupled Device (Q-Imaging). 
2.8.2. Transmission electron microscopy (TEM) 
Transmission electron microscopy was done in collaboration with Dr David Goulding 
(Sanger Institute). Pelleted spores were re-suspended in a freshly prepared primary fixative 
containing 2% paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) 
with added magnesium and calcium chloride at 0.1% and 0.05%, respectively, at RT for 10 min 
before transfer to an ice bath for the remainder of 2 h. The spores were pelleted again at 5,000 x g 
and were rinsed three times, for 10 min each time, in sodium cacodylate buffer with added chlorides 
on ice. Secondary fixation with 1% osmium tetroxide in sodium cacodylate buffer only was carried 
out at RT for 1 h. All subsequent steps were performed at RT. Spores were rinsed three times in 
cacodylate buffer over 30 min and were mordanted with 1% tannic acid for 30 min, followed by a 
rinse with 1% sodium sulfate for 10 min. The samples were dehydrated through an ethanol series of 
20%, 30% (staining en bloc with 2% uranyl acetate at this stage), 50%, 70%, 90%, and 95% for 20 min 
at each stage and then were subjected to 100% ethanol three times (for 20 min each time). This step 
and all subsequent steps were carried out on a rotator to aid infiltration through the spore coat. 
Ethanol was exchanged for propylene oxide (PO) twice, for 15 min each time, followed by a 1:1 
mixture of PO and Epon resin for at least 1 h and undiluted Epon (with a few drops of PO) overnight. 
The spores were embedded in a flat molded tray with fresh resin and were cured in an oven at 65°C 
for 24 h. Sections (thickness, 40 nm) were cut on a Leica UCT ultramicrotome, contrasted with uranyl 
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acetate and lead citrate, and imaged on a 120-kV FEI Spirit BioTWIN transmission electron 
microscope using an F415 Tietz charge-coupled device camera. 
2.9. Microarray analysis 
2.9.1. Microarray design 
The microarray was constructed by determining all unique genes from the predicted coding 
sequences of C. difficile strains 630, QCD-32g58, 196, R20291 plasmid pCD630. Multiple optimal 
hybridisation 60-mer oligonucleotide sequences were designed (Oxford Gene Technologies), from 
which a minimal non-redundant subset of oligonucleotides were selected with a target coverage of 
three 60-mers per gene. Arrays were manufactured on the Inkjet in situ synthesized platform 
(Agilent) using the 8x15k format. 
2.9.2. RNA labelling 
5 µg of RNA in 21 µl of nuclease-free water was incubated with 5 µl of random primers for 
3 min at 95°C and chilled on ice for 5 min. 24 µl  of reaction mixture (10 µl 5x First Strand Buffer; 5 µl 
10x dNTPs; 5 µl DTT; 2.5 µl Super Script II (Invitrogen); 1.5 µl Cy3) was added. Samples were 
incubated for 10 min at 25°C and for 90 min at 42°C and then cleaned-up using the PCR Purification 
MiniElute Kit (Qiagen) according to manufacturer’s guidelines. 
2.9.3. DNA labelling 
1 µg of gDNA in 26 µl of nuclease-free water was incubated with 5 µl of random primers for 
3 min at 95°C and chilled on ice for 5 min. 19 µl of reaction mixture (10 µl 5x buffer, 5 µl 10x dNTPs, 
1.5 µl Exo-Klenow, 1.5 µl Cy5) was added. Samples were incubated for 2h at 37°C and then cleaned-
up using the PCR Purification MiniElute Kit (Qiagen) according to manufacturer’s guidelines. 
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2.9.4. Hybridization, washing and scanning 
9 µl of Cy3-labled cDNA and Cy5-labled gDNA were mixed with 4.5 µl of 10x Blocking Agent 
and 22.5 µl of Hybridization buffer and incubated for 3 min at 95°C and for 30 min at 37°C. Samples 
were then applied to a C. difficile OGT array CDv2.0.1 (BµG@S) and incubated for 24h in a 
hybridization oven set to 65°C. The microarray slide was washed for 5 min in wash buffer 1, 1 min in 
wash buffer 2 pre-heated to 37°C, fixed in acetonitrile for 1 min and dried in Stabilization and Drying 
Solution for 30 s. Microarrays were scanned using an Agilent G2565CA Scanner. 
2.9.5. Data analysis 
Microarray data extraction was performed using ImaGene software (BioDiscovery), and 
further processed using MAVI Pro software (MWG Biotech). Normalization and statistical analysis 
were performed using GeneSpring v7.3.1 software (Agilent Technologies). Gene specific data was 
derived from average intensity of between 1 and 5 oligonucleotide reporters. Gene values below 
0.01 were set to 0.01. Each gene's measured intensity was divided by its control channel value in 
each sample; if the control channel was below 10 then 10 was used instead. If the control channel 
and the signal channel were both below 10 then no data was reported.  Each measurement was 
divided by the 50th percentile of all measurements in that sample. Replicate timepoints were 
normalized to the 180 minute time point: each measurement for each gene was divided by the 
median of that gene's measurements in the corresponding control samples. Following the initial 
experiment covering eight time points (0', 15', 30', 45', 60', 90', 120' and 180'), two additional 
biological replicates were carried out for time points 30', 60', 90' and 180'. Each time point was 
independently tested versus 180 min using 1-way ANOVA using Benjamini-Hochberg multiple testing 
correction and p=0.01 or 0.05. 
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2.9.6. Accession numbers 
The array design (CDv2.0.1) is deposited in BmG@Sbase (Accession No. A-BUGS-49; 
http://bugs.sgul.ac.uk/A-BUGS-49) and ArrayExpress (Accession No. A-BUGS-49). Fully annotated 
microarray data have been deposited in BmG@Sbase (accession number E-BUGS-145; 
http://bugs.sgul.ac.uk/E-BUGS-145) and also ArrayExpress (accession number E-BUGS-145). 
2.10. Transposon mutagenesis and TraDIS 
2.10.1. Plasmid construction 
Plasmid pRPF215 used to create a transposon mutant library in C. difficile was designed 
and constructed in its entirety by Dr Robert Fagan. Briefly, codon-optimised Himar1 hyperactive C9 
transposase (Lampe et al., 1999) was cloned into pRPF177, a plasmid carrying the inducible Ptet 
promoter but lacking a transcriptional terminator directly downstream of tetR gene. The Mariner-
based transposon was generated by PCR amplifying the ermB gene from pMTL82254 and adding a 
transcriptional terminator and the transposon inverted terminal repeats (ITRs) in successive PCR 
reactions. The resulting DNA fragment was cloned downstream of the transposase giving pRPF215. 
2.10.2. Library construction 
Plasmid pRPF215 was conjugated into C. difficile 630Δerm as described above. Pure 
transconjugant colonies were used to inoculate 5 ml O/N cultures in TY broth supplemented with 15 
µg/ml thiamphenicol. These were sub-cultured the following morning, grown to OD 0.3 and spread 
out on pre-reduced BHIS agar supplemented with 5 µg/ml erythromycin and 100 ng/ml 
anhydrotetracycline (ATc) to allow for Himar1-mediated transposition (150 square Petri dishes 
[120mm x 120mm] were used). Following O/N incubation colonies were scraped of in TY broth and 
the resulting culture (input library) was used to inoculate 20 ml nutrient-rich TYG broth 
supplemented with 5 µg/ml erythromycin and 100 ng/ml ATc. The following day the resulting culture 
was sub-cultured 1:10 in 20 ml SM broth supplemented with 5 µg/ml erythromycin and 100 ng/ml 
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ATc, grown to OD 0.6 and spread out on SM agar plates to induce sporulation. Spores were 
harvested and purified as described above (spore library) and incubated O/N in BHIS broth 
supplemented with 0.5% Tch to allow for spore germination and outgrowth (germinated library). 
2.10.3. Transposon-Directed Insertion Site Sequencing (TraDIS) 
TraDIS was carried out at the Wellcome Trust Sanger Institute. Briefly, genomic DNA was 
extracted from the three and fragmented to an average size of 300bp using Covaris Focused-
Ultrasonicator. Illumina sequencing adapters were ligated, according to the manufactures 
instructions and purified using Ampure XP beads. Fragments containing the transposon were PCR 
enriched using transposon and adapter-specific primers to enrich for transposon containing 
fragments. The PCR products were purified before being quantified by qPCR. Single end sequencing 
was performed on the enriched fragments using an Illumina Hiseq 2500 sequencer.  
2.10.4. Data analysis 
TraDIS data analysis was carried out in its entirety by Dr. Christine Boinett and Dr. Amy Cain 
at the Wellcome Trust Sanger Institute as described in Myho et al. (in press). Briefly, approx. two 
million reads per samples were generated. Illumina FASQ files containing 50 bp reads were parsed 
for 100% identity to the transposon. The tags were stripped from the resulting reads and mapped 
back onto their corresponding references using SMALT-0.7.2 and the precise insertion site of the 
transposon was determined. 
2.11. Phenotypic assays 
2.11.1. Sporulation efficiency assay 
C. difficile O/N cultures were sub-cultured to OD600 0.1 in fresh, pre-reduced medium, 
allowed to reach logarithmic growth phase (OD ~ 0.6) and sub-cultured once more to OD600 0.1. 
These were then used to inoculate 10 ml of fresh, pre-reduced medium in order to synchronise the 
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culture and minimise the amount of spores carried over from the initial culture. Upon reaching 
stationary phase (T0) 0.5 ml samples were taken, 10-fold serial dilutions were prepared and spotted 
in triplicate onto BHIS agar + 0.1% Tch (total counts). For spore counts, samples were incubated at 
70°C for 30 min, prior to dilution. Colonies were enumerated after 24h of incubation at 37°C under 
anaerobic conditions. In addition, in order to differentiate between germination and sporulation 
defects the entire experiment was monitored via phase-contrast microscopy. 
2.11.2. Spore chemical resistance assay 
Purified C. difficile spores were re-suspended in 5 ml of sterile water, 70% EtOH, lysozyme 
solution (250 µg/ml), 1% Virkon or 1% ParaSafe to OD600 0.1. At given time points 0.5 ml samples 
were taken, centrifuged at 10,000 x g for 1 min, washed with 1 ml of sterile water and re-suspended 
in 0.5 ml of sterile water. 10-fold serial dilutions were prepared and 20 µl drops were spotted in 
triplicate onto BHIS agar + 0.1% Tch. Colonies were enumerated after 24h of incubation at 37°C 
under anaerobic conditions. 
2.11.3. Spore thermal resistance assay 
Purified C. difficile spores were re-suspended in 1 ml of sterile water to OD600 0.1 and 
incubated at 60°C, 70°C or 80°C for 24h. At given time points, 10-fold serial dilutions were prepared 
and 20 µl drops were spotted in triplicate onto BHIS agar + 0.1% Tch. Colonies were enumerated 
after 24h of incubation at 37°C under anaerobic conditions. 
2.11.4. Germination dynamics assay 
Purified C. difficile spores were re-suspended in 10 ml of BHIS + 0.5% Tch to OD600 1. The 
gradual drop in OD600 due to Ca2+-DPA release was monitored over time and expressed as relative 
OD600 (OD600 tx/OD600 t0). In addition, for each time point 0.5 ml samples were taken, 10-fold serial 
dilutions were prepared and spotted in triplicate onto BHIS agar + 0.1% Tch (total counts). For spore 
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counts, samples were incubated at 70°C for 30 min, prior to dilution. Colonies were enumerated 
after 24h of incubation at 37°C under anaerobic conditions. The germination process was 
additionally monitored via phase contrast and fluorescence microscopy as described in paragraph 
8.1. 
2.11.5. Swimming motility assay 
Swimming motility was assessed by inoculating a plate of 0.3% BHIS agar with 1 µl of O/N 
culture. Growth was monitored over 96 h. The non-motile C. difficile 630 Δerm fliC::erm strain was 
used as a negative control. 
2.11.6. Capsule staining 
O/N cultures of C. difficile were mixed 1:1 with 1% (w/v) aqueous Congo Red and dried 
onto a poly-L-lysine-coated glass slide. Slides were flooded with modified Maneval Solution (3.0 g of 
ferric chloride; 5% (v/v) acetic acid; 3.9 ml of phenol; 95 ml of distilled water) and incubated for 5 
min at RT. Excess liquid was blotted, slides were gently washed with water, dried, mounted in water 
and imaged as described in paragraph 8.1. 
2.12. Bioinformatics 
Routine operations on DNA and protein sequences including sequence visualisation, 
sequence alignment, sequencing result analysis, in silico cloning and creation of plasmid maps were 
carried out using Geneious 5.6.5 (Biomatters). Protein parameters including molecular weight and 
isoelectric point calculation as well as prediction of hydrophobic regions and secondary structure 
were done using tools from the ExPASy website (http://www.expasy.ch/tools). Signal peptide 
predictions were done using SignalP (http://www.cbs.dtu.dk/services/SignalP/) or LipoP 
(http://www.cbs.dtu.dk/services/LipoP/). Bacterial promoter regions were predicted using Softberry 
BPROM (http://www.softberry.com). Primers for Gibson Assembly vectors were designed using 
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NEBuilder (http://nebuilder.neb.com/). TraDIS plots were viewed using Artemis 
(http://www.sanger.ac.uk/resources/software/artemis/). 
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Chapter III 
Characterisation of C. difficile 630 sporulation and 
germination dynamics 
3.1. Introduction 
It is well established that sporulation efficiency can vary greatly depending on the choice of 
growth medium (Errington, 1993). While the mechanism of B. subtilis sporulation has been well 
characterised over the years and the optimal conditions for spore development have been described 
(Schaffer et al, 1965), a molecular description of the sporulation mechanisms of C. difficile has been 
lacking and the precise conditions for optimal C. difficile sporulation remain to be elucidated. As a 
consequence, even though reproducible methods for preparing B. subtilis spores and measuring 
sporulation efficiency have been known for a number of years, there have been few published 
examples of using these methods to study sporulation in C. difficile and the ones that have been 
published vary significantly from study to study in the methodologies used (reviewed in Burns and 
Minton, 2011). To date, brain-heart infusion (BHI) has been the most commonly used medium for 
inducing C. difficile sporulation, used neat or supplemented with 0.1% L-cysteine and 0.5% yeast 
extract (BHIS) (Sorg and Sonenshein, 2008, Sorg and Sonenshein, 2009, Sorg and Sonenshein, 2010, 
Burns et al., 2010b, Burns et al., 2010a, Underwood et al., 2009). In other studies, trypticase 
peptone sporulation medium (SM) more commonly known as Wilson’s broth has been suggested as 
an optimal medium for inducing C. difficile sporulation (Lawley et al., 2009, Wilson, 1983, Wilson et 
al., 1982, Deakin et al., 2012, Pereira et al., 2013). Germination has also been extensively studied in 
B. subtilis and the signals known to stimulate germination of B. subtilis spores have been well 
described (reviewed in Setlow, 2003). Yet, at the onset of this study, only the bile salt taurocholate 
together with glycine have been strongly linked to stimulating germination of C. difficile spores, 
improving spore recovery on solid media (Wilson et al, 1982; Wilson, 1983). 
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In the first part of this chapter I set out to establish a platform for studying sporulation in C. 
difficile and the phenotypic analysis of sporulation-deficient mutants. A number of C. difficile 
sporulation methods have been tested and the corresponding sporulation efficiency has been 
assessed in order to establish the optimal conditions for large scale spore production. Spore 
purification methods have been optimised to facilitate the rapid removal of cell debris and 
vegetative cells from sporulated cultures and the properties of the resulting spore preparation have 
been analysed. Finally, in the second part of this chapter the optimal germination conditions for C. 
difficile spores have been assessed in preparation for transcriptional analysis of temporal gene 
expression patterns during germination and outgrowth. Some of the results presented here have 
been published in Dembek et al. (2013) and are referenced accordingly. 
3.2. Results 
3.2.1. Identification of conditions suitable for efficient C. difficile sporulation 
As part of preliminary work leading up to studying germination in C. difficile, an efficient 
method for producing large quantities of spores had to be developed. To this end, previously existing 
sporulation protocols were refined and optimized to ensure reproducible results and the highest 
possible yields. C. difficile 630 (tcdA+, tcdB+; PCR ribotype 012) a virulent, multidrug-resistant, 
epidemic strain was chosen for our analysis as its full genome sequence has been published 
(Sebaihia et al., 2006) and its culture under laboratory conditions has been well defined. 
Sporulation was induced through nutrient starvation in BHI broth, BHIS broth or SM broth 
and its efficiency was assessed over a period of 5 days by measuring the number of colony forming 
units (CFU) on agar plates after incubation at 70°C for 30 min. The rationale for this approach is that 
only spores will survive heat treatment and the colonies recovered on plates are therefore 
representative of spores within the population. By comparing the number of spore CFUs to the 
number of total CFUs obtained from samples that were not heat-treated, one can assess the 
dynamics of sporulation and its efficiency. In addition, at each time point, spore formation was 
85 
Chapter III. Characterisation of C. difficile sporulation and germination dynamics 
 
monitored via phase contrast microscopy. As O/N cultures of C. difficile may contain varying 
amounts of spores, in order to minimise potential spore carry-over and the resulting bias in spore 
counts, starter cultures were sub-cultured twice and grown to stationary phase (t0) prior to starting 
the experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. C. difficile 630 sporulation efficiency in liquid media and on solid media. O/N cultures of C. difficile 630 were 
sub-cultured to OD 0.01 in (A) BHI broth, (B) BHIS broth, (C) SM broth, grown to exponential phase and sub-cultured once 
more in order to prevent spore carry-over. At given time points, 10-fold serial dilutions were prepared and spotted in 
triplicate onto BHIS agar supplemented with 0.1% Tch. Colonies were enumerated following 24h of incubation in an 
anaerobic cabinet. For spore counts, samples were heat-treated at 70°C for 30 min before diluting. (D) O/N cultures of C. 
difficile 630 were sub-cultured in SM broth, grown to exponential phase and plated onto SM agar plates. At given time 
points, growth from each plate was scraped off in 1 ml of sterile PBS, 10-fold serial dilutions were prepared and spotted in 
triplicate onto BHIS agar supplemented with 0.1% Tch. Colonies were enumerated following 24h of incubation in an 
anaerobic cabinet and expressed as CFU/ml of initial SM broth culture at t0. Data represented as means ± SD from three 
biological replicates. Limit of detection is marked with a horizontal dotted line. 
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As shown in Figure 3.1, no heat-resistant CFUs could be detected at the onset of the 
experiment (t0). This number grew to approx. 5 x 105 CFU/ml within the first 24h. Irrespective of the 
medium used, maximum spore yields were detected within 48h and remained relatively constant 
reaching a maximum of 2.68 x 106 CFU/ml in BHI, 2.25 x 106 CFU/ml in BHIS and 1.05 x 106 CFU/ml in 
SM (Figure 3.1A, 3.1B and 3.1C). This corresponds to a sporulation efficiency of 0.4%, 0.73% and 
1.66% for BHI, BHIS and SM respectively, expressed as max spore CFU recorded throughout the 
experiment/total CFU at t0. 
Phase contrast microscopy of the sporulating liquid cultures revealed that while the typical 
morphological stages of spore formation could be observed throughout the experiment, a vast 
majority of cells lysed within 24 hours from initiation of sporulation (t0) (Figure 3.2). This suggests 
that only a subset of the initial population would eventually undergo sporulation, possibly explaining 
the relatively low sporulation efficiency described above. Furthermore, even though a vast majority 
of the population sporulated within 24-48h from initiation, the process was highly asynchronous as 
single, sporulating cells could be seen even five days into the experiment. This underlines the 
heterogeneity of bacterial population in regards to sporulation, a phenomenon previously reported 
in B. subtilis (Chung and Stephanopoulos, 1995, Grossman, 1995, Veening et al., 2005). 
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Figure 3.2. Phase contrast microscopy of sporulating C. difficile 630. Sporulating cultures were harvested at given time 
points, fixed with 3.7% formaldehyde and dried onto glass slides. Significant cell lysis can be observed in BHI broth, BHIS 
broth and SM broth but not SM agar. Fully developed, phase-bright spores are visible in all cultures. Microscopy data 
representative of three biological replicates. Scale bar provided. 
88 
Chapter III. Characterisation of C. difficile sporulation and germination dynamics 
 
In order to overcome the low sporulation efficiency observed in liquid media, a combination 
of nutrient starvation and desiccation on solid medium was employed (Permpoonpattana et al., 
2011, Putnam et al., 2013). In this method, starter cultures grown in nutrient medium (TGY broth) 
are sub-cultured into minimal medium (SM broth), allowed to reach exponential growth phase, 
plated onto SM agar and incubated for 5-7 days. At given time points, the growth from each plate 
was re-suspended in sterile PBS and the number of total and heat-resistant spore CFUs was 
measured and expressed as CFU/ml of initial SM broth culture at t0. As previously, maximum spore 
yields were observed within 48h and reached 7.76 x 108 CFU/ml corresponding to a sporulation 
efficiency of 59.38%, a 2-log increase when compared to results obtained in liquid culture (Figure 
3.1D). Importantly, when compared to sporulating liquid cultures, significantly less lysis was 
observed. SM agar was therefore used in subsequent experiments as the optimal method for 
producing C. difficile spores. 
3.2.2. Spore purification 
Transcriptional analysis of germination would require spore preparations of the highest 
purity, free of vegetative cells and residual cell debris as these could interfere with downstream 
analysis. To this end, a protocol for purifying spores had to be developed. While a number of such 
methods have been published (Lawley et al., 2009, Permpoonpattana et al., 2011), most involve the 
use of detergents, lysozyme and sonication in order to separate spores from cell debris. Such harsh 
treatment could potentially disrupt the outer layers of the spore and in result affect its ability to 
germinate. Therefore a more gentle protocol based on density gradient centrifugation was adapted. 
The purity of the resulting spore suspension was confirmed using phase contrast microscopy, 
revealing mature, phase-bright spores, free of vegetative cells and cell debris (Figure 3.3A and 3.3B). 
Transmission Electron Microscopy (TEM) analysis of the purified spores revealed the typical spore 
ultrastructure observed in other Gram-positive sporeformers, with concentric layers corresponding 
to the inner core surrounded by a primordial germ cell wall, a thick cortex and an electron-dense 
89 
Chapter III. Characterisation of C. difficile sporulation and germination dynamics 
 
proteinacious coat (Figure 3.3C and 3.3D). A closer examination revealed further details of this layer, 
including laminations resembling the striated outer coat of Bacillus spores. An additional, 
fragmented layer, most probably corresponding to the exosporium could also be observed, loosely 
associated with the spore coat, consistant with previous observations of C. difficile spores 
(Permpoonpattana et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Phase contrast and TEM images of C. difficile 630 endospores. (A) Crude spore preparation contaminated 
with vegetative cells and cell debris. (B) Spore preparation after purification containing phase-bright endospores, free of 
contaminants (C and D) TEM images of spore ultrasections. Concentric layers corresponding to the spore core (Cr), cortex 
(Cx) and coat (Ct) can be observed. Arrows indicate fragments of putative exosporium basal layer loosely associated with 
the outer coat. Scale bars provided. 
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3.2.3. Characterisation of spore resistance to environmental stresses 
Due to their multi-layered structure, spores are resistant to most chemical and physical 
insult including extremes of temperature and pH, high pressure, irradiation, desiccation, enzyme 
action as well as a variety of noxious chemicals (reviewed in Setlow, 2006). In order to confirm that 
the purification process has not detrimentally affected the integrity of the spore, heat and chemical 
resistance was assessed. Previous studies have shown that C. difficile spores are able to survive 
incubation at 60-80°C for 10-30 min without loss of viability (Burns et al., 2010a). Indeed, when 
incubated at temperatures below 80°C, no significant changes in spore viability were observed up to 
24 hours into the experiment. In contrast, spores incubated at 80°C showed a gradual decrease in 
viability with a 2-log decrease at 4 hours, 4-log decrease at 8h and complete loss of viability at 24h 
into the experiment (Figure 3.4A). As expected, neither ethanol nor lysozyme treatment had any 
noticeable effect on spore viability. Interestingly, Virkon, an oxidant-based, multi-purpose 
disinfectant used in hospitals, laboratories and nursing homes was only marginally effective in killing 
C. difficile spores, with a 2-log decrease in spore viability 2 hours into the experiment. In contrast, 
PERAsafe® (0.2% paracetic acid) originally developed as a safer alternative to 2% activated 
glutaraldehyde, with documented activity against spores, showed the highest efficiency in spore 
killing out of all the chemicals tested, as no viable spores could be detected 90 min after exposure 
(Figure 3.4B). Taken together these results show that (i) purified spores show the same level of 
thermal and chemical resistance as indicated previously in literature and that (ii) Virkon does not 
show sufficient sporicidal activity to be used against C. difficile spores as reported previously by 
Dawson et al. (2011). 
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Figure 3.4. C. difficile 630 spore thermal and chemical resistance. Purified spores (1 x 108) were resuspended in 1ml 
sterile water and (A) incubated for 24 hours at 60°C, 70°C or 80°C, (B) resuspended in 1ml sterile water, 70% EtOH, 
lysozyme in PBS (250µg/ml), 1% Virkon or 1% PERASafe™. The viability of heat treated or chemically treated spores was 
assessed at given time points by measuring spore CFUs following plating of 10-fold serial dilution in triplicate onto BHIS 
agar supplemented with 0.1% Tch. Data represented as means ± SD from thre technical replicates. Limit of detection 
indicated as a horizontal dashed line. 
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3.2.4. Characterisation of spore germination dynamics 
In order to carry out a transcriptional analysis of the temporal gene expression during 
germination, it was first necessary to gain more insight into the dynamics of the process. To this end, 
the time required for germination, the morphological changes that accompany it and the optimal 
conditions for germination were analysed. Spore germination is typically measured as a drop in 
optical density (OD) of a spore suspension, resulting from an alteration to the spore’s optical 
properties, that occurs with the release of dipicolinic acid (DPA) from the spore core (Setlow, 2003). 
This is then followed by an increase in OD600, correlated with outgrowth and cell division as the cells 
re-enters vegetative growth. OD600 measurement of liquid cultures containing germinating C. difficile 
630 spores, combined with total/spore CFU counts and phase-contrast microscopy revealed that 
>99.9999% of the spore population undergoes germination when grown in nutrient medium (BHIS) 
supplemented with the germinant, sodium taurocholate (Tch) as indicated by a rapid decrease in 
OD600 (approx. 50% of initial value within 5 minutes of induction) and a 5-log drop in the number of 
recovered spore CFUs (Figure 3.5A and 3.5C). Importantly, basing on phase contrast and 
fluorescence microscopy analysis, spore germination in nutrient medium supplemented with an 
excess of Tch (0.5%) was largely synchronous and appeared to be complete within 180 min from 
induction. This would be critical in subsequent transcriptomic analysis of gene expression during 
germination as it ensured that the population was in the same phase of germination. No significant 
difference in germination was observed between cultures incubated in the presence of 0.1%, 0.5% 
and 1% of Tch (data not shown). 
Microscopic analysis revealed that immediately upon induction of germination, the 
dormant spores lost their phase-bright appearance and increased in volume, presumably due to 
Ca2+-DPA release and subsequent rehydration of the spore core, resulting in increased susceptibility 
to Hoechst 33258 DNA staining (0 - 30 min). This was followed by hydrolysis of cortex peptidoglycan, 
breakdown of the outer spore layers on one of the cell poles and shedding of the empty coat ‘shell’ 
during outgrowth (45-60 min). Upon removal of these ‘physical constraints’, germinating cells 
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entered a phase of longitudinal growth, coinciding with DNA replication, and followed by symmetric 
cell division (60-180 min) (Figure 3.6A and 3.6B). In contrast, spores grown in medium devoid of the 
germinant failed to germinate, as no changes in OD600, spore CFU count or spore morphology could 
be observed throughout the 6h incubation period (Figure 3.5A and 3.5D; Figure 3.6D). Interestingly, 
no germination was observed when liquid cultures were incubated aerobically, presumably due to 
the inhibitory presence of oxygen. Even though a decrease in OD600 and spore CFUs was observed 
immediately after induction with Tch, and the spores lost their phase-bright appearance (indicative 
of Ca2+-DPA release and core rehydration), becoming susceptible to DNA staining, progression to 
outgrowth was not observed. These compromised spores were eventually killed, as indicated by the 
gradual drop in total CFUs (Figure 3.5A and 3.5C; Figure 3.6C). This is consistent with recent findings 
(Nerandzic and Donskey, 2010) and suggests that oxygen is a negative regulator of C. difficile 
endospore germination acting downstream of any signalling events that induce germination. 
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Figure 3.5. Growth characteristics during spore germination and outgrowth. Purified C. difficile 630 spores were 
resuspended in BHIS ± 0.5% sodium taurocholate (Tch) to an OD600 of 0.1 and incubated either aerobically or 
anaerobically for 6 h at 37°C. Growth was monitored via OD600 measurements and total/spore CFU counts. (A) C. 
difficile 630 germination dynamics growth curve. Spores incubated in the presence of 0.5% Tch showed a rapid 
decrease in OD600 immediately after re-suspension, in both aerobic and anaerobic conditions. No decrease in OD600 
was observed for spores incubated in the absence of Tch. (B) CFU counts for spores germinated anaerobically in BHIS 
+ 0.5% Tch. (C) CFU counts for spores germinated aerobically in BHIS + 0.5% Tch. (D) CFU counts for spores 
germinated anaerobically in BHIS. Data reported as mean ± SD from three biological replicates. Previously published 
in Dembek et al. (2013). 
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Figure 3.6. Morphological changes during spore germination and outgrowth. Purified C. difficile 630 spores were re-
suspended in BHIS ± 0.5% sodium taurocholate (Tch) to an OD600 of 0.1 and incubated either aerobically or anaerobically 
for 6 h at 37°C. At given time points, samples were fixed with 3.7% formaldehyde and analysed using phase contrast 
microscopy and fluorescence microscopy following DNA staining with Hoechst 33258. (A) and (B) Spores germinated 
anaerobically in BHIS +0.5% Tch. Upon induction of germination, dormant spores lose their phase-bright appearance and 
become susceptible to DNA staining. This is followed by a gradual increase in volume and shedding of spore outer layers 
which remain visible as empty ‘shells’. Once the physical constraints of the outer spore layers are removed, the spore 
enters a phase of longitudinal growth coinciding with DNA replication followed by symmetric cell division. (C) Spores 
germinated aerobically in BHIS +0.5% Tch. Following induction of germination, spores lose their phase-bright appearance 
and become susceptible to DNA staining but fail to progress to outgrowth. (D) Spores germinated anaerobically in BHIS. 
No changes in spore appearance and no DNA staining could be observed. Previously published in Dembek et al. (2013). 
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3.3. Discussion 
While our understanding of sporulation and germination in the model organism B. subtilis is 
well grounded in years of research, studies aimed at understanding the molecular basis of 
sporulation and germination in C. difficile have been lagging behind, primarily due to the difficulties 
in culturing the pathogen, the lack of established methodologies and the scarcity of genetic tools 
necessary for studying the intricacies of C. difficile physiology. Here, an attempt was made to create 
a platform for the analysis of sporulation and germination in C. difficile, and the phenotypic 
characterisation of mutants with sporulation and/or germination defects.  
One of the primary goals was to establish a reproducible method for sporulating C. difficile. 
Considering the low sporulation efficiency in liquid culture and the significant cell lysis observed 
irrespective of the medium used, neither of the sporulation methods described to date seems to be 
optimal for efficient sporulation of C. difficile strains. While gradual desiccation on solid media 
increases spore yields and makes sporulation more homogeneous, sporulation efficiency is still 
significantly lower that than that seen in B. subtilis, suggesting that further optimisation of 
sporulation methods is necessary. Density gradient centrifugation proved to be a viable alternative 
to more complex methods of spore purification that require the use of detergents, enzymes and 
sonication, yielding spore suspensions free of noticeable contaminants. Importantly, an in-depth 
analysis of the purified spores revealed that their general characteristics including spore 
ultrastructure and their resistance to heat, chemicals and lysozyme were no different than those 
described for B. subtilis spores. 
Analysis of germination dynamics confirmed that C. difficile spores respond to the bile salt 
sodium taurocholate (Tch) as the primary germinant and that anaerobic conditions are essential for 
the completion but not initiation of germination as spores stimulated with Tch in the presence of 
oxygen did lose their phase-bright appearance but failed to progress through the remaining stages of 
germination. This is intriguing as in B. subtilis, once induced, spores are committed to continue 
through germination even if the germinant is removed (Yi and Setlow, 2010). The dynamics of the 
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germination process were significantly different than those previously described for the closely 
related C. botulinum (Broussolle et al., 2002) and C. sporogenes (Bassi et al., 2013) where initiation 
of germination was found to be a much slower process. Importantly, basing on phase contrast and 
fluorescence microscopy analysis, spore germination in nutrient medium supplemented with an 
excess of Tch was largely synchronous and appeared to be complete within 180 min from induction. 
This is somewhat surprising as germination in Bacillus species, as well as the more closely related C. 
perfringens and C. botulinum has been shown to be highly heterogeneous (Ghosh and Setlow, 2009, 
Ghosh and Setlow, 2010, Stringer et al., 2005, Wang et al., 2011), with a sub-population of spores 
failing to germinate immediately upon exposure to germinants. This phenomenon of 
'superdormancy' has been correlated with a low level of specific germination receptors in individual 
spores (Ghosh et al., 2012) and is thought to be an example of 'bet hedging', ensuring the survival of 
a given population in a rapidly changing environment. Under the conditions tested 99.9999% of the 
C. difficile 630 spore population germinated synchronously. This might be a reflection of the unique 
germination mechanism present in C. difficile and/or the fact that the human gut is a relatively 
stable environment eliminating the need for super-dormancy. 
Taken together, results presented in this chapter have provided further insight into the 
physiology of sporulation and germination in C. difficile, laying down the groundwork for the 
transcriptional analysis of the temporal gene expression patterns during germination and an in-
depth characterisation of sporulation and germination deficient mutants presented in subsequent 
chapters of this thesis.  
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Chapter IV 
Transcriptional analysis of temporal gene expression in 
germinating C. difficile 630 endospores 
4.1. Introduction 
Determination of the complete C. difficile genome sequence (Sebaihia et al., 2006) was a 
turning point in C. difficile research, paving the way for comprehensive genetic analysis of the 
pathogen’s physiology. The first studies of Clostridial gene expression using microarray platforms 
(Alsaker and Papoutsakis, 2005, Jones et al., 2008, Tomas et al., 2003) were instrumental in the 
characterisation of the cell cycle, particularly in the context of sporulation. While transcriptomic 
analysis of gene expression during germination has been carried in B. subtilis (Keijser et al., 2007) 
and more recently C. novyi-NT (Bettegowda et al., 2006) and C. sporogenes (Bassi et al., 2013), no 
such studies have been attempted in  C. difficile.  
To address this issue, in this chapter I describe the use of genome-wide transcriptome 
analysis to explore the physiological, morphological, and transcriptional changes that occur during 
three continuous steps of C. difficile 630 in vitro life cycle: spore dormancy, germination and 
outgrowth of vegetative cells, trying to elucidate some of the metabolic changes that occur during 
the transformation of a dormant spore into an actively growing vegetative cell. Results presented in 
this chapter have been published in Dembek et al. (2013) and are referenced accordingly. 
4.2. Results 
4.2.1. Optimisation of RNA extraction 
RNA quality is of paramount importance in any transcriptional analysis of gene expression. 
While a number of well-defined RNA extraction methods are available, allowing researchers to 
choose the most suitable protocol for a particular application, working with spores entails a new set 
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of challenges. This is largely due to their robust characteristics and the resulting difficulties in 
disrupting the protective layers of the spore, necessitating the use of extremely harsh lysis 
conditions which can jeopardise RNA quality. It was therefore critical to develop a method for 
extracting RNA that would not only be able to penetrate the spore outer layers and provide high 
recovery rates, but would also ensure that the integrity of RNA was maintained. A number of 
methods were tested. Mechanical disruption with silica beads followed by acid phenol-based 
extraction was shown to give the highest quality RNA, reproducibly yielding between 2 and 10 µg of 
total RNA per 108 spores. The amount of extracted RNA coincided with the status of the spore, 
increasing gradually as the spores went from dormancy, through germination to outgrowth (Figure 
4.1A). This could be explained by the increasing susceptibility of the spore envelope to lysis during 
germination and/or the initiation of RNA synthesis (Setlow, 2003). All RNA preparations were of high 
purity and integrity as indicated by a 260/280nm absorption ratio in the range of 2.05 to 2.18 and 
Bioanalyzer electropherograms showing sharp peaks suggesting little RNA degradation (Figure 4.1B 
and 4.1C). Interestingly, distinct differences in the ribosomal RNA (rRNA) profiles of spores and 
vegetative cells were observed. In addition to the 16S and 23S rRNA species, two smaller rRNA 
species were identified in dormant spores, represented by small peaks on Bioanalyzer spectra 
(Figure 4.1C). These could only be discerned in dormant spores and reduced in intensity as 
germination progressed. A similar phenomenon has been previously reported in Bacillus (Keijser et 
al., 2007) as well as the more closely related Clostridium novyi (Bettegowda et al., 2006) and 
Clostridium sporogenes (Bassi et al., 2013), although its significance remains to be elucidated. One 
could argue that these smaller species might represent rRNA fragments or be indicative of RNA 
maturation within the germinating spore (Bleyman and Woese, 1968). 
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Figure 4.1. RNA extraction and quality control. (A) Gradual increase in RNA recovery observed during spore 
germination. (B) Bioanalyzer pseudogel with RNA integrity number (RIN) values (C) Bioanalyzer electropherograms 
showing two distinct peaks corresponding to 16S and 23S rRNA. In addition, two smaller rRNA species were identified 
in dormant spores and in early germination, represented by small peaks on Bioanalyzer spectra. 5S rRNA peak visible at 
retention time 23 seconds. Previously published in Dembek et al. (2013). 
 
101 
Chapter IV. Transcriptional analysis of temporal gene expression in germinating C. difficile 630 endospores 
 
4.2.2. Microarray analysis 
4.2.2.1. Experimental design and general observations 
Total RNA samples extracted from germinating spores at eight time points representing 
dormancy (0 min), germination (15, 30, 45, 60 min) and outgrowth (90, 120, 180 min) were analysed 
by competitive RNA/DNA hybridisations using the CDv2.0.1 microarray designed and manufactured 
by the Bacterial Microarray Group at St. George’s (BµG@S). The microarray experiment itself, 
including sample preparation, hybridisation and scanning was carried out at the London School of 
Hygiene and Tropical Medicine (LSHTM) in collaboration with Dr. Richard Stabler and Prof. Brendan 
Wren. 
Gene expression was found to be highly dynamic during germination and outgrowth, 
involving a large part of the genome. Relatively few transcripts were identified in dormant spores 
(see below), consistent with their metabolically dormant state. In contrast, a significant up-
regulation of gene expression was observed immediately after induction of germination, peaking at 
30 min (Figure 4.2). Two time points were chosen for further investigation: 30 min, when all spores 
are actively germinating, and 180 min post germination, when normal vegetative growth has 
commenced.  In total, 263 genes were up-regulated and 248 genes down-regulated at 30 min when 
compared to the 180 min time point (p ≤ 0.01). The magnitude of change of the statistically up-
regulated genes ranged from 1.3-fold to 80-fold, and that of down-regulated genes ranged from 1.3- 
to 100-fold (Figure 4.2). Fully annotated microarray data have been deposited in BµG@Sbase 
(accession number E-BUGS-145; http://bugs.sgul.ac.uk/E-BUGS-145) and also ArrayExpress 
(accession number E-BUGS-145). In addition, lists of up- and down-regulated genes (p ≤ 0.01) with a 
minimum of 2-fold change in expression are included in Appendix B, Table B1 and B2 respectively. 
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Figure 4.2. All genes differentially expressed during germination. Microarray gene expression data represented as 
normalised intensity with respect to control conditions. 511 genes were found to be differentially regulated at 30 min 
into germination when compared to a vegetative cell (180 min). Data represented as means ± SD from three 
biological replicates. Analysed using 1-way ANOVA with Benjamini-Hochberg false discovery rate (FDR) correction (p ≤ 
0.01). Previously published in Dembek et al. (2013). 
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4.2.2.2. Microarray validation 
Array-based experiments are prone to artifacts which can be introduced at any stage of 
the procedure. Large datasets generated through measurements of gene expression profiles using 
microarray technology can thus be difficult to interpret and always require validation. Under most 
circumstances this has to be done on a gene-to-gene basis, as in silico confirmation is often not 
possible due to lack of previously published results. In order to validate the microarray data 
obtained in this study, semi-quantitative RT-PCR was used to confirm the temporal expression 
pattern for a number of selected genes showing a wide range of distinct expression profiles. These 
included genes encoding cell wall binding proteins: Cwp7 and Cwp10, the two toxins TcdA and TcdB 
and a putative membrane protein. In all cases, the expression profiles obtained matched those seen 
throughout the microarray experiment (Figure 4.3). 
 
 
  
Figure 4.3. RT-PCR validation of microarray results. cDNA was prepared from total RNA using reverse transcription. 
Primers internal to five selected genes were used to amplify fragments of 150 bp: (CD2782 - cell wall binding protein, 
CD2796 - cell wall binding protein, CD0663 - toxin A, CD0660 - toxin B, CD2625 - putative membrane protein). C. difficile 
630 gDNA was used as a positive control reaction. 25 reaction cycles were carried out to ensure non-saturating 
conditions. (A) microarray expression profiles (normalised to 180 minutes), (B) agarose gel electrophoresis of the PCR-
amplified DNA fragments. Previously published in Dembek et al. (2013). 
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4.2.2.3. Spore transcripts 
Despite early research hinting at the presence of mRNA in spores (Chambon et al., 1968, 
Jeng and Doi, 1974), until recently it has been generally assumed that dormant spores do not 
contain functional RNA transcripts. This view has now changed as studies conducted in B. subtilis 
(Keijser et al., 2007), C. novyi-NT (Bettegowda et al., 2006) and C. sporogenes (Bassi et al., 2013) 
have all shown that mRNA is abundant in spores and that its composition differs from that observed 
in vegetative cells. A number of explanations for this phenomenon have been suggested. Spore 
transcripts might represent mRNA that has been entrapped in the forespore during the late phases 
of sporulation and is later degraded to act as a reservoir of nucleotides during germination. Indeed, 
six out of fifteen most abundant spore transcripts identified in this study represented late-
sporulation genes such as those encoding a putative spore coat protein (CD0213), small acid-soluble 
proteins A and B (CD2688 and CD3249 respectively) and a stage IV sporulation protein (CD0783), 
while the second most abundant transcript encoded a putative Mn-dependent superoxide 
dismutase (CD1631), an orthologue of SodA found in B. subtilis, involved in oxidative cross-linking of 
spore coat proteins during the late stages of spore morphogenesis (Henriques et al., 1998, 
Permpoonpattana et al., 2011). Alternative explanations argue that transcripts might be stored to 
equip the spore with proteins that will become necessary during the transformation into a 
vegetative cell, such as those involved in metabolism, protein synthesis and secretion, transport, 
detoxification etc. One such group of transcripts present at relatively high levels in dormant spores 
were those involved in redox reactions, including an NADH oxidase (CD2540), an NADH-dependent 
flavin oxidoreductase (CD2709) as well as two putative oxidoreductase complexes with ferrodoxin 
activity (CD2197-CD2199A and CD2427-CD2429A). The inclusion of such a large number of redox 
genes within the spore transcriptome is intriguing, particularly in the light of the anaerobic life cycle 
of C. difficile. While C. difficile spores are resistant to ambient oxygen concentrations, even short 
exposure to oxygen can kill vegetative cells. It would thus be tempting to speculate that at least a 
subset of these genes might play a role in detoxification by scavenging reactive oxygen species (ROS). 
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Finally, consistent with previous reports (Bettegowda et al., 2006), we found that a large proportion 
of spore transcripts encode proteins of unknown function (nine out of top fifteen hits). This not only 
underlines the difference in mRNA composition between spores and vegetative cells but also the 
need for more research into the spore transcriptome of major spore-forming bacteria. A list of the 
top 50 spore transcripts found in this study is included in Appendix B, Table B3. 
4.2.2.4. Functional analysis 
Many gene clusters encoding enzyme complexes or biochemical pathways and 
identified as differentially expressed during germination appeared to be co-ordinately regulated. In 
order to dissect these interactions and obtain a more precise image of the metabolic changes that 
accompany germination and outgrowth, a functional analysis of the microarray data was performed. 
To this end the Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used to identify 
differentially regulated genes and organise them according to metabolic pathways they take part in. 
Selected examples have been listed below and summarised in Table 4.1.  Where appropriate, genes 
that marginally failed the stringent statistical cut-off (0.01 ≤ p ≤ 0.05) are also mentioned.  
 
 
 
 
 
 
 
 
 
Functional group Up-regulated Down-regulated 
Two-component systems 26 5 
ABC-transporters 71 34 
Phosphotransferase system 11 30 
Ribosomal proteins 12 1 
Transcriptional regulators 45 24 
Flagellum and chemotaxis 0 34 
Type IV pili 0 7 
Peptidoglycan biosynthesis 9 1 
Secondary cell wall polymers 12 0 
Table 4.1. Numbers of genes 
differentially regulated during 
germination. The total number of 
genes within specific functional groups 
up-regulated or down-regulated at 30 
min into germination was determined 
using microarray analysis (p ≤ 0.05). 
Previously published in Dembek et al. 
(2013). 
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4.2.2.4.1. Two-component signal transduction systems 
Two-component regulatory systems serve as a basic stimulus-response coupling 
mechanism to allow organisms to sense and respond to changes in many different environmental 
conditions. They typically consist of a membrane-bound histidine kinase that senses a specific 
environmental stimulus and a corresponding response regulator that mediates the cellular response, 
mostly through differential expression of target genes (reviewed in Stock et al., 2000). C. difficile 630 
has fifty-one two-component sensor histidine kinases and fifty-four response regulators. Nine kinase 
genes and seventeen response regulator genes were up-regulated in germinating spores. Only five 
genes (three kinases and two response regulators) were down-regulated (Figure 4.4).[more about 
how spores sense the environment] 
  
Figure 4.4. Two-component signal transduction system genes differentially regulated during germination. 26 genes 
were up-regulated regulated while 5 genes were down-regulated at 30 min into germination when compared to a 
vegetative cell (180 min). Gene expression data represented as normalised intensity with respect to control 
conditions, as means ± SD from three biological replicated. Analysed using 1-way ANOVA with Benjamini-Hochberg 
false discovery rate (FDR) correction(p ≤ 0.05). Previously published in Dembek et al. (2013). 
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4.2.2.4.2. Transport of metabolites and sugars 
Re-establishment of cell metabolism in a germinating spore requires a large supply of 
metabolites and cofactors. Consistent with this requirement, 100 out of 229 ABC-transporter genes 
contained within the C. difficile 630 genome were found to be differentially regulated during 
germination. A majority of these (71 genes) were up-regulated during germination when compared 
to the vegetative state, including the appABC operon (peptide/nickel ABC-transporter), the entire 
potABCD locus (spermine/putrescine ABC-transporter), and the ssuABC operon 
(sulfonate/nitrate/taurine ABC-transporter). Other ABC-transporters that had at least one 
significantly up-regulated gene included maltose/maltodextrin ABC-transporter (9.5-fold), lactose/L-
arabinose ABC-transporter (13.6-fold) and iron complex ABC-transporter (2.6-fold). In contrast, two 
ABC-transporter complexes involved in cobalt and nickel transport and encoded by the cbiMNOQ 
operon were down-regulated (Figure 4.5A). 
The PTS system is a complex phosphate translocation mechanism involved in the transport 
of sugars such as glucose, mannose and mannitol. As such it plays a key role in cell metabolism 
driving glycolysis. Unlike ABC-transporters, sugar transport was largely inactive during germination 
with the entire branch of the system responsible for glucose trafficking significantly down-regulated 
(from 1.9- to 23.8-fold) in germinating spores when compared to vegetative cells, including 
members of the pstG-ABC operon. In contrast, a number of genes involved in fructose and lactose 
metabolism were up-regulated in germinating spores. These included CD2270 (putative 1-
phosphofructokinase; 79.8-fold), fruABC (fructose-specific phosphotransferase; 75.2-fold) and 
CD1806 (putative fructokinase; 2.8-fold) (Figure 4.5B). While this could simply reflect the 
composition of the culture medium, it could also indicate the preference for fructose as the main 
carbon source in early germination. 
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Figure 4.5. Genes involved in transport and metabolism of sugars differentially regulated during germination. (A) 
71 genes encoding ABC-transporters were up-regulated while 29 were down-regulated at 30 min into germination 
when compared to a vegetative cell (180 min).  (B) 13 genes involved in the PTS system were up-regulated while 30 
were down-regulated at 30 min into germination when compared to a vegetative cell (180 min). Gene expression 
data represented as normalised intensity with respect to control conditions, as means ± SD from three biological 
replicated. Analysed using 1-way ANOVA with Benjamini-Hochberg false discovery rate (FDR) correction (p ≤ 0.05). 
Previously published in Dembek et al. (2013). 
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4.2.2.4.3. Ribosomal proteins and transcriptional regulators 
Exit from dormancy requires the bacterium to rebuild most of the structures found in 
a vegetative cell, necessitating large amounts of protein synthesis. It is not surprising then that a 
significant up-regulation of genes involved in transport, coincided with up-regulation of transcription 
and translation. In general, all genes encoding ribosomal proteins were up-regulated during 
germination. These included three genes encoding 30S subunit proteins and eight genes encoding 
50S subunit proteins (Figure 4.6A). Similarly, genes encoding DNA-directed RNA polymerase were 
up-regulated, although only the genes encoding the β and β' subunits of the polymerase had a p 
value ≤ 0.05. Furthermore, sixty-eight genes encoding transcriptional regulators were up-regulated 
(from 1.3- to 10.9-fold) while twenty-four genes were down-regulated (from 1.3- to 21.2-fold) in 
germinating spores (Figure 4.6B). These included members of the gntR, tetR araC, marR, merR, rpiR, 
copR, deoR and lysR gene families. On the whole, genes encoding tRNA synthetases were down 
regulated in germinating spores when compared to a vegetative cell. Similarly, enzymes involved in 
amino acid metabolism were largely down-regulated during germination, possibly reflecting the 
preferential catabolism of endogenous nutrients as a means for obtaining the necessary 'building 
blocks' for protein synthesis in early germination. 
  
110 
Chapter IV. Transcriptional analysis of temporal gene expression in germinating C. difficile 630 endospores 
 
  
Figure 4.6. Ribosomal proteins and transcriptional regulators differentially regulated during germination. (A) 12 genes 
encoding ribosomal proteins were up-regulated while one was down-regulated at 30 min into germination when 
compared to a vegetative cell (180 min).  (B) 68 genes encoding transcriptional regulators were up-regulated while 24 
were down-regulated at 30 min into germination when compared to a vegetative cell (180 min). Gene expression data 
represented as normalised intensity with respect to control conditions, as means ± SD from three biological replicated. 
Analysed using 1-way ANOVA with Benjamini-Hochberg false discovery rate (FDR) correction (p ≤ 0.05). Previously 
published in Dembek et al. (2013). 
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4.2.2.4.4. Secretion and cell wall components 
The Sec machinery provides a major pathway of protein translocation from the cytosol 
across the cytoplasmic membrane in bacteria (Mori and Ito, 2001). A number of components of the 
sec secretory pathway can be identified in C. difficile 630 including secA1, secA2, secE and secY 
(Fagan and Fairweather, 2011). In general, all genes within the secAYEG operon were up-regulated in 
germinating spores, although only secA2 (3.4-fold) and secE (3.8-fold) significantly so. The 
lipoprotein signal-peptidase lspA was also up-regulated (2.6-fold) as was the signal recognition 
particle encoded by ffh (4.16-fold) and prolipoprotein diacylglyceryl transferase encoded by lgt (3-
fold). 
 The C. difficile flagellar assembly is encoded by thirty-five genes located within a single 
cluster. A vast majority of flagellar genes were inactive in germinating spores when compared to 
vegetative cells. In addition, five genes encoding components of the bacterial chemotaxis machinery 
including motA, motB,  cheY, cheD and cheW were also found to be down-regulated in germinating 
spores (Table 4.2; Figure 4.7A) as were seven genes within two gene clusters encoding type IV pilus 
proteins (Table 4.3; Figure 4.7B). As cell motility is typically initiated upon nutrient deprivation in 
stationary phase, the overall inactivity of genes involved in motility during germination is in 
accordance with expectations, in that flagellar genes are dormant during germination and are 
transcribed in vegetative cells. 
 
Table 4.2. Type IV pili genes differentially expressed during germination 
Systematic name Gene product p-value Fold change 
CD3295 putative type IV pilus-assembly protein 0.0211 +1.3 
CD3504 putative type IV prepilin leader peptidase 0.00385 -2.4 
CD3505 putative type IV pilus retraction protein  0.0186 -2.5 
CD3507 putative type IV pilin 0.00579 -2.5 
CD3508 putative type IV pilin 0.0141 -2.3 
CD3509 putative type IV pilus assembly protein 0.0191 -2.3 
CD3511 type IV pilus assembly protein 0.0245 -3.4 
CD3512 type IV pilus assembly protein 0.0091 -2.9 
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 Table 4.3. Flagellar assembly genes differentially expressed during germination 
Systematic name Gene product p-value Fold change 
CD0228 flagellar motor switch protein 0.0248 -1.9 
CD0230 putative flagellar biosynthesis protein 0.0151 -3.7 
CD0231 putative flagellar hook-associated protein 0.0204 -3.6 
CD0232 flagellar hook-associated protein 0.0167 -5.0 
CD0235 flagellar protein FliS 0.0106 -3.7 
CD0236 flagellar protein 0.0161 -4.0 
CD0237 flagellar cap protein 0.0165 -3.1 
CD0239 flagellin subunit 0.0282 -2.0 
CD0246 flagellar basal-body rod protein 0.0271 -3.1 
CD0247 flagellar hook-basal body complex protein 0.0117 -3.8 
CD0248 flagellar M-ring protein 0.0177 -3.9 
CD0249 flagellar motor switch protein 0.0187 -4.8 
CD0250 flagellar assembly protein 0.0115 -5.6 
CD0251 flagellum-specific ATP synthase 0.0139 -5.7 
CD0252 flagellar protein 0.0172 -6.1 
CD0253 putative flagellar hook-length control protein 0.0177 -5.7 
CD0255 flagellar hook protein 0.00833 -6.0 
CD0255A putative flagellar protein 0.0154 -6.2 
CD0256 chemotaxis protein 0.0164 -6.4 
CD0257 chemotaxis protein 0.0236 -6.0 
CD0258 flagellar basal body-associated protein 0.00927 -5.3 
CD0259 putative flagellar protein 0.0297 -4.9 
CD0260 flagellar biosynthetic protein 0.0394 -4.4 
CD0261 flagellar export protein 0.0393 -4.9 
CD0262 flagellar export protein 0.0364 -5.4 
CD0263 flagellar export protein 0.0232 -5.5 
CD0265 flagellar number regulator 0.0284 -6.3 
CD0268 flagellar basal-body rod protein FlgG 0.0078 -6.6 
CD0269 putative flagellar basal-body rod protein 0.00932 -6.5 
CD0270 putative flagellar motor switch protein 0.00953 -6.7 
CD0271 putative flagellar motor switch protein 0.0475 -4.6 
CD0533 chemotaxis protein 0.017 -1.8 
CD0535 chemotaxis protein 0.0329 -1.9 
CD0540 chemotaxis protein 0.0257 -1.6 
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Figure 4.7. Flagellar assembly and type IV pili genes differentially regulated during germination. (A) 29 genes 
encoding flagellar proteins were down-regulated at 30 min into germination when compared to a vegetative cell 
(180 min).  (B) One gene encoding type IV pili were up-regulated while one was down-regulated at 30 min into 
germination when compared to a vegetative cell (180 min). Gene expression data represented as normalised 
intensity with respect to control conditions, as means ± SD from three biological replicated. Analysed using 1-way 
ANOVA with Benjamini-Hochberg false discovery rate (FDR) correction (p ≤ 0.05). Previously published in Dembek 
et al. (2013). 
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As a hallmark of cell expansion during germination and outgrowth, genes involved in cell 
wall biosynthesis were found to be significantly up-regulated in germinating spores. Peptidoglycan is 
produced from N-acetylglucosamine (NAG) and N-acetylemuramic acid (NAM) in a series of 
reactions involving incorporation of D-glutamine and D-alanyl-D-alanine. Genes encoding the 
enzymatic components of this pathway are largely located within the mur-mra cluster. Ten enzymes 
involved in peptidoglycan biosynthesis were up-regulated in germinating spores, including ddl (D-Ala 
D-Ala ligase B; 7.3-fold) glnA (glutamine synthase; 2.6-fold) and murF (UDP-MurNAc-pentapeptide 
synthase; 2.4-fold) as well as other members of the mur-mra cluster: murGDE and mraYW (Table 4.4; 
Figure 4.8). 
 
Table 4.4. Peptidoglycan biosynthesis genes differentially expressed during germination. 
Systematic name Gene product p-value Fold change 
CD0784 putative N-acetylmuramoyl-L-alanine amidase 0.0195 +2.0 
CD1343 glutamine synthetase 0.0081 +2.6 
CD1408 D-alanine--D-alanine ligase B 0.00843 +7.3 
CD2651 
UDP-N-acetylglucosamine--N-acetylmuramyl-(penta peptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine transferase 0.022 +1.4 
CD2653 UDP-N-acetylmuramoylalanine--D-glutamate ligase 0.0105 +1.5 
CD2654 phospho-N-acetylmuramoyl-pentapeptide-transferase 0.0145 +1.7 
CD2655 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alan ine ligase 0.00508 +2.4 
CD2664 
putative UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-
diaminopimelate ligase 0.0344 +2.4 
CD3563 putative spore cortex-lytic enzyme 0.0245 +2.2 
CD1898 putative phage-related cell wall hydrolase (endolysin) 0.0174 -6.1 
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Figure 4.8. Peptidoglycan biogenesis genes differentially regulated during germination. 9 genes were up-regulated 
regulated at 30 min into germination when compared to a vegetative cell (180 min). Gene expression data represented as 
normalised intensity with respect to control conditions, as means ± SD from three biological replicated. Analysed using 1-
way ANOVA with a   p ≤ 0.05 cut-off. Previously published in Dembek et al. (2013). 
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In addition to peptidoglycan, the Gram-positive cell wall can also contain secondary cell wall 
polymers (SCWP) such as teichoic, teichuronic acids and lipoteichoic acids which can make up 
between 10 and 60% of its structure. Although the genes specifying these components have not 
been identified in C. difficile, it might be relevant that a cluster of genes (CD2769-80) encoding 
glycosyltransferases and related enzymes was found to be significantly up-regulated in germinating 
spores (Table 4.5; Figure 4.9). 
 
Table 4.5. SCWP biosynthesis genes differentially expressed during germination. 
 
 
  
Systematic name Gene product p-value Fold change 
CD2769 capsular polysaccharide biosynthesis protein 0.0201 +2.9 
CD2770 putative capsular polysaccharide biosynthesis glycosyl transferase 0.00656 +2.7 
CD2771 putative UDP-glucose 6-dehydrogenase 0.00681 +2.4 
CD2772 putative teichuronic acid biosynthesis glycosyl transferase 0.016 +2.2 
CD2773 putative beta-glycosyltransferase 0.0115 +2.3 
CD2774 putative teichuronic acid biosynthesis glycosyl transferase 0.019 +2.2 
CD2775 putative minor teichoic acid biosynthesis protein 0.016 +2.3 
CD2776 putative glycosyl transferase 0.0408 +2.4 
CD2777 putative polysaccharide polymerase 0.0182 +2.5 
CD2778 putative polysaccharide biosynthesis protein 0.0311 +2.5 
CD2779 putative mannose-1-phosphate guanylyltransferase 0.0116 +2.2 
CD2780 putative phosphomannomutase/phosphoglycerate mutase 0.00636 +2.7 
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4.2.2.4.5. Toxins 
Of central importance in C. difficile is the pathogenicity locus (PaLoc) containing five 
genes encoding two large clostridial toxins: TcdA and TcdB as well as their regulators (tcdC, tcdR) and 
export machinery (tcdE) (Voth and Ballard, 2005). Both toxin A and B are represented by multiple 
probes on the microarray.  tcdA was down-regulated during germination when compared to the 
vegetative cell. No transcripts for tcdB could be detected in either state, consistent with the 
observation that toxins are expressed in stationary phase. 
 
 
 
 
 
Figure 4.9. Secondary Cell Wall Polymer biogenesis genes differentially regulated during germination. 12 genes were up-
regulated regulated at 30 min into germination when compared to a vegetative cell (180 min). Gene expression data 
represented as normalised intensity with respect to control conditions, as means ± SD from three biological replicated. 
Analysed using 1-way ANOVA with a   p ≤ 0.05 cut-off. Previously published in Dembek et al. (2013). 
 
118 
Chapter IV. Transcriptional analysis of temporal gene expression in germinating C. difficile 630 endospores 
4.3. Discussion 
The aim of the work presented in this chapter was to provide a genome-wide overview of 
the temporal gene expression patterns found during germination and outgrowth of C. difficile spores. 
Particular attention was paid to the events that follow initiation of germination and are critical in the 
transformation of a metabolically dormant spore into an actively growing vegetative cell. Using this 
approach, around 14% of the genome (511 genes out of 3679) was found to be differentially 
regulated during germination when compared to the vegetative cell and a number of functional 
groups of genes appeared to be co-regulated. 
The germinating spore requires a large supply of metabolites and cofactors to facilitate re-
establishment of cell metabolism. Indeed, a number of genes involved in transport were found to be 
differentially regulated. ABC-transporters were one such group with 34 significantly up-regulated in 
germinating spores. A few of these were particularly interesting, including the 
spermidine/putrescine transporter involved in polyamine trafficking which in turn play a crucial role 
in DNA replication, cell division and stress response (Pegg and McCann, 1982, Tabor and Tabor, 
1984). Interestingly, polyamines have previously been implicated in the shift from a quiescent to a 
proliferating state in bacterial spores (Setlow, 1974), fungal spores (reviewed in Stevens and Winther, 
1979) and plants (Mirza and Bagni, 1991). The sulfonate/nitrate/taurine ABC-transporter on the 
other hand is of particular interest as taurine conjugated with cholate yields taurocholate, the 
primary germinant for C. difficile spores. One could speculate that the up-regulation of this 
transporter might be a part of a positive feedback loop providing a constant supply of the germinant 
and the basis for commitment in germinating spores. In contrast, sugar transport was largely inactive 
during germination as the entire arm of the PTS system responsible for glucose trafficking was 
significantly down-regulated. Fructose transport on the other hand was highly up-regulated. In fact 
the gene encoding 1-phoshofructokinase (CD2270), a central enzyme in fructose catabolism 
catalysing the rate limiting, committed step in glycolysis, showed an 80-fold up-regulation when 
compared to vegetative cells, the highest values seen throughout this experiment. This could 
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indicate the preferential catabolism of fructose as opposed to glucose during the early stages of 
germination. Activation of transport coincided with a rapid up-regulation of transcription, translation 
and protein secretion pathways, all necessary in re-building of the basic structures of a vegetative 
cell as well as regulation of the re-established metabolism. Interestingly, amino acid biogenesis was 
largely inactive during early germination, possibly reflecting the preferential catabolism of 
endogenous nutrients as a means for obtaining the necessary 'building blocks' for protein synthesis. 
Genes involved in motility and chemotaxis were also down-regulated in germination when 
compared to a vegetative cell. The entire flagellar assembly was largely inactive as were the 
associated chemotaxis genes. Similarly, genes encoding type IV pili, responsible for twitching motility 
on C. difficile were also down-regulated. These observations are not surprising as cell motility is 
typically initiated upon nutrient deprivation in stationary growth. Finally, a number of genes involved 
in peptidoglycan biogenesis and SCWP biogenesis were also up-regulated, a hallmark of cell 
expansion during outgrowth.  
One of the most intriguing aspects of this study was the RNA composition of the dormant 
spore, particularly with regards to the small rRNA species identified during RNA extraction as well as 
the abundance of mRNA transcripts and their potential function during the early stages of 
germination. One group of transcripts that were significantly overrepresented in the spore 
transcriptome were those encoding redox enzymes, possibly involved in detoxification by scavenging 
reactive oxygen species (ROS). Similar findings were previously reported by Bettegowda et al. (2006) 
in their microarray analysis of C. novyi-NT spores and it seems plausible that this is a common 
feature among anaerobic sporeformers. 
While the microarray experiment presented here was informative regarding the metabolic 
changes that accompany germination, the limitations of the methodology used meant that the 
mechanisms that underpin spore germination could not be studied. This is largely due to the fact 
that factors involved in germination such as germination receptors and enzymes involved in cortex 
degradation are expressed in the late stages of sporulation and come pre-packed in the spore, ready 
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to act immediately upon stimulation.  These issues are addressed in Chapter VI where recently 
developed methods are used in forward genetic studies to supplement the microarray data 
presented here and provide a more complete view of germination in C. difficile. 
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Chapter V 
Characterisation of C. difficile cell wall protein Cwp7 
5.1. Introduction 
While the primary goal of the microarray analysis described in Chapter IV was to provide a 
genome-wide overview of the metabolic changes that accompany germination and outgrowth, the 
experiment was also a ‘fishing exercise’ intended to identify a subset of genes that could be 
followed-up in greater detail using standard genetic and biochemical approaches. This would not 
only provide ‘proof-of-principle’ for the entire experiment but would also give more mechanistic 
insight into how a metabolically dormant spore returns to vegetative growth. 
Research carried out in the Fairweather lab is focused on understanding the structure and 
assembly of the C. difficile cell wall and its contribution to the establishment and maintenance of the 
colonized state during infection. Considering that a germinating spore needs to rebuild most of its 
structures before returning to vegetative growth, studying germination could provide useful insight 
into the events that contribute to cell wall biogenesis. Particular attention was therefore paid to 
genes implicated in the assembly of the cell wall and its surface layer. Three genes encoding 
previously uncharacterised S-layer proteins (cwp7, cwp10 and cwp29) showing interesting 
expression profiles in the microarray experiment were chosen for further in vitro analysis. Disrupting 
cwp10 and cwp29, two genes significantly down-regulated in germination and highly active in 
vegetative cells, did not yield distinct phenotypes (data not shown). In contrast, knocking-out cwp7, 
the only CWP gene significantly up-regulated during germination, provided intriguing results which 
are detailed below. 
In this chapter I describe the creation of a cwp7 mutant using ClosTron insertional 
mutagenesis followed by an in-depth analysis of the effect cwp7 disruption has on C. difficile 
physiology. These results are validated by direct comparison with a cwp7 null mutant obtained using 
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the recently developed pyrE-based allele-coupled exchange system, highlighting some of the 
limitations of ClosTron mutagenesis. Finally, in an attempt to elucidate the function of Cwp7, 
protein-protein interactions are analysed and a potential molecular partner for Cwp7 is identified. 
5.2. Results 
5.2.1. General characteristics 
The cwp7 gene (CD2782) encodes a putative cell wall binding protein and is located within 
a ~52 kb genomic region containing a number of genes previously described as being involved in cell 
wall biogenesis and S-layer assembly (Figure 5.1A). Upstream of cwp7 are 12 genes encoding 
members of the CWP gene family, including the major S-layer protein SlpA (Calabi et al., 2001), the 
putative colonisation factor Cwp66 (Dr Zoe Seager, unpublished results), the cysteine protease 
involved in SlpA processing Cwp84 (de la Riva et al., 2011; Janoir et al., 2007; Kirby et al., 2009) as 
well as Cwp2, a highly conserved protein recently implicated in flagellar motility (Dr Aaron Dale, 
unpublished results). Located between cwp2 and slpA is secA2, an accessory ATPase shown to be 
essential in energizing the translocation of at least two CWP substrates across the cell membrane via 
the canonical SecYEG translocase (Fagan and Fairweather, 2011). Located directly downstream of 
cwp7 is mviN, a homolog of the Salmonella typhimurium mouse virulence factor identified as an 
essential gene implicated in peptidoglycan (PG) biogenesis in a number of organisms including E. coli 
and Mycobacterium tuberculosis (Gee et al., 2012; Inoue et al., 2008; Ruiz, 2008). Further 
downstream are 12 genes forming a putative secondary cell wall polymer (SCWP) biogenesis locus, 
all of which were found to be significantly up-regulated during germination in the microarray 
analysis described above. 
 With a predicted mass of 39.3 kDa, Cwp7 is one of the smallest members of the CWP family 
and displays the typical structural organisation seen in other proteins within this group, consisting of 
an N-terminal type I signal peptide followed by three repeats of the cell wall binding domain Pfam 
04122 (Figure 5.1B). In contrast to most CWPs however, no functional domain has been identified in 
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Cwp7. Instead, a hydrophobic region spanning 21 amino acids followed by three charged residues 
(R344, R347 and K351) can be found on the C-terminus of the protein. Bioinformatic analysis of genome 
sequences from 12 C. difficile strains revealed that Cwp7 is highly conserved with a 99.3% pairwise 
identity (Figure 5.1C). However no homologue could be identified in other bacterial species, possibly 
due to the lack of a defined functional domain.  
  
Figure 5.1. General characteristics of C. difficile cell wall protein Cwp7. (A) Genomic localisation of cwp7. Members of 
the CWP family are depicted in green, the putative SCWP biogenesis locus in yellow, mviN in blue, secA2 in pink and 
CD2783, a putative glucosyltransferase, in purple. (B) Domain structure of Cwp7. The signal peptide is depicted in purple, 
Pfam 04122 cell wall binding domains in blue and a predicted transmembrane helix in orange. A prediction of 
transmembrane regions and the proteins orientation within the membrane is provided below. (C) Multiple alignment of 
Cwp7 protein sequences from 12 C. difficile strains showing 99.3% pairwise identity. Disagreements from consensus are 
highlighted. Created using ClustalW and BLOSUM 62 cost matrix. 
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5.2.2. RT-PCR analysis of cwp7 expression patterns 
In order to confirm cwp7 expression and characterise its patterns, transcripts extracted 
from both germinating spores and vegetative cells were analysed via reverse transcriptase PCR (RT-
PCR). Two distinct phases of gene expression could be observed. During germination, cwp7 
expression peaked at 30-45 min after induction, dropping off at 60 min. As cells progressed to 
outgrowth (90-180 min), cwp7 expression raised, eventually levelling off and remaining constitutive 
throughout exponential growth. This level of gene expression was then maintained during stationary 
phase (Figure 5.2A and 5.2B). 
  
Figure 5.2. Reverse transcriptase PCR analysis of cwp7 expression patterns. Total RNA extracted at given time points form  
(A) germinating spores, (B) vegetative cultures was reverse transcribed into cDNA and used in standard Taq PCR reactions 
using primers specific to cwp7 [1671/1672]. 25 reaction cycles were used to ensure non-saturating conditions. RNA was 
checked for DNA contamination using standard 16S rRNA reactions. C. difficile 630Δerm gDNA was used as a positive control. 
During germination, cwp7 expression peaked at 30-45 min after induction, dropping off at 60 min. As cells progressed to 
outgrowth (90-180 min), cwp7 expression raised, eventually levelling off and remaining constitutive throughout exponential 
growth. This level of gene expression was then maintained during stationary phase. 
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5.2.3. Disruption of cwp7 expression through ClosTron insertional 
mutagenesis 
In an attempt to elucidate the role of Cwp7 in C. difficile physiology, particularly in the 
context of sporulation, germination and cell wall biogenesis, ClosTron insertional mutagenesis was 
used to disrupt cwp7 expression in C. difficile 630Δerm, an erythromycin-sensitive derivative of C. 
difficile 630 obtained through serial passages of the parental strain (Hussain et al., 2005). To this end, 
a pMTL007-based vector carrying a 344 bp cwp7-specific intron targeting region was synthesised 
(DNA2.0) and conjugated into 630Δerm as described in Materials and Methods. Thiamphenicol-
resistant transconjugants carrying the plasmid were re-streaked onto Brazier’s agar plates 
supplemented with 5 µg/ml erythromycin to select for group II intron integration and activation of 
the ermR cassette. Standard PCR techniques were used to screen potential mutants for correct 
integration and orientation of the group II intron (Figure 5.3A) and were followed by Southern blot 
analysis to exclude the possibility of multiple insertions (Figure 5.3B). The resulting mutant, C. 
difficile 630 Δerm cwp7::erm (designated cwp7::CT) was then complemented with plasmid pMLD024 
carrying the complete cwp7 ORF under the control of a well characterised constitutive Pcwp2 
promoter (designated cwp7::CT [pCwp7]). The phenotypes of these two strains were analysed and 
compared to the isogenic wild-type (WT) strain. 
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  Figure 5.3. PCR screening of cwp7 ClosTron mutant. (A) Genomic DNA extracted from a putative cwp7 ClosTron mutant 
was subjected to PCR analysis using primers flanking the group II intron insertion site [1719/1672] to confirm intron 
integration, primers flanking the retroposition-activated marker (RAM) [RAM-F/RAM-R] to confirm the excision of the 
group I intron and an EBS universal primer to confirm the appropriate orientation of the group II intron within the C. 
difficile genome. pMTL007 and WT gDNA were used as templates in negative controls. (B) Southern blot analysis of cwp7 
ClosTron mutant. A single band corresponding to the predicted product size of 5,736 bp can be identified in cwp7::CT but 
not WT confirming a single insertion event. (C) Schematic representation of cwp7 insertional mutagenesis. Primer 
binding sites and the intron insertion site (dashed line) are indicated. 
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5.2.4. Phenotypic analysis of cwp7::CT 
5.2.4.1. Growth rate 
In order to assess the effect cwp7 disruption had on general strain fitness, growth rate 
in liquid culture was monitored. Disruption of cwp7 expression resulted in a significant growth 
defect with an average 47% drop in growth rate observed throughout exponential phase. Endpoint 
culture density following O/N incubation was also significantly lower than WT. This was alleviated 
through plasmid-mediated in trans complementation, restoring the growth rate to WT levels (Figure 
5.4A). Routine observations carried out during culture revealed that long-term viability of the 
mutant was significantly reduced as cultures inoculated with colonies that were left in the anaerobic 
cabinet for more than seven days often failed to grow or grew more slowly than corresponding WT 
and complemented cultures. 
5.2.4.2. Colony and single cell morphology 
Determining the morphology of a single colony growing on the surface of a plated 
culture can be an important tool in the description of microorganisms as any alterations to WT 
colony morphology are typically an early sign of phenotypic variation. The cwp7 mutant formed 
small, smooth-edged, convex colonies as compared to the large, flat, rough-edged colonies of the 
isogenic WT strain. These typically took two days to grow following a re-streak, consistent with 
growth rate data described above, and shared a distinct mucoid appearance (Figure 5.4B).  As with 
the growth defect, colony morphology was restored to WT upon complementation. Phase contrast 
microscopy of the analysed strains revealed significant changes in single cell morphology. In contrast 
to the straight bacilli of the WT strain, cwp7::CT cells were thinner, slightly curved and appeared to 
lack rigidity. Surprisingly, this phenotype was even more pronounced in the complemented mutant, 
in which a subset of cells showed a >180° bend (Figure 5.4B). The percentage of cells exhibiting this 
extreme curvature ranged from approx. 5% to 50% between different experiments and was found to 
depend largely on the growth phase, with exponentially growing cultures containing less curved cells 
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than those that reached stationary phase. Upon closer examination of non-immobilized cells, by 
changing the focal plane during imaging, these cells showed ‘corkscrew’ morphology as seen in 
helical bacterial species such as Campylobacter jejuni and Helicobacter pylori suggesting a severe 
alteration to the cell cytoskeleton. Over-expression of cwp7 in the WT background did not result in a 
similar phenotype (data not shown), suggesting that the observed phenotype could be a result of a 
polar effect of cwp7 disruption on downstream genes, most of which are predicted to be involved in 
cell wall biogenesis.   
In an attempt to gain further insight into what effect cwp7 disruption has on cell wall 
biogenesis and the general cell ultrastructure, TEM analysis was performed in collaboration with Dr 
Dave Goulding (Sanger Institute). While electron micrographs of the cwp7 mutant and the 
complemented strain confirmed the disrupted single-cell morphology initially identified through 
phase-contrast microscopy, and layers corresponding to the cell membrane, cell wall peptidoglycan 
and the S-layer could be clearly discerned, no obvious differences in cell wall organisation were 
observed between cwp7::CT, cwp7::CT [pCwp7] and WT (Figure 5.5). 
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Figure 5.4. Characterisation of cwp7 ClosTron mutant phenotype. (A) Growth curve indicating a severe defect in 
cwp7::CT growth rate when compared to WT and the complemented mutant. Data represented as mean ± SD from three 
biological replicates. (B) Phase contrast analysis of single cell morphology revealing slightly curved cells for the cwp7 
mutant when compared to the straight bacilli seen in WT. The mutant also displayed altered colony morphology, showing 
small, smooth, mucoid colonies as compared to the large, rough colonies seen in WT. Changes in the single cell 
morphology of the complemented mutant were even more severe, with a subset of cells being tightly curved. Colony 
morphology was not affected. Images representative of three biological replicates. Universal scale bar provided. 
5 mm 5 µm 
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Figure 5.5. Transmission electron microscopy (TEM) examination of cwp7 ClosTron mutant single cell morphology. 
Changes to single cell morphology previously identified for each of the analysed strains via phase-contrast microscopy 
are evident. Individual scale bars are indicated under each image. 
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5.2.4.3. Flagellar motility 
The small colony morphology seen in cwp7::CT could indicate a possible defect in 
motility. To investigate this further, a swimming motility assay was performed. To this end 0.3% BHIS 
agar plates were inoculated with exponentially growing cultures and growth was monitored for 96h. 
C. difficile 630 Δerm fliC::erm (designated fliC::CT), a non-motile strain obtained by disrupting the 
expression of the major flagellar protein FliC, was used as a negative control. No significant 
difference in swimming motility was observed between WT, cwp7::CT and cwp7::CT [pCwp7] 
suggesting that cwp7 disruption has no effect on flagellar motility (Figure 5.6). 
  
Figure 5.6. Assessment of cwp7 ClosTron mutant swimming motility. Exponentially growing cultures were used to 
inoculate 0.3% BHIS agar plates. Growth was monitored over a period of 96h. The non-motile fliC::CT mutant was used 
as a negative control. No significant changes in motility were observed for cwp7::CT when compared to WT and the 
complemented mutant. Images representative of two biological replicates. Universal scale bar provided. 
10 mm 
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5.2.4.4. S-layer composition 
It is well established that lateral interactions between the various CWPs comprising the 
S-layer are important in maintaining its integrity and that disruption of a single protein might have 
far reaching consequences for the entire structure. To further elucidate the effect cwp7 disruption 
has on cell wall composition, S-layer extracts and culture supernatants were prepared and analysed 
via SDS-PAGE followed by Coomassie staining (Figure 5.7). Strikingly, while the composition of cell 
wall associated S-layer extracts did not seem to differ between the three strains, the cwp7::CT 
culture supernatant contained significantly more protein than WT and cwp7::CT [pCwp7]. This was 
further verified by probing the samples for S-layer proteins and CWPs using Western 
immunoblotting. While the amounts of the major S-layer proteins, HMW SLP and LMW SLP, were 
essentially equal in the S-layer extracts of all analysed strains, large amounts of the proteins were 
found to be present in the supernatant of the cwp7 mutant. Interestingly, a band corresponding to 
unprocessed, full length SlpA was also identified indicating deficiencies in SlpA maturation. This 
coincided with shedding of Cwp84, a cysteine protease essential for SlpA cleavage. Both Cwp2 and 
Cwp66 were also found to be shed into the culture supernatant although only the later was depleted 
in the S-layer extract of cwp7::CT. While the amount of protein shed by cwp7::CT [pCwp7] was 
dramatically lower than the mutant, in trans complementation did not fully restore the WT 
phenotype. 
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Figure 5.7. Examination of cwp7 ClosTron mutant S-layer composition. S-layer extracts were prepared from O/N 
cultures using low pH glycine. Proteins shed into the supernatant were precipitated using trichloroacetic acid (TCA). All 
samples were separated using SDS-PAGE and probed for HMW-SLP, LMW-SLP, Cwp2, Cwp66 and Cwp84. Significant 
amount of all analysed proteins were found to be shed into the culture supernatant. Stark differences in S-layer 
composition were also observed, particularly with regard to Cwp66 and Cwp84. Phenotype was largely restored to WT 
upon complementation. Data representative of three biological replicates. 
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5.2.4.5. Sub-cellular localisation of Cwp7 
Despite the high expression levels of cwp7 seen in the microarray experiment and 
subsequently validated by RT-PCR, both during germination and vegetative growth, Cwp7 could not 
be detected in S-layer extracts separated on Coomassie stained gels. This suggested that Cwp7 might 
not localize to the S-layer. Taking into account that previous bioinformatic analysis using TMpred 
(http://www.ch.embnet.org/) revealed a 'high scoring', C-terminal transmembrane helix spanning 21 
hydrophobic amino acids followed by three charged residues, it would seem likely that Cwp7 is a 
membrane protein. To investigate this, inverse PCR was used to delete the transmembrane helix in 
pMLD024 resulting in pMLD026 which was then conjugated into the cwp7 ClosTron mutant. Crucially, 
the growth rate, colony and single cell morphology as well as S-layer composition of the resulting 
strain (designated cwp7::CT [pCwp7trunc]) were largely identical to those observed in cwp7::CT (data 
not shown) indicating that the transmembrane helix is an essential functional part of the protein 
(data not shown). 
To further elucidate the sub-cellular localisation of Cwp7, a Cwp7-specific antiserum was 
raised in mice. To this end, a fragment of cwp7 lacking the N-terminal signal peptide and the C-
terminal transmembrane helix was cloned into the pET28a expression vector yielding pMLD023 
(pET28a-cwp726-323), which was then transformed into E. coli Rosetta competent cells. Cwp7 was 
over-expressed, purified form inclusion bodies via detergent-assisted on-column refolding and used 
to immunize mice. The resulting serum was subsequently used to probe membrane fractions 
prepared from WT, cwp7::CT, cwp7::CT [pCwp7] and cwp7::CT [pCwp7trunc]. A band corresponding to 
a protein of approx. 39 kDa was detected in the membrane fractions from WT and cwp7::CT [pCwp7] 
but not cwp7::CT (Figure 5.8A). While a slightly smaller protein species was observed for the cwp7 
mutant complemented with a truncated copy of the gene, the intensity of the corresponding band 
was significantly lower than that seen in WT and cwp7::CT [pCwp7]. Taken together these results 
indicate that (i) unlike most members of the CWP family, Cwp7 is an integral membrane protein, (ii) 
the 21 amino acid C-terminal hydrophobic region is essential in anchoring Cwp7 to the cell 
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membrane and that (iii) the protein’s location is essential in exerting its function within the cell as 
complementation with a truncated copy of the gene does not restore WT phenotype. 
To obtain visual confirmation of Cwp7 membrane localisation and gain further insight into its 
spatial distribution within the cell, a number of localisation methods were tested. Unfortunately, 
while the Cwp7 anti-serum proved to be highly specific in immunoblotting experiments, attempts to 
use it for immunofluorescence purposes were unsuccessful, most likely due to the peptidoglycan 
layer forming a physical barrier preventing antibodies from binding to their target. Similarly, 
attempts at using immunogold labelling were also unsuccessful as no specific binding could be 
observed via TEM (data not shown). To overcome this problem, a number of fluorophores were 
tested in fusion with Cwp7, including the green-fluorescent LOV domain, the red-fluorescent SNAP-
TMR-STAR and the red-fluorescent mCherry. The latter was found to be the most effective in C. 
difficile (data not shown). The cwp7 ClosTron mutant complemented with a plasmid carrying cwp7 C-
terminally fused with codon-optimised mCherry (designated cwp7::CT [pCwp7mCherry]) showed a 
distinct membrane stain (Figure 5.8B), although significant differences in signal level were observed 
between individual cells within the population, possibly a consequence of using the Pcwp2 promoter 
to drive cwp7 expression. No signal was observed for WT cells (negative control). 
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Figure 5.8. Investigation of Cwp7 sub-cellular localisation. (A) Membrane fractions and soluble fractions were 
separated via SDS-PAGE and probed for Cwp7 by Western blotting. Cwp7 could be detected in the membrane fractions 
from WT and cwp7::CT [pCwp7] but not cwp7::CT. Deletion of the C-terminal transmembrane helix resulted in a 
significantly decreased amount of Cwp7 within the membrane fraction. (B) Fluorescence microscopy of cwp7::CT 
complemented with Cwp7-mCherry fusion protein. Distinct membrane staining can be observed in a subset of cells. 
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5.2.4.6. Sporulation efficiency 
Sporulation is a crucial part of C. difficile life cycle and requires considerable 
remodelling of the bacterial cell wall. It is thus conceivable that defects in cell wall organisation 
could have a detrimental impact on spore formation. In order to confirm whether cwp7 disruption 
had any effect on C. difficile spore formation, sporulation efficiency was assessed. While previous 
experiments showed that spore formation on solid media is far more efficient and homogenous than 
when carried out in liquid culture, technical limitations render the method unsuitable for accurate 
quantification of spores, particularly when comparing multiple strains. Furthermore, while 
sporulation in SM broth was more efficient than in BHIS broth, the latter was found to provide far 
more reproducible results. BHIS broth was therefore used to assess sporulation efficiency of 
cwp7::CT mutant as described previously in Chapter 3. Strikingly, no spores could be detected for the 
cwp7 ClosTron mutant throughout the duration of the experiment. This defect was alleviated 
through in trans complementation, restoring sporulation efficiency to WT levels (Figure 5.9A). As the 
read-out of the sporulation assay requires the strain to be both sporulation and germination-
proficient, in order to differentiate between sporulation and germination defects the entire 
procedure was monitored using phase contrast microscopy. This confirmed that spores were not 
present in the cwp7::CT culture (Figure 5.9B). Interestingly, when compared to WT and cwp7::CT 
[pCwp7] strains, the cwp7 mutant appeared to lyse more quickly, losing the structural integrity of 
the cells within 24h from the onset of the experiment. While cell lysis was also present in the other 
two strains, it was more gradual as intact cell sacculi could be detected even 72h into the 
experiment (Figure 5.9B). 
 
  
138 
Chapter V. Characterisation of C. difficile cell wall protein Cwp7 
 
  
Figure 5.9. Assessment of cwp7 ClosTron mutant sporulation efficiency. Sporulation was induced via nutrient 
starvation in BHIS broth and was assessed over a period of 5 days by (A) measuring total and spore CFUs and (B) 
monitoring spore formation using phase-contrast microscopy. No spore CFUs were identified in cwp7::CT throughout 
the duration of the experiment. Spore formation was restored to WT levels upon in trans complementation. While 
significant cell lysis was observed in all strains, this was more severe in cwp7::CT where a rapid loss of cell integrity was 
observed within 24h. Numerical data represented as means ± SD from three biological replicates. Limit of detection 
indicated as a horizontal dashed line. Microscopy data representative of two biological replicates. Scale bar provided. 
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To overcome the low sporulation efficiency in liquid culture and the relatively high limit of detection 
of the quantification methods used, an attempt was made to sporulate cwp7::CT on SM agar and 
purify the resulting spores. While not quantifiable, the purification process would allow for sample 
enrichment and thus, when sufficiently scaled-up, even relatively minute amounts of spores could 
be readily detected. Indeed, some spores were recovered from cwp7::CT cultures sporulated on 
solid media, although sporulation efficiency was significantly lower than that seen in WT and 
cwp7::CT [pCwp7]. Interestingly, upon phase-contrast analysis, the cwp7::CT spores demonstrated a 
propensity to form clumps containing large amounts of cell debris (Figure 5.10). These were resistant 
to mild detergents (0.01% Tween 20) thus preventing accurate quantification and their use in further 
experiments. 
  
Figure 5.10. Phase-contrast microscopy examination of purified spores. Sporulation was carried out on solid media and 
spores were purified via density gradient centrifugation. Spores of the cwp7 ClosTron mutant showed a propensity to 
form clumps contaminated with significant amount of cell debris. Spore yields were also significantly reduced. Scale bar 
provided. 
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5.2.5. Disruption of cwp7 expression through Allele-Coupled Exchange (ACE) 
Since its development in 2007, ClosTron insertional mutagenesis has quickly become the 
gold standard in genetic manipulation of C. difficile, providing a fast, reliable and reproducible 
method for targeted disruption of genes. While numerous studies successfully using this technique 
have now been published, the ClosTron system does have its limitations. Polar effects are common 
as insertion of the group II intron can disrupt the expression of neighbouring genes. Multiple 
insertions, while rare, have been reported necessitating the use of time consuming screening 
techniques. The limited availability of suitable selection markers makes creating multiple gene 
deletions difficult.  Finally, as in situ complementation of a disrupted gene is not possible, plasmid-
based in trans complementation has to be used, often resulting in unwanted gene dosage effects. 
Recently developed methods for creating non-marked mutations in C. difficile have helped overcome 
these problems. One such method, using pyrE-based allelic exchange allows the rapid insertion of 
heterologous DNA of any size or complexity into the genome. In order to exclude the possibility of 
polar effects in the phenotype seen for the cwp7::CT mutant, pyrE-based ACE was used to create a 
660 bp in-frame deletion in cwp7 as described by Ng et al. (2013). To this end, the mutated allele 
was created by amplifying 750bp-long homology regions flanking the deletion site and cloning them 
into pMTL-YN3 via Gibson assembly. The resulting plasmid, pMLD061 was then conjugated into C. 
difficile 630 Δerm ΔpyrE, a strain auxotrophic for uracil and resistant to 5-fluoroorotic acid (FOA). 
Following two passages on BHIS agar supplemented with 5 µg/ml uracil, 15 µg/ml thiamphenicol and 
250 µg/ml cycloserine, colonies that were noticeably larger (indicative of plasmid integration) were 
screened by colony PCR to identify single-crossover mutants using (i) primers 2308/2309 flanking the 
upstream and downstream homology regions and (ii) one of these primers in conjunction with a 
plasmid-specific primer 2369 to amplify across the integration junction (Figure 5.11A). Pure, single 
crossover mutants were streaked onto C. difficile minimal medium (CDMM) supplemented with 5 
µg/ml uracil and 2 mg/ml FOA to select for plasmid excision. The isolated FOA-resistant colonies 
were screened by PCR using primers 2308/2309. Double-crossover mutants in which the mutated 
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allele was successfully integrated yielded products 660 bp smaller than those seen in WT revertants 
(Figure 5.11B). 
In order to restore the pyrE+ phenotype, plasmid pMTL-YN1 carrying the WT pyrE allele was 
conjugated into the isolated double-crossover mutant. The resulting colonies were re-streaked onto 
non-supplemented CDMM agar to select for uracil prototrophy indicating successful allele exchange 
(designated Δcwp7). Restoration of the pyrE allele was confirmed by colony PCR using primers 
2429/2430 flanking the pyrE locus (Figure 5.11B) followed by Sanger sequencing of the amplified 
product. 
In order to complement the mutants, WT cwp7 allele including the Ribosome Binding Site 
(RBS) was cloned into pMTL-YN1C using SacI and BamHI sites under the control of the constitutive 
Pcwp2 promoter. The resulting plasmid (pMLD073) was conjugated into the isolated double-crossover 
mutant. Following 96h of incubation individual transconjugants were re-streaked onto non-
supplemented CDMM agar to select for uracil prototrophy indicating successful allele exchange and 
the introduction of the WT cwp7 allele immediately downstream of the concomitantly restored pyrE 
locus (designated Δcwp7 + cwp7). Complementation was confirmed by colony PCR using primers 
2429/2430 flanking the pyrE locus followed by Sanger sequencing of the amplified product (Figure 
5.11B). 
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Figure 5.11. Disruption of cwp7 expression using allele-coupled exchange (ACE). (A) PCR screening of single-crossover 
mutants using primers flanking the deletion site [2308/2309] and one of these primers in conjunction with a plasmid-
specific primer 2369 to amplify across the integration junction. (B) PCR screening of cwp7 ACE mutant following 
restoration of the pyrE locus and complementation. Primers [2429/2430] flank the disrupted pyrE locus used for 
complementation. 
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5.2.6. Comparison of cwp7::CT and Δcwp7 phenotypes 
While the ACE cwp7 mutant showed a growth defect similar to that seen in its ClosTron 
counterpart (approx. 46% drop in growth rate throughout exponential phase), both endpoint culture 
density and long term viability of the strain did not seem to be affected (Figure 5.12A). Importantly, 
both cwp7::CT and Δcwp7 had identical colony morphology and showed the same abnormalities in 
single cell structure, including a curved morphology. Interestingly, while the cells of the 
complemented ClosTron mutant showed exaggerated curvature, no such effect was seen in the 
complemented ACE mutant which shared the appearance of the WT strain, thus confirming that the 
extreme curvature seen in cwp7::CT [pCwp7] was not a direct effect of cwp7 disruption but rather a 
consequence of polar effects exerted by the mutation in conjunction with over-expression of the WT 
allele (Figure 5.12B). S-layer composition was largely identical between the two mutants. As in the 
case of the ClosTron mutant, the supernatants from ACE mutant cultures contained significant 
amounts of partially degraded S-layer proteins including HMW-SLP, LMW-SLP, Cwp2, Cwp66 and 
Cwp84. Interestingly full length SlpA could not be detected indicating that disruption of SlpA 
processing observed in cwp7::CT could also be a result of a polar effect (Figure 5.13). While the 
sporulation efficiency of the Δcwp7 mutant was still lower than that recorded for WT and 
complemented mutant, it was significantly higher that seen for the ClosTron mutant in which no 
spores could be detected throughout the duration of the experiment (Figure 5.14A). This was further 
supported by purifying Δcwp7 spores from SM agar plates. In contrast to the ClosTron mutant, 
where significant clumping was observed, Δcwp7 spore preparations were no different than WT 
(Figure 5.14B), allowing for the measurement of germination dynamics. To this end purified spores 
of WT, Δcwp7 and Δcwp7 + cwp7 were resuspended in BHIS broth + 0.5% Tch and the drop in OD 
corresponding to Ca2+-DPA release was measured over time. No significant difference in germination 
dynamics were observed between the analysed strains (Figure 5.14C). Taken together these results 
indicate that at least part of the phenotypes seen for the ClosTron cwp7 mutant could be attributed 
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to polar effects exerted on neighbouring genes and that non-marked mutations are a more suitable 
method for disrupting genes in C. difficile. 
 
Figure 5.12. Characterisation of cwp7 ACE mutant phenotype. (A) Growth curve indicating a severe defect in cwp7::CT 
growth rate when compared to WT and the complemented mutant. Data represented as mean ± SD from three biological 
replicates. (B) Phase contrast analysis of single cell morphology revealing slightly curved cells for the cwp7 mutant when 
compared to the straight bacilli seen in WT. The mutant also displayed altered colony morphology, showing small, 
smooth, mucoid colonies as compared to the large, rough colonies seen in WT. No changes to single cell morphology or 
colony morphology were observed for the complemented mutant. Microscopy data representative of three biological 
replicates. Universal scale bar provided. 
5 mm 5 µm 
145 
Chapter V. Characterisation of C. difficile cell wall protein Cwp7 
 
  
Figure 5.13. Examination of cwp7 ACE mutant S-layer composition. S-layer extracts were prepared from O/N cultures 
using low pH glycine. Proteins shed into the supernatant were precipitated using trichloroacetic acid (TCA). All samples 
were separated using SDS-PAGE and probed for HMW-SLP, LMW-SLP, Cwp2, Cwp66 and Cwp84. Significant amount of 
all analysed proteins were found to be shed into the culture supernatant. Stark differences in S-layer composition were 
also observed, particularly with regard to Cwp66 and Cwp84. 
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Figure 5.14. Characterisation of cwp7 ACE mutant sporulation and germination dynamics. (A) Sporulation efficiency 
was assessed in BHIS broth over a period of 5 days by measuring total and spore CFUs. A significant sporulation defect 
was observed for Δcwp7 and was alleviated upon complementation. Data presented as means ± SD from three 
biological replicates. Limit of detection indicated as a horizontal dashed line (B) Phase-contrast microscopy analysis of 
purified spores. No significant difference was observed between WT, Δcwp7 and Δcwp7 + cwp7. Scale bars provided. 
(C) Germination dynamics were assessed by measuring the drop in OD600 over a period of 90 min, concomitant with the 
release of Ca2+-DPA. No significant differences in germination dynamics were observed between WT, Δcwp7 and 
Δcwp7 + cwp7. Data represented as means ± SD from three biological replicates. 
147 
Chapter V. Characterisation of C. difficile cell wall protein Cwp7 
 
5.2.7. Identification of Cwp7 molecular partners 
While some proteins perform their functions independently, the vast majority interact with 
others forming complexes that exert a biological effect only when fully assembled. Characterizing 
protein-protein interactions is thus crucial in understanding protein functions. A number of methods 
for studying these interactions are now available, including yeast and bacterial two-hybrid systems, 
co-immunoprecipitation, cross-linking and pull-down assays allowing researchers to adapt their 
experiments depending on the strength of the interaction in question. Considering the effect cwp7 
disruption has on C. difficile physiology and the apparent lack of a functional domain within its 
predicted structure, it is likely that Cwp7 is part of a larger complex that requires additional proteins 
to function. 
5.2.7.1. Optimisation of cross-linking conditions 
To investigate the interactions between Cwp7 and its potential molecular partners, 
formaldehyde cross-linking, a well-established method for studying weak and transient interactions 
between proteins, was used. Due to its small size, formaldehyde can rapidly permeate cell walls and 
membranes, cross-linking proteins by adding a covalent methyl bridge between amine groups. As 
the optimal cross-linking conditions may vary significantly and need to be empirically verified on a 
case-by-case basis, a range of formaldehyde concentrations and exposure times were tested on 
cwp7::CT [pCwp7] (Figure 5.15A). Irrespective of the formaldehyde concentration used, exposure 
times of more than 30 min resulted in significant depletion of soluble protein in whole cell extracts 
from cross-linked cultures and caused an accumulation of large-scale, non-physiological protein 
agglomerates that could not be separated by SDS-PAGE as indicated by Coomassie staining of gel 
wells. Under the conditions tested a formaldehyde concentration of 0.5% and an exposure time of 
15 min were deemed optimal. 
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5.2.7.2. Cwp7-FLAG cross-linking 
In order to facilitate the pull-down of Cwp7 complexes from cross-linked samples, the 
protein was C-terminally FLAG-tagged by inverse PCR and the resulting plasmid (pMLD089) was 
conjugated into cwp7::CT as previously described, producing 630 Δerm cwp7::erm [pRPF144-cwp7-
FLAG] (designated cwp7::CT [pCwp7FLAG]). Exponentially growing cultures of cwp7::CT [pCwp7FLAG] 
and WT (negative control) were cross-linked and processed as described in Materials and Methods. 
Protein complexes containing FLAG-tagged Cwp7 were pulled-down, heat-treated to break the 
cross-links and analysed using SDS-PAGE and Western immunoblotting. As expected, a single band 
corresponding to the expected molecular weight of Cwp7-FLAG (40.3 kDa) was detected in cwp7::CT 
[pCwp7FLAG] but not in WT samples. In the non-heated sample, an additional band corresponding to 
a protein species of approx. 85 kDa and reacting with both anti-Cwp7 and anti-FLAG antibodies was 
also detected. This band was absent in the heated sample, where it was replaced by a 45 kDa protein 
species (Figure 5.15B). In order to confirm the identify of the pulled-down proteins, MALDI peptide 
mass fingerprinting was carried out (Dr Len Packman, PNAC Facility, University of Cambridge). The 
~40 kDa protein was identified as Cwp7, the ~45 kDa protein was identified as a putative lipoprotein 
(CD2701) while the ~85 kDa protein was identified as a complex of the two. 
CD2701 encodes a previously uncharacterised putative lipoprotein with a predicted mass of 
44.5 kDa. Microarray results confirmed that, as in the case of cwp7, CD2701 is significantly up-
regulated during germination (2.1-fold change; p=0.0129). According to Pfam analysis the CD2701 
product belongs to the DUF3798 family of bacterial lipoproteins that share a distant similarity to 
membrane-bound, ligand binding proteins. Bioinformatic analysis using the LipoP prediction server 
confirmed the presence of an N-terminal type II signal peptide followed by a cysteine residue at 
position 21 forming a canonical lipobox motif LTG/C (Juncker et al., 2003). The protein was also 
found to be present in C. difficile 630 lipoproteome as identified my mass spectrometry (Tom 
Charlton, unpublished results). Interestingly, in 2011 a crystal structure of CD2701 was released by 
the Joint Centre for Structural Genomics, suggesting that it is a nutrient binding protein and that the 
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overall structure resembles the sugar binding domain of ABC transporters 
(http://www.jcsg.org/images/stim/3qi7-YP_001089212.1.html). Further genetic and biochemical 
analysis would be required to confirm and dissect the interaction between Cwp7 and CD2701 and to 
elucidate the role these two proteins exert on C. difficile physiology. 
 
  Figure 5.15 Investigation of Cwp7 protein-protein interactions. (A) Optimisation of formaldehyde cross-linking reaction 
conditions. O/N WT cultures were exposed to varying amount of formaldehyde for either 10 or 30 min. Membrane 
fractions were prepared, separated via SDS-PAE and probed for Cwp7 using Western blotting. The diminishing amount 
of Cwp7 detected indicates formation of protein complexes. (B) Identification of Cwp7 molecular partners. The cwp7 
ClosTron mutant complemented with a FLAG-tagged copy of the gene was cross-linked using formaldehyde. Protein 
complexes were pulled-down using affinity chromatography, separated via SDS-PAGE and probed for Cwp7 and FLAG-
tag using Western blotting. A protein complex of approx. 85 kDa could be identified in cross-linked samples. Proteins of 
interest were identified using MALDI peptide mass fingerprinting. 
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5.3. Discussion 
Considering its structure and the apparent lack of a predicted functional domain, Cwp7 does 
not seem to be a promising target for detailed analysis. Indeed, historically, priority has been given 
to CWPs harbouring defined functional domains and many of these have now been characterised, 
including the major S-layer protein SlpA, the putative colonisation factor Cwp66, the cysteine 
proteases Cwp84 and Cwp13, the phase-variable protein CwpV and the highly conserved cell wall 
protein Cwp2. Following up on results obtained through the microarray analysis described in 
Chapter IV, in which cwp7 was found to be the only CWP gene with significantly up-regulated 
expression during germination, an attempt was made to further investigate this previously 
uncharacterised gene. The genomic localisation of cwp7 is intriguing as it lies on the verge of two loci 
previously implicated in cell wall and S-layer biogenesis: a cluster of CWP-encoding genes and genes 
encoding accessory proteins necessary for their translocation across the cell membrane, located 
upstream, as well as a putative SCWP biogenesis locus located downstream, preceded by mviN, 
clearly involved in peptidoglycan synthesis in other organisms. Considering that within this ~52 kb 
region lie many genes that are known to be critical for cell wall and S-layer biogenesis, one could 
predict a similar role for cwp7. 
Early RT-PCR validation experiments confirmed that cwp7 expression peaks at 30 min into 
germination and remains at relatively high levels throughout exponential and stationary growth 
phases, pointing at the gene’s importance in vegetative growth. This was further supported by 
disrupting cwp7 expression in C. difficile 630Δerm using ClosTron insertional mutagenesis, as the 
resulting mutant showed a severe growth defect and reduced long term viability. Intriguingly, the 
effects of cwp7 disruption were not limited to a reduced growth rate. Phase-contrast microscopy 
analysis revealed significant changes in single cell morphology, suggesting defects in the general 
organisation of the cell wall. This was reflected in S-layer composition and stark deficiencies in S-
layer assembly as significant amounts of CWPs were being shed into the culture supernatant during 
growth. Coincidently the large amount of protein shed could explain the mucoid colony phenotype 
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seen for the mutant strains. Since motility assays carried out in soft agar failed to identify any 
difference in swimming motility between the cwp7 mutant and WT, the observed phenotype could 
be a result of highly viscous, proteinaceous extra-cellular matrix formed by degraded S-layer 
proteins  ‘gluing’ the cells together. Most surprising was the fact that unlike all CWPs characterised 
so far and despite carrying the canonical Pfam 04122 cell wall-binding domains, Cwp7 does not 
localise to the cell wall but instead is anchored to the membrane via a 21 aa-long transmembrane 
helix. This forced us to rethink the dogma of S-layer assembly and consider the possibility that other, 
previously uncharacterised CWPs might also localise to the membrane and not the cell surface. 
Indeed upon closer inspection, following bioinformatic analysis of the proteins sequences, two 
additional members of the CWP family, Cwp18 and Cwp27 were identified as putative membrane 
proteins carrying predicted lipo-box motifs (Figure 5.16). While disruption of cwp18 and cwp27 
expression via ClosTron did not result in any obvious phenotypes, further work would be necessary 
to explore the functioning of the somewhat controversial Gram-positive periplasmic space 
‘sandwiched’ between the cell membrane and cell wall peptidoglycan, particularly since this is the 
most likely location for proteins involved in cell wall biogenesis. 
 
  
Figure 5.16. Schematic representation of C. difficile cell wall. A thick layer of peptidoglycan (purple) is anchored to the 
membrane through interweaving lipoteichoic acids and is covered by a two-dimensional, paracrystaline protein array 
forming the S-layer, composed of the major S-layer protein SlpA (white-blue) and minor CWPs scattered throughout. The 
putative Gram-positive periplasmic space is ‘sandwiched’ between the cell membrane and the peptidoglycan layer. 
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Since the initial suggestion of the gene’s importance in the general physiology of C. difficile 
came from studying germination, we were keen to investigate whether cwp7 disruption had any 
effect on spore formation and germination. While germination did not seem to be affected in the 
ACE mutant and could not be measured in the ClosTron mutant due to problems with purifying 
spores, a sporulation defect was observed in both the ClosTron and the ACE mutant, potentially 
explaining the reduced long term viability of cwp7::CT and the observed difficulties in culturing the 
mutant following prolonged incubation in the anaerobic cabinet. The severity of the observed 
sporulation defect was more pronounced in the ClosTron mutant, a likely consequence of using 
insertional mutagenesis and the inherent polar effects exerted on neighbouring genes. The 
limitations of ClosTron mutagenesis were further highlighted in direct comparison of the two 
mutants and although most phenotypes initially identified in cwp7::CT were also present in Δcwp7, 
several differences were observed, particularly relating to in trans complementation and the 
resulting gene-dosage effects. 
Considering the lack of a functional domain it is likely that Cwp7 forms a complex with 
additional proteins in order to exert its function. Indeed a molecular partner was identified in the 
form of CD2701, a previously uncharacterised lipoprotein, although its significance remains to be 
seen as the complete characterisation of the protein and its role within the complex lies outside of 
the scope of this study. 
Taken together, these results illustrate the predictive power of genome-wide analysis in 
identifying targets that under different circumstances could have been overlooked due to the lack of 
features that are typically taken into account when choosing genes for further characterisation. 
Cwp7 is one such target. While our analysis does not give a definite answer as to the function of the 
protein, the severe phenotypes observed upon its disruption suggest a central role in cell wall 
maintenance. Further work would be necessary to elucidate the exact mechanism by which Cwp7 
exerts its effect and the potential interactions with CD2701 and other components of the cell wall. 
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Chapter VI 
Construction of a transposon mutant library in C. difficile 630Δerm 
6.1. Introduction 
Understanding the genetic and molecular basis of C. difficile pathogenicity is a crucial step in 
the development of effective therapeutics. A number of methods for directed gene inactivation are 
now available including ClosTron insertional mutagenesis (Heap et al., 2010, Heap et al., 2007) and 
the recently developed allele-coupled exchange (Cartman et al., 2012, Heap et al., 2012, Ng et al., 
2013), allowing for reverse genetic studies, in which the exact role of a gene, hypothesized to be 
important in a particular phenotype, can be elucidated experimentally. While certainly useful, 
reverse genetic studies are limited in that they are always based on pre-made assumptions regarding 
a particular gene’s function. An alternative approach would be to use random mutant libraries in 
forward genetic studies aimed at identifying the genetic basis of a particular phenotype without 
making any assumptions about the genes involved. In other organisms, this is typically achieved 
through transposon-mediated mutagenesis creating random mutant pools that can be then 
screened to identify genes involved in a particular phenotype. While in vitro transposon mutagenesis 
systems have been successfully used in the closely related C. perfringens (Vidal et al., 2009, Lanckriet 
et al., 2009), they rely on being able to transform the recipient organisms. This makes them 
unsuitable for use in C. difficile, as at the time of writing this, DNA can be transferred into C. difficile 
only through conjugation. In 2010, an attempt was made to generate random libraries of C. difficile 
mutants in vivo, by introducing mariner-based transposons via segregationally unstable, ‘pseudo-
suicide’ vectors (Cartman and Minton, 2010). The mariner-transposable element Himar1 has been 
previously shown to insert randomly into TA target sites in genomes of many bacterial species via a 
‘cut-and-paste’ mechanism mediated by the Himar1 transposase (Lampe et al., 1996, Lampe et al., 
1998), a useful characteristic considering the low GC-content found in the C. difficile genome. While 
the experiment provided good evidence that a mariner-based transposon could be an effective tool 
154 
Chapter VI. Construction of a transposon mutant library in C. difficile 630Δerm 
for generating random mutants in C. difficile, and a number of stable mutants carrying single 
insertions were identified, the lack of a well-defined conditional replicon meant that the system 
provided little control over the transposition event and was not suitable for the creation of large 
scale libraries. Considering the recent advancements in high throughput sequencing methods, 
allowing researchers to simultaneously screen libraries comprising of as many as one million 
mutants in virtually any genetically tractable microorganism (reviewed in Barquist et al., 2013), a 
method for creating random libraries of transposon mutants could become a valuable tool in 
identifying genomic regions required for survival under a particular set of conditions. 
In this chapter I describe the design and construction of the first comprehensive transposon 
mutant library in Clostridium difficile using a conditional plasmid recently developed in our group. 
This is followed by TraDIS analysis of three individual mutant libraries in order to identify genes 
involved in the process of sporulation and germination. These results are validated in silico by 
analysing genes previously known to be essential for vegetative growth or required for sporulation 
and/or germination, as well as in vitro, by targeted deletion of selected genes followed by in-depth 
analysis of the resulting phenotypes. 
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6.2. Results 
6.2.1. Design of the mariner plasmid and construction of transposon mutant 
libraries 
Plasmid pRPF215 used to create a comprehensive transposon mutant library in C. difficile 
was designed and constructed in its entirety by Dr Robert Fagan. Briefly, codon-optimised Himar1 
hyperactive C9 transposase (Lampe et al., 1999) was cloned into pRPF177, a plasmid carrying the 
inducible Ptet promoter but lacking a transcriptional terminator directly downstream of tetR (see 
Appendix A, Figure A1). As a consequence the plasmid is segregationally-unstable upon induction 
due to transcriptional read-through from the inducible promoter and is rapidly lost from the 
population as indicated by loss of thiamphenicol resistance shortly after induction with ATc (Dr 
Robert Fagan, unpublished results). The mariner-based transposon was generated by PCR amplifying 
the ermB gene from pMTL82254 and adding a transcriptional terminator and the transposon 
inverted terminal repeats (ITRs) in successive PCR reactions. The resulting DNA fragment was cloned 
downstream of the transposase giving pRPF215. 
In order to identify genes involved in sporulation and/or germination, three mutant 
libraries were created by successively passaging a comprehensive mutant pool under selective 
conditions as described in Materials and Methods. Briefly, the input library was created by spreading 
out a culture of C. difficile 630Δerm [pRPF215] onto BHIS agar supplemented with 15 µg/ml 
thiamphenicol to select for the plasmid, 5 µg/ml erythromycin to select for the transposon and 100 
ng/ml anhydrotetracycline (ATc) to allow for Himar1-mediated transposition. Following O/N 
incubation, the resulting colonies were scraped off, thus forming a library of mutants carrying 
insertions in all but the essential genes. This culture was then sporulated on SM agar to produce the 
spore library. At this stage, all mutants carrying insertions in genes required for sporulation were lost 
from the mutant pool. Following purification, the spore library was germinated back into vegetative 
cells, losing all mutants carrying insertions in genes required for germination (Figure 6.1). Genomic 
DNA was extracted from all three libraries and submitted for TraDIS analysis. 
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6.2.2. Transposon-Directed Insertion site Sequencing (TraDIS) 
TraDIS analysis was carried out in its entirety by Dr Christine Boinett and Dr Amy Cain at 
the Wellcome Trust Sanger Institute using the HiSeq 2500 platform (Illumina). Sequencing reads 
were first filtered to only contain those that match the transposon exactly and then stripped of the 
transposon tag. These were mapped to the reference C. difficile 630Δerm genome. In order to 
reduce signal to noise ratio, 10% of insertion sites at the 3’ end were trimmed of as these may not 
alter the function of the encoded protein drastically. Complete lists of genes with significantly 
decreased numbers of insertions in the sporulation and germination libraries are included in 
Appendix B, Tables B1 and B2 respectively. 
Figure 6.1. Construction of transposon mutant libraries in C. difficile 630Δerm. Transconjugants carrying the pRPF215 
plasmid were spread out on BHIS agar supplemented with 15 µg/ml thiamphenicol, 5 µg/ml erythromycin and 100 ng/ml 
ATc to allow for Himar1-mediated transposition. Following O/N incubation colonies were scraped of in TY broth and the 
resulting culture (input library) was used to inoculate 20 ml of nutrient-rich TYG broth supplemented with 5 µg/ml 
erythromycin and 100 ng/ml ATc. The following day the resulting culture was sub-cultured 1:10 in 20 ml SM broth 
supplemented with 5 µg/ml erythromycin and 100 ng/ml ATc, grown to OD 0.6 and spread out on SM agar plates to induce 
sporulation. Spores were harvested and purified as described in Materials and Methods to create the spore library. These 
were then incubated O/N in BHIS broth supplemented with 0.5% Tch to create the germinated library. 
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6.2.3. In silico validation of sequencing results 
One of the most valuable applications of transposon-insertion site sequencing is the ability 
to identify genes important in a condition of interest, by comparing differences in the numbers of 
sequencing reads from input libraries (control) and output libraries that have been subject to 
passaging under a certain growth condition. Genes that either enhance or detract from survival 
and/or growth under the given conditions can thus be identified by a decreased or increased 
insertion frequency. 
As a first step to validate the results obtained through TraDIS, genes that were either known 
to be essential in most bacteria or were previously identified in C. difficile as essential for growth 
were screened for the presence of transposon insertions. These included genes involved in initiation 
of DNA replication dnaA, dnaB, dnaC and dnaD; gyrA encoding the A subunit of type II 
topoisomerase; murA encoding UDP-N-acetylglucosamine 1-carboxyvinyltransferase, an enzyme 
involved in the early steps of peptidoglycan biosynthesis; slpA encoding the major S-layer protein 
and secA2 encoding an accessory ATPase shown to be essential in energizing the translocation of 
SlpA across the cell membrane. In general, no insertions were identified in any of the genes in the 
input library (Figure 6.2). While a small number of insertions could be identified for some of the 
genes, particularly in the sporulation library, this was most likely a result of sequencing noise. 
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Figure 6.2. Analysis of transposon insertion sites for genes previously identified as essential for vegetative growth. 
Insertions identified in each of the mutant libraries via TraDIS were mapped to the C. difficile 630Δerm genome and 
visualised using Artemis. Scale on the right-hand side of each graph indicates numbers of individual reads. Genomic 
regions corresponding to essential genes (greyed-out areas) were free of insertions in all the analysed libraries. 
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In order to verify whether the created libraries can be used to identify genes involved in 
sporulation and/or germination, genes previously implicated in these aspects of the C. difficile life 
cycle were screened, including spo0A, the master regulator of sporulation essential in spore 
formation but not in vegetative growth (Deakin et al., 2012). As expected, while a significant number 
of insertions could be identified in spo0A in the input library, no insertions were present in either the 
sporulation or the germination library (Figure 6.3). Similarly, genes previously identified as essential 
in germination such as cspC encoding the first germination receptor identified in C. difficile (Francis 
et al., 2013) sleC encoding the major cortex-lytixc enzyme (Burns et al., 2010, Paredes-Sabja et al., 
2009) and cspB encoding a subtilisin-like serine protease essential for SleC activation (Adams et al., 
2013) were found to lack insertions in both the sporulation and germination library, although few 
insertions were identified in the input library (Figure 6.3). This is puzzling as neither of these genes 
has been shown to be required for vegetative growth. 
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Figure 6.3. Analysis of transposon insertion sites for genes previously identified as involved in sporulation and 
germination. Insertions identified in each of the mutant libraries via TraDIS were mapped to the C. difficile 630Δerm 
genome and visualised using Artemis. Scale on the right-hand side of each graph indicates numbers of individual 
reads. Genomic regions corresponding to genes involved in sporulation and/or germination (greyed-out areas) were 
free of insertions. 
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6.2.4. In vitro validation of sequencing results 
Knowing that the basic principle of the experiment was validated I set out to identify genes 
that were not previously confirmed as sporulation/germination factors. To this end, non-essential 
genes exhibiting significantly decreased numbers of insertions in the sporulation and/or germination 
library were screened to identify potential targets for ‘proof-of-principle’ experiments. Insertion 
plots generated through Artemis were visually analysed and targets with clear differences between 
the vegetative and sporulation/germination phase were further dissected through BLAST and 
literature searches for homology with genes previously implicated in sporulation and/or germination 
in other organisms. The list of potential targets was narrowed down to four genes which are 
described below (Figure 6.4). 
CD3494 encodes a putative spore protein belonging to the YabP superfamily (Pfam 07873), 
consisting of small proteins conserved in a wide range of bacteria and involved in spore coat 
assembly during the process of sporulation. The best studied member of this family is the σE-
dependent, spore coat-associated protein YabP from B. subtilis. Using fusions to green fluoresecent 
protein (GFP), YabP-GFP from Bacillus subtilis was shown to assemble into two rings around the 
forespore before redistributing to form a shell around the developing spore (van Ooij et al., 2004). 
Disruption of yabP leads to a severe sporulation defect in late stages of spore morphogeneis as 
phase–contrast analysis of the sporulating mutant revealed phase-grey spores that failed to brighten 
upon maturation (Fawcett et al., 2000). The product of CD3494 shows 32.6% pairwise identity with 
YabP from B. subtilis. 
CD0106 encodes a germination-specific N-acetylmuramoyl-L-alanineamidase, and a putative 
orthologue of B. subtilis CwlD required for muramic-δ-lactam formation during sporulation 
(Sekiguchi et al., 1995). This structural modification of peptidoglycan is found uniquely in the spore 
cortex and allows for substrate recognition by spore cortex-lytic enzymes (CLEs). While spores of a B. 
subtilis cwlD mutant are able to complete the earliest stages of germination, including the release of 
Ca2+-DPA and partial spore core rehydration, cortex lysis and, therefore, spore outgrowth does not 
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occur (Sekiguchi et al., 1995, Moir, 2003, Popham et al., 1996). The product of CD0106 shows 37% 
pairwise identity with CwlD from B. subtilis. 
CD3567 encodes a putative cell wall hydrolase that shows homology to peptidoglycan-
binding proteins belonging to the LysM (Lysine Motif) family of enzymes involved in bacterial cell 
wall degradation (reviewed in Buist et al., 2008). Interestingly, LysM domains have previously been 
shown to play a role in spore development as tandem LysM domains from the B. subtilis coat protein 
YaaH fused to β-lactamase were sufficient to target the fusion protein to the surface of the 
developing spore (Kodama et al., 2000). YaaH is also predicted to be involved in L-alanine-dependant 
germination as its disruption results in a severe germination defect (Kodama et al., 1999). Further 
evidence came from studying SafA and SpoVID, two LysM-carrying, spore coat morphogenetic 
proteins also found in B. subtilis. SafA is initially targeted to the cortex-coat interface, possibly via its 
LysM domain, while in a second stage it forms a complex with SpoVID through direct protein-protein 
interaction. Both proteins promote attachment of the spore coat to the spore cortex and are likely 
to interact with additional coat components (Costa et al., 2006). 
Finally, CD0125 encodes a putative cell wall endopeptidase and an orthologue of B. subtilis 
SpoIIQ, a σF-dependent, forespore-expressed membrane protein initially identified as required at a 
late stage of engulfment (Londono-Vallejo et al., 1997). SpoIIQ localizes to the septum in the 
forespore membrane (Rubio and Pogliano, 2004, Rodrigues et al., 2013, Fredlund et al., 2013) where 
it interacts with the mother cell proteins encoded by the spoIIIA locus, several of which show 
homology to type III and type IV secretion systems (Camp and Losick, 2008). One such protein, 
SpoIIIAH, directly interacts with SpoIIQ (Doan et al., 2005, Blaylock et al., 2004) forming a channel 
that spans the intermembrane space ensuring communication between the two compartments of 
the sporulating cell (Meisner et al., 2008, Doan et al., 2009, Camp and Losick, 2009). While being 
dispensable for engulfment (Sun et al., 2000), SpoIIQ-SpoIIIAH it is essential in maintaining forespore 
integrity and late forespore gene expression (Doan et al., 2005, Doan et al., 2009).  
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Figure 6.4. Analysis of transposon insertion sites for genes potentially involved in sporulation and germination. 
Insertions identified in each of the mutant libraries via TraDIS were mapped to the C. difficile 630Δerm genome and 
visualised using Artemis. Scale on the right-hand side of each graph indicates numbers of individual reads. Genomic 
regions corresponding to genes involved in sporulation and/or germination (greyed-out areas) were free of insertions. 
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6.2.4.1. Mutant construction 
The validation of hypotheses derived from transposon-insertion sequencing requires 
the construction of targeted deletions, as individual mutants cannot be recovered from libraries 
unless specialized protocols have been followed during library construction. To this end, null 
mutants were created in the four genes described above. The following strains were constructed: 
ΔCD3494 – 150 bp in-frame deletion covering aa 11 – 60 out of 85; ΔCD0106 – 390 bp in-frame 
deletion covering aa 21 – 150 out of 235; ΔCD3567 – 1,137 bp in-frame deletion covering aa 84 – 462 
out of 517; ΔCD0125 – 462 bp in-frame deletion covering aa 42 – 195 out of 517. All mutants were 
generated using pyrE-based allele coupled exchange as described previously in Chapter 5. Briefly, 
mutated alleles were generated by cloning PCR-amplified upstream and downstream homology 
regions (750 bp for CD3494, 1,200 bp for CD0106, CD3567 and CD0125) into pMTL-YN3 using Gibson 
Assembly according to manufacturer’s instructions. The resulting plasmids were conjugated into 
630ΔermΔpyrE as described previously. Following two passages on BHIS agar supplemented with 5 
µg/ml uracil, 15 µg/ml thiamphenicol and 250 µg/ml cycloserine, colonies that were noticeably 
larger (indicative of plasmid integration) were screened by colony PCR to identify single-crossover 
mutants using (i) primers flanking the upstream and downstream homology regions and (ii) one of 
these primers in conjunction with a plasmid-specific primer to amplify across the integration 
junction. 
Pure, single crossover mutants were streaked onto C. difficile minimal medium (CDMM) 
supplemented with 5 µg/ml uracil and 2 mg/ml 5-fluoroorotic acid (FOA) to select for plasmid 
excision. The isolated FOA-resistant colonies were screened by PCR. Double-crossover mutants in 
which the mutated allele was successfully integrated yielded products smaller than those seen in WT 
revertants. 
In order to restore the pyrE+ phenotype, plasmid pMTL-YN1 carrying the WT pyrE allele 
was conjugated into the isolated double-crossover mutants. The resulting colonies were re-streaked 
onto non-supplemented CDMM agar to select for uracil prototrophy indicating successful allele 
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exchange. Successful restoration of the pyrE allele was confirmed by colony PCR using primers 
flanking the pyrE locus [2429/2430] (Figure 6.5) followed by Sanger sequencing of the amplified 
product. 
In order to complement the mutants, WT alleles including the Ribosome Binding Site (RBS) and 
their native promoter signals identified via BPROM (Softberry) were cloned into pMTL-YN1C using 
Gibson assembly. The resulting plasmids were conjugated into the isolated double-crossover 
mutants. Following 96h of incubation individual transconjugants were re-streaked onto non-
supplemented CDMM agar to select for uracil prototrophy indicating successful allele exchange and 
the introduction of the WT allele immediately downstream of the concomitantly restored pyrE locus. 
Complementation was confirmed by colony PCR using primers flanking the pyrE locus (Figure 6.5) 
followed by Sanger sequencing of the amplified product. 
  
Figure 6.5. Disruption of CD3494, CD0106, CD3567 and CD0125 expression using allele-coupled exchange (ACE). PCR 
screening of ACE mutants following restoration of the pyrE locus and complementation using primers flanking the 
deletion sites (lanes 1 and 2) and primers flanking the disrupted pyrE locus used for complementation (lanes 3, 4 and 5). 
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6.2.4.2. Phenotypic analysis 
6.2.4.2.1. General characteristics 
In order to confirm that disruption of the analysed genes did not have any effect on the 
general fitness of the strains which could introduce bias into further analysis, growth rate in liquid 
culture was monitored. No significant changes in growth rate could be observed between WT, 
mutant and complemented strains (Figure 6.6). Similarly, no changes to colony morphology or single 
cell morphology were noted (data not shown). 
  
Figure 6.6 Characterisation of ΔCD3494, ΔCD0106, ΔCD3567, ΔCD0125 growth rate. O/N cultures in TY broth were 
sub-cultured to OD 0.05 and growth was monitored over a period of 9h by measuring OD600 at given time points. No 
significant differences in growth rate were observed between the WT, mutants and complemented strains. Data 
represented as means ± SD from two biological replicates. 
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6.2.4.2.2. Sporulation efficiency 
Sporulation efficiency in liquid BHIS culture was measured as previously described in 
Chapter V. While no significant change in sporulation efficiency could be observed for ΔCD3494, all 
remaining mutants were characterised by significantly reduced spore CFU counts. The number of 
spore CFUs recovered for both ΔCD0106 and ΔCD0125 was on average 3-log lower than in WT or the 
complemented mutants. In addition a significant delay in spore formation was observed for 
ΔCD0106 as the first spore CFUs were detected after 48h as opposed to the 24h seen in WT, 
ΔCD3494 and ΔCD0125. The sporulation defect was even more pronounced in ΔCD3567 where no 
spore CFUs could be detected throughout the duration of the experiment (Figure 6.7). As CFUs were 
the primary read-out of this assay, only cells proficient in both sporulation and germination could be 
detected. Thus, in order to differentiate between sporulation and germination defects, phase-
contrast and fluorescence microscopy were used to monitor spore formation. In support of the 
sporulation efficiency data, no obvious changes in sporulation were identified for ΔCD3494. 
Interestingly, even though spore CFU counts for ΔCD0106 were significantly lower than those seen in 
WT, microscopic analysis failed to identify any defects as mature, phase-bright spores were present 
in numbers similar to those seen in WT samples. This would suggest that the product of CD0106 is 
involved in germination and not sporulation, a notion supported by significant homology between 
CD0106 and cwlD found in B. subtilis. In accordance with the sporulation efficiency assay, both 
ΔCD3567 and ΔCD0125 showed a severe sporulation defect. While ΔCD3567 did form small, phase-
dark spores that were eventually released following autolysis of the mother cell compartment, no 
spores could be identified for ΔCD0125, suggesting that sporulation was blocked at an early stage of 
development (Figure 6.8). Importantly, all phenotypes observed through this analysis were restored 
to WT upon complementation. 
  
168 
Chapter VI. Construction of a transposon mutant library in C. difficile 630Δerm 
 
 
Figure 6.7.  Assessment of CD3494, CD0106, CD3567 and CD0125 ACE mutant sporulation efficiency. Sporulation was 
induced via nutrient starvation in BHIS broth and was assessed over a period of 5 days by measuring total and spore 
CFUs. A severe defect in spore CFU recovery was identified in ΔCD0106, ΔCD3567 and ΔCD0125 throughout the 
duration of the experiment. In all cases spore CFU levels were restored to WT levels upon complementation. No 
significant changes in sporulation efficiency were observed for ΔCD3494. Data represented as means ± SD from two 
biological replicates, each consisting of three technical replicates. A spo0A mutant was included in each biological 
replicate as a sporulation-negative control but was omitted from analysis for reasons of clarity. Limit of detection 
indicated with a horizontal dashed line. 
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Figure 6.8. Phase contrast and fluorescence microscopy analysis of sporulation in ΔCD3494, ΔCD0106, ΔCD3567 and 
ΔCD0125. Cultures were sporulated on SM agar for 24h, harvested in PBS and stained with FM4-64 (membrane stain) and 
Hoechst 33258 (DNA stain). Severe sporulation defects were observed in ΔCD3567 and ΔCD0125 but not in ΔCD3494 and 
ΔCD0106. In ΔCD3567, small, phase-dark spores were identified (black arrows). These were eventually released into the 
culture medium following autolysis of the mother cell compartment but could not be isolated form the culture by density 
gradient centrifugation. In ΔCD0125, no spores were identified as sporulation was aborted at the forespore formation step 
(white arrows). Microscopy data representative of two biological replicates. Scale bars provided. 
171 
Chapter VI. Construction of a transposon mutant library in C. difficile 630Δerm 
 
6.2.4.2.3. ΔCD0106 and ΔCD3494 germination dynamics 
In order to confirm the germination defect observed in ΔCD0106, germination dynamics 
of purified spores were measured. ΔCD0106 spores re-suspended in BHIS supplemented with 0.5% 
Tch showed only a 4% drop in OD600 after 15 min of incubation as compared to a 54% drop seen in 
WT (Figure 6.9A). This was further supported by phase-contrast analysis of germinating spores, 
which revealed that ΔCD0106 spores remain phase-bright even after 180 min of incubation in the 
presence of the germinant, a period of time sufficient for completion of germination by germination-
proficient strains (Figure 6.9B). As previously, WT phenotype was restored upon complementation. 
No germination defect was seen for ΔCD3494 (Figure 6.9A and 6.9B). 
6.2.4.2.4. ΔCD3494 lysozyme resistance 
Since CD3494 encodes a putative orthologue of the spore coat-associated protein YabP, 
and disruption of YabP has been shown to result in spore coat defects, the integrity of ΔCD3494 
spore coat was assessed by testing the spore’s resistance to lysozyme. To this end purified spores 
were re-suspended in PBS supplemented with 250 µg/ml lysozyme. At given time points serial 
dilutions were prepared, spread out on BHIS agar supplemented with 0.1% Tch and CFUs were 
enumerated following O/N incubation. No significant difference in resistance to lysozyme could be 
observed between WT, ΔCD3494 or ΔCD3494 + CD3494 (data not shown). 
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Figure 6.9. Characterisation of germination dynamics in ΔCD0106 and ΔCD3494. Purified spores were re-suspended in 
BHIS + 0.5% Tch and germination was monitored by (A) measuring the drop in OD600 concomitant with Ca
2+-DPA release 
and (B) phase-contrast microscopy on formaldehyde fixed samples. A severe germination defect was observed in 
ΔCD0106 as little Ca2+-DPA release was observe when compared to WT and complemented strains and spores remained 
phase-bright throughout the duration of the experiment. Germination dynamics were restored to WT levels upon 
complementation. No significant changes in germination dynamics were observed for ΔCD3494. Numerical data 
presented as means ± SD from three biological replicates. Microscopy data representative of two biological replicates. 
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6.3. Discussion 
As with many aspects of C. difficile research, forward genetic studies of C. difficile physiology 
have been hampered by the lack of suitable genetic tools and while transposon mutagenesis has 
been successfully used in closely related organisms, until now, similar methods have not been 
available for use in C. difficile. Taking advantage of a conditional replicon recently developed in our 
lab I set out to construct the first comprehensive mutant library in C. difficile and use it to identify 
genes involved in sporulation and germination using TraDIS. 
 In silico validation of the sequencing results confirmed that our approach could be 
successfully used to identify genes that are essential for vegetative growth as well as those required 
for sporulation and/or germination. This was further supported by targeted disruption of selected 
genes followed by analysis of the resulting phenotypes. Out of the four genes analysed, both CD3567 
and CD0125 were shown to be required in sporulation, albeit at different stages of the process. 
Considering that the product of CD3567 belongs to the same protein family as YaaH, SafA  
and SpoVID found in B. subtilis, it seem likely that it is involved in spore coat morphogenesis. Indeed, 
while disruption of CD3567 did not prevent spore formation, the resulting spores were significantly 
smaller than ones observed in WT and were phase-dark. Interestingly, the aberrant spores formed 
by the CD3567 mutant failed to germinate. This again is consistent with disruption of the spore coat 
which under normal circumstances is responsible for efficient interaction of the spore with 
compounds that trigger germination (Driks, 1999, Henriques and Moran, 2000). As purification of 
these defective spores proved to be impossible, classical methods used to identify spore coat defects 
such as measuring lysozyme resistance could not be used. TEM imaging would be necessary to 
confirm potential changes in spore coat morphology. 
While a small number of heat-resistant spores were detected for ΔCD0125 in the sporulation 
efficiency assay (3-log drop in spore CFUs when compared to WT), no spores could be visualised 
using phase-contrast microscopy, most likely due to the relatively high detection limit of this method. 
Instead, a significant number of cells that appeared to be arrested at forespore formation stage 
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could be observed. This phenotype is consistent with the predicted function of the CD0125 
orthologue found in B. subtilis, spoIIQ. While deletion of spoIIQ causes a severe sporulation defect in 
B. subtilis, it does not block spore formation completely (Rodrigues et al., 2013). Furthermore, TEM 
analysis of ΔspoIIQ spores revealed that spoIIQ disruption causes the forespore to collapse and lose 
its integrity (Doan et al., 2009). This coincides with loss of metabolic potential (Camp and Losick, 
2009). A detailed analysis of spore morphogenesis would be required to confirm whether similar 
phenotypes could be identified in the ΔCD0125 mutant. 
The germination defect observed in the ΔCD0106 mutant (4-log drop in spore CFUs when 
compared to WT) is largely consistent with studies carried out in B. subtilis, where disruption of cwlD 
expression resulted in 4 to 8-log drop in spore CFUs recovered following heat-treatment (Popham et 
al., 1996, Sekiguchi et al., 1995). While ΔcwlD spores were able to carry out the first steps of 
germination and only a slight delay in Ca2+-DPA release and loss of optical refractibility was observed 
(Sekiguchi et al., 1995), cortex hydrolysis did not occur thus blocking further steps of germination 
and outgrowth. In contrast, ΔCD0106 spores remained phase bright-throughout the duration of the 
experiment, suggesting that Ca2+-DPA release did not occur. To some extent, this is consistent with 
work carried out in the more closely related C. perfringens where disruption of sleC, a cortex lytic 
enzyme involved in cortex PG degradation resulted in a severe germination defect, characterised by 
a significant decrease in the amount of Ca2+-DPA released and the corresponding delay in loss of 
optical refractibility (Paredes-Sabja et al., 2009). These results were later recreated in C. difficile by 
disrupting a sleC homologue (CD0551) (Burns et al., 2010). Since the product of CD0106 is expected 
to be involved in the formation of muramyl-δ-lactam, a structural modification found in cortex PG 
essential for SleC function, one could expect that CD0106 disruption could exert a similar effect in C. 
difficile. Yet the severity of the germination defect observed in ΔCD0106 was higher than that seen 
upon sleC disruption in both C. perfringens and C. difficile suggesting that additional factors might be 
in play. While a detailed analysis of the ΔCD0106 germination characteristics lies outside the scope 
of this study, it would be useful to test whether the colony-forming efficiency of ΔCD0106 spores 
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was restored to WT levels after decoating and plating on BHIS agar supplemented with lysozyme as 
has been reported for C. difficile and C. perfringens sleC mutants  (Burns et al., 2010, Paredes-Sabja 
et al., 2009). 
Finally, disruption of CD3494, a putative spore protein belonging to the YabP superfamily did 
not result in any obvious phenotype. This is somewhat puzzling as the ΔCD3494 mutant was absent 
from both the sporulation and germination library while being present in the input library, 
suggesting that CD3494 is essential in sporulation. In fact, out of all the genes analysed, CD3494 
showed the most significant decrease in transposon insertions when comparing the input library to 
the sporulation library (p = 5.88 x 10-37). It is important to note however, that ‘essentiality’ is always 
relative to growth conditions and has traditionally been determined in clonal populations. Since 
high-throughput transposon sequencing protocols contain a short period of competitive growth 
before DNA extraction, some mutants might be lost form the population due to competition from 
the remaining mutant pool (false positive). Conversely, as many otherwise essential genes tolerate 
insertions in their 3’ coding region if this does not encode an essential domain, judging a gene purely 
by the presence of insertions can result in required genes being identified as non-essential (false 
negative). Determination of required genomic regions can thus be difficult and care should be taken 
when interpreting the results of high-throughput assays of gene requirements. 
Despite these issues, ‘proof-of-principle’ experiments carried out in this study have provided 
good evidence that TraDIS analysis of random mutant libraries is a viable method for identifying 
genes required for sporulation and germination. 
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VII. General discussion 
Despite the falling numbers of CDI cases reported in the UK in recent years, C. difficile 
remains a heavy burden on the healthcare system, causing disruptions in the functioning of hospitals 
and care homes, draining valuable resources, and resulting in significant morbidity and mortality 
(Dubberke and Olsen, 2012).  In the United States alone, CDI develops in >500 000 patients, with up 
to 20 000 deaths per year and its economic impact cannot be underestimated as the yearly 
healthcare burden in both the United States and Europe has been estimated to be >$3 billion 
(Rupnik et al., 2009). While progress has been made in understanding the molecular basis of C. 
difficile pathogenicity, the majority of treatment methods currently available are aimed at reducing 
the bacterial load and preventing toxin-associated symptoms, rather than the onset of infection 
itself. Spores represent the principal infective stage within the C. difficile life cycle (Gerding et al., 
2008, Riggs et al., 2007) but must germinate to allow for vegetative cell growth and toxin 
production, representing an attractive target for intervention. A detailed understanding of 
sporulation and germination could thus have direct applications for disease prevention in the 
healthcare environment, facilitating the development of new disinfection regimes, molecular 
diagnostics and targeted treatments such as vaccines or antibiotics. It has already been shown that 
germinants can be used in clinical settings to stimulate germination of C. difficile spores on 
contaminated surfaces (Nerandzic and Donskey, 2010, Nerandzic and Donskey, 2013). The resulting 
vegetative cells are extremely sensitive to stresses such as oxygen, traditional decontamination 
procedures and the gastric barrier and can therefore be easily killed. Conversely, chemical inhibition 
of spore germination could reduce the ability of C. difficile to colonise the gut and cause disease, 
becoming an effective tool in CDI prevention and infection control (Howerton et al., 2013). 
Historically, C. difficile research has been lagging behind studies carried out in other Gram-
positive sporeformers such as the model organism B. subtilis and the closely related C. perfringens, 
primarily due to difficulties in culturing the pathogen and the limited availability of suitable 
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methodology. However, recent advancements in the field precipitated by the introduction of new 
genetic tools have facilitated a more detailed understanding of C. difficile physiology. A number of 
key studies have recently been published, combining large scale genomic, transcriptomic and 
proteomic approaches with classic microbiology techniques to provide valuable insight into C. 
difficile sporulation, germination and spore morphology. The spore differentiation pathway has been 
described in great detail, highlighting some of the differences in the spatial and temporal 
programme of gene expression among sporeformers (Pereira et al., 2013). In a genome-wide 
analysis of cell type-specific gene transcription, Saujet at al. (2013) have used promoter mapping 
together with transcriptional analyses to define the C. difficile σF, σE, σG and σK regulons, identifying 
approx. 225 genes under the control of these sigma factors. Finally, by combining RNA sequencing 
with a detailed analysis of the spore proteome, Pettit at al. (2014) have dissected the Spo0A regulon, 
validating Spo0A as a positive regulator of novel sporulation genes as well as a number of virulence-
associated factors and metabolic pathways. 
Capitalizing on this wealth of new data as well as new genetic tools developed in the 
Fairweather lab and by other groups, this study aims to provide a genome-wide overview of 
sporulation and germination in C. difficile. In the final chapter of this thesis I discuss the main 
conclusions of my work in a broader, biological context, provide further perspectives for studying 
sporulation and germination in C. difficile, and attempt to address some of the questions raised 
throughout this thesis. 
 
7.1. Sporulation and germination dynamics in C. difficile 
While sporulation and germination in the model sporeformer B. subtilis has been 
characterised in great detail over the years, at the onset of this project, studies aimed at dissecting 
the molecular basis of sporulation and germination in C. difficile have been lacking, primarily due to 
difficulties in culturing the pathogen, inconsistencies in methodology and the scarcity of genetic 
tools necessary for studying the intricacies of C. difficile physiology. Here, as part of preliminary work 
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leading up to a more detailed analysis, we attempted to create a platform for studying sporulation 
and germination in C. difficile, and the phenotypic characterisation of mutants with sporulation 
and/or germination defects. To this end the optimal conditions for C. difficile sporulation have been 
assessed and the general characteristics of C. difficile spores have been analysed.  
One of our primary goals was to develop a reproducible method for preparing C. difficile 
spores. In line with previous reports (Putnam et al., 2013, Pereira et al., 2013), sporulation in liquid 
culture was found to be extremely inefficient, irrespective of the medium used. This, combined with 
significant cell lysis observed throughout the experiment, suggests that neither of the sporulation 
methods described to date seems to be optimal for efficient sporulation of C. difficile strains. While 
gradual desiccation on solid media increased spore yields and made sporulation more 
homogeneous, sporulation efficiency was still significantly lower that than that seen in B. subtilis, 
suggesting that further optimisation of sporulation methods is necessary. Density gradient 
centrifugation proved to be a viable alternative to more complex methods of spore purification that 
require the use of detergents, enzymes and sonication, yielding spore suspensions free of noticeable 
contaminants. Importantly, an in-depth analysis of the purified spores revealed that their general 
characteristics including spore ultrastructure and their resistance to heat, chemicals and lysozyme 
were no different than those described for B. subtilis spores. This would be expected, considering 
that the basic ‘blueprint’ for endosporulation has evolved within the Firmicutes phylum some 2.5 
billion years ago (Paredes et al., 2005). 
While both spore morphology and the general programme of sporulation appeared to be 
conserved, several key differences were noticed during spore germination, particularly with regard 
to the dynamics of the process, its relative synchronicity and the potential role of anaerobic 
conditions in regulating progression into outgrowth. Analysis of germination dynamics confirmed 
that C. difficile spores respond to the bile salt sodium taurocholate (Tch) as the primary germinant.  
Interestingly, our experiments also highlighted the importance of maintaining anaerobic conditions 
during germination. While spores stimulated with Tch in the presence of ambient oxygen levels did 
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lose their phase-bright appearance, indicating initiation of germination, progression through the 
remaining stages of the process and eventually outgrowth did not occur. This suggests that oxygen 
affects signalling downstream of the germination receptor ‘circuitry’, an intriguing phenomenon, 
particularly in the light of the fact that in B. subtilis, once induced, spores are committed to continue 
through germination even if the germinant is removed (Yi and Setlow, 2010). While both the 
molecular basis of this ‘fail-safe’ mechanism and the fate of germination-arrested spores remain 
unclear, a means for monitoring ambient oxygen levels in the environment certainly makes sense in 
the light of the pathogens strictly anaerobic life cycle, as it would prevent premature germination 
under potentially harmful conditions. 
Another intriguing finding of this study was that the dynamics of the germination process 
differed from those previously described in the closely related C. botulinum (Broussolle et al., 2002) 
and C. sporogenes (Bassi et al., 2013) where initiation of germination was found to be a much slower 
process. Importantly, germination was largely synchronous and appeared to be complete within 
three hours from induction. This is somewhat surprising, particularly when confronted with the 
heterogeneity of germination rate observed in Bacillus species, as well as the more closely related C. 
perfringens and C. botulinum (Ghosh and Setlow, 2009, Ghosh and Setlow, 2010, Stringer et al., 
2005, Wang et al., 2011), in which a sub-population of spores fails to germinate upon induction. This 
kind of ‘bet hedging’ is often seen in nature, as it ensures the survival of given population in rapidly 
changing environments. One could argue that the relative homogeneity of the spore population 
observed under the conditions tested and the resulting synchronicity of germination is a reflection of 
the unique germination mechanism present in C. difficile and/or the fact that the human gut is a 
relatively stable environment eliminating the need for superdormancy. 
 
7.2. Metabolic changes during germination 
Work presented in Chapter IV, has demonstrated the application of microarray technology in 
providing a genome-wide overview of the temporal gene expression patterns during germination 
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and outgrowth of C. difficile spores, highlighting some of the metabolic changes that accompany 
these events. Particular attention was paid to genes expressed in the early stages of germination, 
which are thought to be critical in the transformation of a metabolically dormant spore into an 
actively growing vegetative cell. Using this approach, around 14% of the genome (511 genes out of 
3679) was found to be differentially regulated during germination when compared to the vegetative 
cell and. Such high percentage of differentially regulated genes is not unusual and has been reported 
previously in microarray studies carried out in other sporeformers (Bassi et al., 2013, Bettegowda et 
al., 2006, Keijser et al., 2007), highlighting the severity of changes that the cell must undergo during 
sporulation. A functional profiling of the microarray results confirmed that many genes identified 
through our analysis were co-regulated. This was particularly true for genes involved in metabolite 
transport, transcription and translation as well as a number of biosynthetic pathways, including 
peptidoglycan and SCWP biogenesis, all necessary in re-building of the basic components of the cell 
and re-establishing of metabolism. 
Potentially, one of the most intriguing aspects of this study was the RNA composition of the 
dormant spore, particularly with regards to the small rRNA species identified during RNA extraction 
as well as the abundance of mRNA transcripts and their potential function during the early stages of 
germination. One group of transcripts that were significantly overrepresented in the spore 
transcriptome were those encoding redox enzymes, possibly involved in detoxification by scavenging 
reactive oxygen species (ROS). Similar findings were previously reported by Bettegowda at al. (2006) 
in their microarray analysis of C. novyi-NT spores and it seems plausible that this is a common 
feature among anaerobic sporeformers. 
 
7.3. Cwp7 and the cell wall 
In order to further validate the microarray results presented in Chapter IV, several targets 
identified as differentially expressed during germination, were studied in more detail. These 
included the previously uncharacterised, putative cell wall proteins: Cwp10 and Cwp29, both of 
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which were shown to be highly expressed during vegetative growth, as well as Cwp7, the sole 
member of the CWP family to be up-regulated during germination. While no significant changes 
were observed upon disruption of either Cwp10 or Cwp29, insertional mutagenesis of Cwp7 resulted 
in a striking phenotype which suggested the genes involvement in cell wall biogenesis and/or 
maintenance. This was somewhat surprising considering the proteins structure and its apparent lack 
of a predicted functional domain. Nonetheless, judging by the data obtained thus far, as well as the 
genomic context of the gene in question, we felt that a detailed characterisation of the cwp7 locus 
was warranted. The localisation of cwp7 within the C. difficile genome was particularly intriguing as 
it lies on the verge of two loci previously implicated in cell wall and S-layer biogenesis: a cluster of 
genes encoding members of the CWP family and accessory proteins necessary for their translocation 
across the cell membrane, as well as a putative SCWP biogenesis locus, preceded by mviN, clearly 
involved in peptidoglycan synthesis in other organisms. Considering that within this ~52 kb region lie 
many genes previously identified as involved in cell wall and S-layer biogenesis, it was plausible that 
cwp7 could play a similar role. 
Indeed, upon disruption, phase contrast microscopy analysis revealed significant changes in 
single cell morphology, suggesting defects in the general organisation of the cell wall. This was 
reflected in S-layer composition and clear defects in S-layer assembly as significant amounts of CWPs 
were being shed into the culture supernatant during growth. The most surprising result of our 
analysis however, was the fact that unlike all CWPs characterised thus far and despite carrying the 
canonical cell wall-binding domains, Cwp7 does not localise to the cell wall but instead is anchored 
to the membrane. This forced us to rethink the current dogma of S-layer assembly and consider the 
possibility that other, previously uncharacterised CWPs might also localise to the membrane and not 
the cell surface. 
While the initial suggestion of the gene’s importance in the general physiology of C. difficile 
came from studying germination, we were unable to identify a germination defect in a cwp7 mutant. 
However, a sporulation defect was observed, potentially explaining the reduced long term viability 
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and the observed difficulties in culturing the mutant following prolonged incubation in the anaerobic 
cabinet. The severity of the observed sporulation defect was more pronounced in the ClosTron 
mutant, a likely consequence of using insertional mutagenesis and the inherent polar effects exerted 
on neighbouring genes. The limitations of ClosTron mutagenesis were further highlighted in direct 
comparison of the two mutants and although most phenotypes initially identified in cwp7::CT were 
also present in Δcwp7, several differences were observed, particularly relating to in trans 
complementation and the resulting gene-dosage effects. 
While we were unable to identify a clear function for Cwp7, phenotypes observed upon its 
disruption point to a role in cell wall biogenesis and/or maintenance. The lack of a defined functional 
domain suggests that Cwp7 forms a complex with additional proteins in order to exert its function. 
Indeed, a molecular partner was identified in the form of CD2701, a previously uncharacterised 
lipoprotein. Interestingly, in Gram-negative organisms, some lipoproteins have been shown to 
interact with and stimulate peptidoglycan synthases, thus playing an important role in cell wall 
biogenesis (Paradis-Bleau et al., 2010, Typas et al., 2010). Considering that disruption of Cwp7 
results in severe changes to cell shape, which is largely dictated by the cell wall, one could speculate 
that the protein is part of a membrane-anchored complex involved in regulating peptidoglycan 
biosynthesis. This opens up the prospect for further research into the Gram-positive periplasmic 
space, the protein complexes located within, and their role in cell wall synthesis. 
 
7.4. Transposon mutagenesis and genome-wide analysis of sporulation and 
germination genes 
As with many aspects of C. difficile research, forward genetic studies of C. difficile physiology 
have been hampered by the lack of suitable genetic tools and while transposon mutagenesis has 
been successfully used in closely related organisms, until now, similar methods have not been 
available for use in C. difficile. Taking advantage of a conditional replicon recently developed in our 
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lab we have constructed the first comprehensive mutant library in C. difficile and used next-
generation sequencing to identify the core gene set required for sporulation and germination. 
In silico validation of the sequencing results confirmed that our approach could be successfully 
used to screen random mutant libraries for genes that are essential under a particular set of 
conditions. This was further supported in ‘proof-of-principle’ experiments where targeted disruption 
of selected genes was followed by a thorough analysis of the resulting phenotypes. Out of all genes 
tested at least three showed clear involvement in either sporulation or germination. One of these 
genes, CD3567, encoding a putative cell hydrolase has since been identified as a homologue of 
SpoVID, a major spore morphogenetic protein involved in tethering the proteinaceous spore coat to 
the spore cortex (Putnam et al., 2013).  
 Importantly, once generated, the mutant library can be used to determine gene requirement 
under any set of selective or permissive conditions. In support of this, in collaboration with Dr 
Robert Fagan and the Sanger Institute we are now exploring the use of this methodology in 
identifying the minimal set of genes required for establishment of the colonised state upon ingestion 
of spores using the mouse model of C. difficile infection developed ant the Sanger Institute (Lawley 
et al., 2009) which could have direct implications in developing effective intervention strategies 
aimed at preventing CDI rather than treating it.  
 
7.5. Concluding remarks 
We are now only beginning to understand the molecular basis of C. difficile physiology. 
However, considering the recent advancements in the field of Clostridial research and the range of 
genetic tools currently at our disposal the path is clear for more robust analysis of the key aspect of 
CDI. We believe that the data presented in this study, and the methods developed throughout, will 
provide a basis for further research aimed at elucidating some of the unanswered questions in C. 
difficile pathogenesis, particularly with regard to sporulation and germination, and the role of 
endospores in establishment of the colonised state. 
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Table A1. C. difficile strains used in this study 
 
Strain No. Genomic background Plasmid Plasmid description Designated name Source 
2001 630 N/A N/A  Peter Mullany 
2015 630 Δerm N/A N/A  Peter Mullany 
2347 630 Δerm cwp10::erm N/A N/A cwp10::CT This study 
2348 630 Δerm cwp29::erm N/A N/A cwp29::CT This study 
2356 630 Δerm cwp7::erm N/A N/A cwp7::CT This study 
2357 630 Δerm cwp7::erm pMLD024 pRPF144-cwp7 cwp7::CT + [pCwp7] This study 
2359 630 Δerm cwp7::erm pMLD026 pRPF144-cwp7trunc cwp7::CT + [pCwp7trunc] This study 
2360 630 Δerm pMTL960 pMTL960 630 Δerm + [pMTL960] This study 
2361 630 Δerm cwp7::erm pMTL960 pMTL960 cwp7::CT + [pMTL960] This study 
2366 630 Δerm cwp18::erm N/A  N/A cwp18::CT This study 
2367 630 Δerm cwp27::erm N/A  N/A cwp27::CT This study 
2411 630 Δerm pMLD024 pRPF144-cwp7 630 Δerm + [pCwp7] This study 
2412 630 Δerm cwp7::erm pMLD035 pRPF144-cwp7-mCherry cwp7::CT + [pCwp7mCherry] 
This study 
2428 630 Δerm  pMLD052 pRPF185-αCD2783   This study 
2429 630 Δerm cwp7::erm pMLD052 pRPF185-αCD2783   This study 
2542 630 Δerm ΔpyrE N/A N/A  Nigel Minton 
2545 630 Δerm fliC::erm N/A N/A  Susan Logan 
2600 630 Δerm cwp7::erm pMLD063 pFT58-Pcwp2-cwp7-SNAP-Cdi   This study 
2601 630 Δerm ΔpyrE Δcwp7 N/A N/A Δcwp7 ΔpyrE This study 
2618 630 Δerm Δcwp7 N/A N/A Δcwp7 This study 
2619 630 Δerm Δcwp7::Pcwp2-cwp7 N/A  N/A Δcwp7::cwp7 This study 
2642 630 Δerm ΔpyrE ΔCD3494 N/A  N/A ΔCD3494 ΔpyrE This study 
2643 630 Δerm ΔpyrE ΔCD0106 N/A  N/A ΔCD0106 ΔpyrE This study 
2644 630 Δerm ΔpyrE ΔCD3567 N/A  N/A ΔCD3567 ΔpyrE This study 
2645 630 Δerm ΔpyrE ΔCD0125 N/A  N/A ΔCD0125 ΔpyrE This study 
2646 630 Δerm ΔCD3494 N/A N/A ΔCD3494 This study 
2647 630 Δerm ΔCD0106 N/A N/A ΔCD0106 This study 
2648 630 Δerm ΔCD3567 N/A N/A ΔCD3567 This study 
2649 630 Δerm ΔCD0125 N/A N/A ΔCD0125 This study 
2654 630 Δerm ΔCD3494::Pnat-
CD3494 N/A N/A ΔCD3494::CD3494 This study 
2655 630 Δerm ΔCD0106::Pnat-
CD0106 N/A N/A ΔCD0106::CD0106 This study 
2656 630 Δerm ΔCD3567::Pnat-
CD3567 N/A N/A ΔCD3567::CD3567 This study 
2657 630 Δerm ΔCD0125::Pnat-
CD0125 N/A N/A ΔCD0125::CD0125 This study 
2621 630 Δerm cwp7::erm pMLD075 pFT58-Pcwp2-SNAP-Cdi cwp7::CT + [pSNAP] This study 
2631 630 Δerm pMLD063 pFT58-Pcwp2-cwp7-SNAP-Cdi cwp7::CT + [pCwp7SNAP] This study 
2698 630 Δerm cwp7::erm pMLD089 pRPF144-cwp7-FLAG cwp7::CT + [pCwp7FLAG] This study 
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Table A2. Plasmids used in this study 
 
Official 
name Descriptive name  Comments 
pMLD011 pMTL007C-E5-cwp10 (42a) ClosTron plasmid targeting cwp10 (CD2796) 
pMLD012 pMTL007C-E5-cwp29 (45a) ClosTron plasmid targeting cwp29 (CD2518) 
pMLD013 pMTL007C-E5-cwp7 (207a) ClosTron plasmid targeting cwp7 (CD2782) 
pMLD023 pET28a-cwp7 26-323 
heterologous expression of cwp7 fragment (aa 26-323) for antibody 
purification. 
pMLD024 pRPF144-cwp7 cwp7 complementation under the control of a constitutive, Pcwp2 promoter 
pMLD026 pRPF144-cwp7-trunc 
cwp7 complementation under the control of a constitutive, Pcwp2 promoter, 
no transmembrane helix 
pMLD027 pMTL007C-E5-cwp18 (346a) ClosTron plasmid targeting  cwp18 (CD1047) 
pMLD028 pMTL007C-E5-cwp27 (82s) ClosTron plasmid targeting cwp27 (CD0440) 
pMLD035 pRPF144-cwp7-mCherry (XhoI/XhoI) 
pMLD034 with mCherry from pZLS016 cloned into the XhoI site (XhoI/XhoI 
cloning) 
pMLD061 pMTL-YN3-Δcwp7 660 bp deletion within the cwp7 ORF with 750 bp LHR and HR 
pMLD062 pMTL84121-linker-SNAP-Cdi 
made by adding a liner to pFT47 [2360/2361]. 6bp different form pFT58 (no 
second stop codon on C-terminus of SNAP-Cdi) 
pMLD063 pFT58-Pcwp2-cwp7-SNAP-Cdi 
cwp7 including Pcwp2 from pMLD024 cloned EcoRI/BamHI into pFT58 to fuse 
with SNAP-Cdi 
pMLD064 pFT58-Pcwp7-cwp7-SNAP-Cdi 
cwp7 including native promoter cloned SacI/BamHI into pFT58 to fuse with 
SNAP-Cdi 
pMLD066 pMTL-YN3-ΔCD3494 
150 bp deletion within the CD3494 ORF with 750 bp LHR and RHR (ΔpyrE 
system) 
pMLD069 pMTL-YN3-ΔCD0106 390bp deletion within the cwlD ORF with 1200bp LHR and RHR (ΔpyrE system) 
pMLD070 pMTL-YN3-ΔCD3567 
1137bp deletion within the CD3567 ORF with 1200bp LHR and RHR (ΔpyrE 
system) 
pMLD071 pMTL-YN3-ΔCD0125 390bp deletion within the cwlD ORF with 1200bp LHR and RHR (ΔpyrE system) 
pMLD073 pMTL-YN1C-Pcwp2-cwp7 Entire cwp7 ORF with under the cotrol of Pcwp2 cloned EcoRI/BamHI 
pMLD074 pMTL-YN1C-Ptet-cwp7 Entire cwp7 ORF with under the cotrol of Ptet cloned KpnI/BamHI 
pMLD075 pFT58-Pcwp2-SNAP-Cdi 
pMLD063 without the cwp7 ORF (effectively Pcwp2-SNAP-Cdi). Constructed via 
inverse PCR using primers [2464/2465] 
pMLD077 pMTL-YN1C-Ptet-cwp7 (-SacI) 
pMLD074 with a SacI site upstream of Ptet removed via inverse PCR using 
primers [2492/2493] 
pMLD085 pMTL-YN1C-Pnat-CD3494 
CD3494 under the control of its native promoter cloned into pMTL-YN1C via 
Gibson Assembly 
pMLD086 pMTL-YN1C-Pnat-CD0106 
CD0106 under the control of its native promoter cloned into pMTL-YN1C via 
Gibson Assembly 
pMLD087 pMTL-YN1C-Pnat-CD3567 
CD3567 under the control of its native promoter cloned into pMTL-YN1C via 
Gibson Assembly 
pMLD088 pMTL-YN1C-Pnat-CD0125 
CD0125 under the control of its native promoter cloned into pMTL-YN1C via 
Gibson Assembly 
pMLD089 pRPF144-cwp7-FLAG cwp7-FLAG fusion under the control of Pcwp2 
pRPF215 
pMTL960-Ptet-himar1 (Tnase) + ermB 
transposon 
Codon-optimised himar1 transposase and a Mariner transposon carrying ermB 
cloned under the control of the inducible Ptet promoter 
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Figure A1. Maps of plasmids used in this study. 
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Table A3. Primers used in this study. 
 
Name Orientation Sequence (5’ -> 3’) Restriction site Comments 
408 F TCTTGAATATCAAAGGTGAGCCAGTACA  16S rRNA amplification for RT-PCR 
409 R TACAGCGTGGACTACCAGGGTATCTAAT  
722 F ACGCGTTATATTGATAAAAATAATAATAGTGGG  RAM amplification for screening ClosTron mutants 
723 R ACGCGTGCGACTCATAGAATTATTTCCTCCCG  
793 F CACCTCCTTTTTGACTTTAAGCCTACGAATACC  pRPF144 plasmid sequencing 
794 R CACCGACGAGCAAGGCAAGACCG  
1063 R CGAAATTAGAAACTTGCGTTCAGTAAAC  ClosTron EBS universal primer 
1322 F CTG GAC TTC ATG AAA AAC TAA AAA AAA TAT TG  pRPF185 plasmid sequencing 
1671 F TCCCTCTTATTCTTTCTACTTTCATTCC 
 cwp7 (CD2782) amplification for RT-PCR (300bp product) 1672 R GAAGGGAGTATACCAGAGATTTCG 
 1673 F GCTGGTTTATCACTTGTTCCTTTTCC 
 cwp10 (CD2796) amplification for RT-PCR (300bp product) 1674 R TTCATTTCAAGCCAGTATAAAAGTACAAGG 
 1675 F TGATGAAGTACCACCTATTACATAACTTTC 
 cwp29 (CD2518) amplification for RT-PCR (300bp product) 1676 R GCTTTATCAATAGAACTTTCTCCACCT 
 1677 F CCATCAAACAATGTAGAAGAAGCTGG 
 tcdA (CD0663) amplification for RT-PCR (300bp product) 1678 R TAGCAAATTCGCTTGTGTTGAATTCATC 
 1679 F AGATTTATGATGGAACTAGGAAAGTATTTAAG 
 tcdB (CD0660) amplification for RT-PCR (300bp product) 1680 R CACCAAGAGAACCTTCAAAATAATTCC 
 1681 F TCTAGCAAACGCTGCATGTGC 
 pfoR (CD2625) amplification for RT-PCR (300bp product) 1682 R ACAACCACTAAATCCACTCCAGG 
 1702 F CTCACCTTGTACTTTTATACTGG 
 for screening cwp10 ClosTron mutants 1703 R AATAAAAGAAAATCTTTTATAAGAACTATAGC 
 1704 F CTTAATCCATCAGCCATTGTGC 
 for screening cwp29 ClosTron mutants 1705 R GTGAAATTAAAGAAATTATTATCACTAGG 
 1718 F GTATAAGTGCAACACCTTTAGC 
 for screening cwp7 ClosTron mutants 1719 R TCTTTAGATACTGCCTTTAAACC 
 1762 F GGATCCAAAAGCTTCCTTATAAATCAAAAAC BamHI for complementation of the cwp7 ClosTron mutant using pRPF144 
1763 R GAGCTCAAAGAAAAGGAATGAGAAC SacI 
1764 F CTCGAGGCTCTTAAATAGACTATAATC XhoI for producing recombinant Cwp7 using pET-28a for antibody production  
1790 R CCA TGG ATG CAA ATC CCA AAA GAG NcoI 
1791 F GATC GG ATC CAA AAG CTT CCT TAT AAA TC BamHI for complementation of the cwp7 ClosTron mutant using pRPF144 
1792 R GATC GA GCT CAA AGA AAA GGA ATG AG SacI 
1804 F GCT CTT AAA TAG ACT ATA ATC ACC TAC TG 
 
to delete the C-terminal transmembrane helix in cwp7 in pMLD024/025 
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1805 R AGG GCA CTT AGA TAT GAG TCG AAA TAG 
 1835 F GACTCATATCTAAGTGCCCTAAATG 
 to amplify a fragment of transcript between cwp7 and mviN via RT-PCR 1836 R AATACTGATTTGTAGTGATAACTTAAGTCG 
 1837 F GTCTTTTCTTTGTCTCAAAGTACATAGG 
 to amplify a fragment of transcript between cwp7 and mviN via RT-PCR 1838 R AAAAACAGCTAAAGCAGCATTGTGG 
 1843 F CAATTTGAAAAATAGTTTTTGATTTATAAGGAAGC 
 to add a C-terminal StrepTag to cwp7 in pMLD024 1844 R TGGATGACTCCATTTCGACTCATAT 
 1845 F CACCACCACTAGTTTTTGATTTATAAGG 
 to add a C-terminal HisTag to cwp7 in pMLD024 1846 R GTGGTGGTGTTTCGACTCATATC 
 1860 F CTA TCT TCT AAG TAG TTT TTG TTT TCC TTT TC 
 to amplify a fragment of transcript between cwp7 and mviN via RT-PCR 1861 F ACA AAT AAT GCC ATA ACA AAC TCA TTT AGC 
 1862 F TCAAATTCATTGCCAGATGCATTGG 
 for screening cwp18 ClosTron mutants 1863 R AATTAAAATAACTTCTGCTGGATTAAGCC 
 1864 F CTGTTTCATTATTGATTGCTAGTTGTCC 
 for screening cwp27 ClosTron mutants 1865 R TTGCTGACAATCCATCAGATAATCC 
 1951 F GAGTAGTTTTTGATTTATAAGGAAGCTTTTGG 
 to add an XhoI site directly upstream of the cwp7 stop codon in pRPF144-cwp7 1952 R GAGTTTCGACTCATATCTAAGTGCCC 
 1953 F GATCCTCGAGGTGAGCAAGGGCGAGGAG XhoI to amplify mCherry from pZLS016 (adds XhoI on both sides) 
1954 R GATCCTCGAGCTACTTGTACAGCTCGTCCATG XhoI 
1985 F GATCCTCGAGCCCAAAAGAGAGTTGATAGAAG XhoI To add an N-terminal StrepTag to cwp7 using pHAS007 construct 
2109 F GATCGAGCTCCTTTGGTACAAGTCGAATAAAAC SacI To amplify CD2783 for antisense RNA 
2110 R GATCGGATCCAATATGGAGGTAACTATGTCTG BamHI 
2206 R GATCGTCGACCTACTTGTACAGCTCGTCCATG SalI to amplify mCherry pZLS016 (adds SalI on 3' end) 
2236 F TTCTCCCGCATTTTCCTAGTC 
 CD2783 ClosTron screening primer (200bp product) 2237 R ATTGCAAGTGAGATTGACTATAGC 
 2280 R GACCTACTTGTACAGCTCGT 
 
to remove the XhoI site from pMLD054  
2301 F GATCGAATTCTGCATCAAGCTAGCTTG EcoRI to clone Pcwp2-cwp7 from pMLD024 into pFT58 (EcoRI/BamHI) 
2302 F GGCGCGCCGCCATTATTTTTTTGAAC 
 to remove the fragment between SbfI/AscI in pMTL-YN3 for Gibson assembly purposes 2303 R CCTGCAGGGGGCCCGATC 
 2304 F CGGGCCCCCTGCAGGAACAAATTGCTCTGTAAATAAAAG 
 
Gibson assembly: pMTL-YN3 -> cwp7 LHR 
2305 R AATCCCAAAATAAAGAAAATCTATACTGCTAGATTAG 
 
Gibson assembly: cwp7 LHR <- cwp7 RHR 
2306 F ATTTTCTTTATTTTGGGATTTGCATCTGC 
 
Gibson assembly: cwp7 LHR -> cwp7 RHR 
2307 R TAATGGCGGCGCGCCTGTACCAAAGAATTATGGATTTAG 
 
Gibson assembly: cwp7 RHR <- pMTL-YN3 
2308 F GTCGTTTCTAAATCCTGCTGC 
 for screening pyrE cwp7 deletion mutants (anneals to the chromosome) 2309 R TAGCATAGTAAAAGGAACAGTTTTATTCG 
 2310 F GGAGCTGGTGAAGTACATC 
 for pFT58 sequencing 2311 R TAAGTTGGGTAACGCCAGG 
 2317 F CATGCGCTCCATCAAGAAG 
 
for sequencing pMTL-YN3 vectors 
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2318 R CTTTCTATTCAGCACTG 
 2360 F AGCTGCTGATAAAGATTGTGAAATGAAGAGAACC 
 pFT47 alteration to add a linker on the N-terminus of SNAP-Cdi 2361 R GCGGATCCCCGGGTACC 
 2368 F CATCAAGAAGAGCGACTTCG 
 for pyrE mutant screening. Binds to pMTL-YN3 plasmid. 2369 R TTCTTTCTATTCAGCACTGTTATGC 
 2374 F CGGGCCCCCTGCAGGGACTTGCTATTTCTTTTTTATATTCC 
 
Gibson assembly: pMTL-YN3 -> CD3494 LHR 
2375 R GAAAGATAGAGGAACTATAAATTCTATGGTATATGC 
 
Gibson assembly: CD3494 LHR F <- CD3494 RHR 
2376 F TATAGTTCCTCTATCTTTCAAAGTTATGTTCTG 
 
Gibson assembly: CD3494 LHR F -> CD3494 RHR 
2377 R TAATGGCGGCGCGCCAAAATCTAGAACTTTTATCACAAAGATAG 
 
Gibson assembly: CD3494 RHR <- pMTL-YN3 
2429 R TGCAAAAGTAGCTCCTACAGC 
 for pyrE screening. Flanks the pyrE locus to confirm WT/pyrE phenotype. 2430 F GAATAAAAAGTTTAGACGAAATAAGAGG 
 2431 F CGGGCCCCCTGCAGGAATGGCTTGTAATTATCCAAG 
 
Gibson assembly: pMTL-YN3 -> CD3567 LHR 
2432 R TAGACGGAATAATCGTATATATATGCAAAGAAGG 
 
Gibson assembly: CD3567 LHR <- CD3567 RHR 
2433 F ATACGATTATTCCGTCTACATTAGAAATAGTATTTTTATC 
 
Gibson assembly: CD3567 LHR -> CD3567 RHR 
2434 R TAATGGCGGCGCGCCCAGTATAAAGAAGTAAGAGCAC 
 
Gibson assembly: CD3567 RHR <- pMTL-YN3 
2435 F TTTAATTTTCCTTCTAAGATTGCTTCTC 
 pyrE CD3567 screening 2436 R AATACCTGCAGTAGGTGTAGC 
 2437 F CGGGCCCCCTGCAGGTTACAGATACCATACTGGTTATG 
 
Gibson assembly: pMTL-YN3 -> CD0106 LHR 
2438 R GTTTGTCTTTTACTACTACTAGACATATCATTGC 
 
Gibson assembly: CD0106 LHR <- CD0106 RHR 
2439 F GTAGTAGTAAAAGACAAACAAGACAGTAAAGAATTATC 
 
Gibson assembly: CD0106 LHR -> CD0106 RHR 
2440 R TAATGGCGGCGCGCCACGCATTTCACCGCTACAC 
 
Gibson assembly: CD0106 RHR <- pMTL-YN3 
2441 F GAGATTTTGTTGTTGTAGTAAATGCAG 
 pyrE CD0106 screening 2442 R GCAACTGGTGTTCCTCCTAATATC 
 2443 F CGGGCCCCCTGCAGGTCCATCACTTATAACTTTAGTTTC 
 
Gibson assembly: pMTL-YN3 -> CD0125 LHR F 
2444 R CACTTTCTATTTTATTAGAAGCCAATTTATCTACATTATTATTTG 
 
Gibson assembly: CD0125 LHR <- CD0125 RHR R 
2445 F CTTCTAATAAAATAGAAAGTGAAGAAGGTATACATG 
 
Gibson assembly: CD0125 LHR -> CD0125 RHR F 
2446 R TAATGGCGGCGCGCCCATCATCAAATCTATCTCCAC 
 
Gibson assembly: CD0125 RHR <- pMTL-YN3 R 
2447 F TGTTTTGTTAGGATTTGTGACTTGC 
 pyrE CD0125 screening 2448 R CTTTCTCCTATAAGAAGATTGTGTTG 
 2449 F AAGTTTATGAATCTGATGAGTGTCC 
 pMTL-YN1 screening 2450 R AGGCGATTAAGTTGGGTAACG 
 2462 F CATGATATAGGTATGCC 
 for pMTL-YN1C and pMTL-YN1X sequencing 2463 R GTGCTGCAAGGCGATTAAG 
 2464 R CATAAGTTCTCATTCCTTTTCTTTGAG 
 to remove cwp7 from pMLD063 2465 F GATAAAGATTGTGAAATGAAGAGAACC 
 2466 F AATCCCAAAAGAGAGTTGATAGAAG 
 
to remove the Cwp7 signal peptide from pMLD063 
2485 F CTTTCTTTAAGCTGTTTATTTGTATTTCAG 
 pyrE CD3494 screening 2486 R GATGGATGAGTTTTGGAATCAGG 
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2492 F GGTACCTTAAGACCCACTTTC 
 to remove SacI upstream of Ptet in pMLD074 via inverse PCR 2493 R GAATTCGTAATCATGGTCATATGG 
 2571 F GGATCCTCTAGAGTCGACG 
 Gibson assembly: pMTL-YN1C-Pcwp2 linearisation  2572 R GAGCTCTTATTATTTTTTCCTTATTTACC 
 2621 R GCGGCCGCTTATTACATCC 
 
pMTL-YN1C linearisation. To be used with 2571 
2622 F GTAATAAGCGGCCGCGAGAGAAGAAGATGAAGTTTAAG 
 Gibson assembly: CD3494 native complementation via pMTL-YN1C 2623 R CGACTCTAGAGGATCCTGCTTACATCTTGAGTAAAAGG 
 2624 F GTAATAAGCGGCCGCTTAAATAGGGGCAGAAATATAATATTATTAC 
 Gibson assembly: CD0106 native complementation via pMTL-YN1C 2625 R CGACTCTAGAGGATCCCTTTAATACAAGCTATTTACATATTTAGAC 
 2626 F GTAATAAGCGGCCGCACATCTAATGTAAAGTTGCAAG 
 Gibson assembly: CD3567 native complementation via pMTL-YN1C 
2627 R 
CGACTCTAGAGGATCCGGTATTATAATACCCTATTATACTTAATTACTTTAAATTTT
TTAATATTAATC 
 2628 F GTAATAAGCGGCCGCAGAAGGAATGGCAGAAGAG 
 Gibson assembly: CD0125 native complementation via pMTL-YN1C 2629 R CGACTCTAGAGGATCCGCTTAACCAAATATGATTAAACTTG 
 2630 F GACGATGACAAGTAGTTTTTGATTTATAAG 
 to replace the HisTag in pMLD024 for FLAG via inverse PCR 2631 R ATCCTTGTAATCTTTCGACTCATATC 
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Table A4. Antibodies used in this study 
 
 
1° antibody Conjugate 
Dilution 
Species Source 
Western blotting Immunostaining 
anti-SLP LMW N/A 1:200,000 1:20 rabbit Robert Fagan, this laboratory 
anti-SLP HMW N/A 1:100,000 1:20 rabbit Emanuella Calabi, this laboratory 
anti-Cwp66 C-term N/A 1:20,000 1:20 mouse Simon Cutting, Royal Holloway 
anti-Cwp2 N/A 1:50,000 1:20 mouse Simon Cutting, Royal Holloway 
anti-Cwp84 N/A 1:4,000 1:20 mouse Simon Cutting, Royal Holloway 
anti-Cwp7 N/A 1:10,000 1:20 mouse This study 
anti-FLAG N/A 1:4,000 N/A mouse Sigma 
2° antibody  Dilution  Source  
anti-rabbit IgG-HRP horse radish peroxidase 1:5,000 N/A goat Dako Cytomation 
anti-mouse IgG-HRP horse radish peroxidase 1:10,000 N/A rabbit Dako Cytomation 
anti-rabbit IgG-FITC fluorescein N/A 1:200 goat Dako Cytomation 
anti-mouse IgG-FITC fluorescein N/A 1:200 rabbit Dako Cytomation 
Anti-his-tag-HRP horse radish peroxidase 1:2;000 N/A N/A Sigma 
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Table B1. Genes significantly up-regulated during germination (p ≤ 0.01). 
Systematic Name Gene product Fold change (30 vs. 180 min) p-value 
CD2270 putative 1-phosphofructokinase +79.8 5.79E-03 
CD2269 PTS system, IIbc component +75.2 5.71E-03 
CD0524 putative peptidase +35.4 7.64E-03 
CD2671 oligopeptide transporter, ATP-binding protein +28.0 1.15E-03 
CD2670 oligopeptide ABC transporter, ATP-binding protein +24.7 1.22E-03 
CD3019 putative transporter +22.7 2.21E-03 
CD2673 oligopeptide ABC transporter, permease protein +21.1 1.46E-03 
CD2541 sodium:dicarboxylate symporter family protein +19.2 7.98E-03 
CD3073 putative membrane protein +19.1 1.81E-03 
CD2966 aldehyde-alcohol dehydrogenase +17.2 8.16E-03 
CD2240 N-acetylneuraminate lyase +16.6 6.58E-03 
CD2674 oligopeptide ABC transporter, permease protein +16.0 5.79E-03 
CD1696 putative sodium:amino acid symporter +13.8 5.71E-03 
CD2548 putative sugar transporter, permease protein +13.6 3.30E-03 
CD2669a putative Na(+)/H(+) antiporter +13.2 5.05E-03 
CD2239 putative sodium:solute symporter +11.6 6.84E-03 
CD1506 putative drug/sodium antiporters +11.4 3.85E-03 
CD2595 PyrR bifunctional protein +10.9 6.58E-03 
CD2040 MerR-family transcriptional regulator +10.9 3.85E-03 
CD1950 putative membrane protein +10.8 4.93E-03 
CD2177 probable amino-acid ABC transporter,substrate-binding protein +10.6 6.42E-03 
CD2594 uracil permease +10.5 4.54E-03 
CD1680 putative FMN-binding exported protein +9.5 5.71E-03 
CD2456 ABC transporter, ATP-binding protein +9.5 2.15E-03 
CD2238 conserved hypothetical protein +9.4 5.96E-03 
CD1679 putative flavodoxin +9.4 3.77E-03 
CD2145 DNA mismatch repair protein +9.3 3.85E-03 
CD3247 putative electron transfer protein +9.2 6.42E-03 
CD2617 putative membrane protein +9.0 5.35E-03 
CD2176 probable amino-acid ABC transporter, permease protein +8.7 1.81E-03 
CD3290 putative protein translocase +8.2 5.59E-03 
CD2107 putative xanthine/uracil permease +7.6 2.78E-03 
CD1408 D-alanine--D-alanine ligase B +7.3 8.43E-03 
CD1681 TetR-family transcriptional regulator +6.9 5.71E-03 
CD0672 conserved hypothetical protein +6.7 2.78E-03 
CD2041 putative regulatory protein +6.7 5.59E-03 
CD2042 putative transcriptional regulator +6.6 2.00E-03 
CD1677 putative membrane protein +6.6 5.71E-03 
CD2175 probable amino-acid ABC transporter, permease protein +6.4 4.45E-03 
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CD2013 TetR-family transcriptional regulator +6.2 3.77E-03 
CD2012 putative hydrolase +6.1 3.77E-03 
CD1998 TetR-family transcriptional regulator +6.1 8.27E-03 
CD2703 conserved hypothetical pentapeptide repeat protein +6.0 5.58E-03 
CD1027 spermidine/putrescine ABC transporter,substrate-binding lipoprotein +5.8 5.71E-03 
CD2024 ABC transporter, ATP-binding protein +5.7 4.67E-03 
CD2471 conserved hypothetical protein +5.7 8.53E-03 
CD1273 putative competence protein +5.5 5.76E-03 
CD1025 spermidine/putrescine ABC transporter, permease protein +5.2 6.37E-03 
CD1617 GntR-family transcriptional regulator +5.1 5.79E-03 
CD1026 putative spermidine/putrescine ABC transporter,permease protein +5.1 5.34E-03 
CD2966A putative membrane protein +5.0 5.59E-03 
CD1488 putative transcriptional regulator +4.8 4.67E-03 
CD0761 putative ATP-dependent RNA helicase +4.7 9.13E-03 
CD2152 putative glutamyl-aminopeptidase +4.7 9.13E-03 
CD2207 putative flavodoxin +4.7 4.45E-03 
CD1621 putative mechanosensitive ion channel protein +4.7 4.24E-03 
CD3646 GntR-family transcriptional regulator +4.6 6.61E-03 
CD2457 conserved hypothetical protein +4.6 6.00E-03 
CD1024 spermidine/putrescine ABC transporter,ATP-binding protein +4.5 8.10E-03 
CD3241 proline reductase +4.4 4.41E-03 
CD2208 MarR-family transcriptional regulator +4.4 6.99E-03 
CD1164 Spo0B-associated GTP-binding protein +4.3 5.71E-03 
CD2025 putative ABC transporter, permease protein +4.3 5.79E-03 
CD2023 GntR-family transcriptional regulator +4.2 1.54E-03 
CD2472 conserved hypothetical protein +4.2 8.33E-03 
CD2214 putative regulatory protein +4.2 5.05E-03 
CD1345 PadR-family transcriptional regulator +4.2 6.98E-03 
CD3243 hypothetical protein +4.2 8.78E-03 
CD2845 rubrerythrin +4.2 2.78E-03 
CD2056 putative membrane protein +4.2 8.43E-03 
CD0806 putative sigma-54-dependent transcriptional regulator +4.1 5.42E-03 
CD0471 penicillinase repressor +4.1 5.18E-03 
CD2215 putative regulatory protein +4.1 5.71E-03 
CD3219 chaperonin +4.0 4.97E-03 
CD3236 putative membrane protein +4.0 5.76E-03 
CD0470 putative beta-lactamase-inducing penicillin-binding protein +3.9 6.80E-03 
CD2840 seryl-tRNA synthetase +3.9 6.30E-03 
CD1676 pyrrolidone-carboxylate peptidase +3.9 5.08E-03 
CD3072 conserved hypothetical protein +3.8 7.09E-03 
CD2102 putative Na(+)/H(+) antiporter +3.8 8.10E-03 
CD1555 putative amino acid permease +3.8 5.79E-03 
CD2151 putative membrane protein +3.8 5.71E-03 
CD1618 ABC transporter, ATP-binding protein +3.7 3.77E-03 
217 
Appendix B 
 
CD1296 segregation and condensation protein B +3.7 4.66E-03 
CD1757 conserved hypothetical protein +3.7 6.73E-03 
CD2236 putative glucokinase +3.7 8.62E-03 
CD2781 putative transmembrane virulence factor MviN family protein +3.5 4.45E-03 
CD0320 two-component response regulator +3.5 5.82E-03 
CD2843 putative zinc-binding dehydrogenase +3.5 5.59E-03 
CD3286 putative sodium-dependent phosphate transporter +3.5 4.41E-03 
CD3289 hypothetical protein +3.5 9.80E-03 
CD3478 conserved hypothetical protein +3.5 5.71E-03 
CD2593 putative antibiotic resistance ABC transporter,ATP-binding protein +3.4 5.00E-03 
CD3592 orotidine 5'-phosphate decarboxylase +3.4 5.34E-03 
CD1229 putative penicillin-binding protein +3.4 6.69E-03 
CD0821 two-component sensor histidine kinase +3.4 9.80E-03 
CD3188 hypothetical protein +3.4 9.91E-03 
CD2792 preprotein translocase SecA subunit +3.4 5.71E-03 
CD2235 RpiR-family transcriptional regulator +3.4 5.37E-03 
CD1471 putative membrane protein (putative phage infection protein) +3.4 5.96E-03 
CD1438 putative multiprotein complex assembly protein +3.4 6.42E-03 
CD2888 ABC transporter, permease protein +3.4 8.10E-03 
CD2043 putative hydrolase +3.3 4.41E-03 
CD0998 putative radical SAM protein +3.3 3.00E-03 
CD2705 putative amidohydrolas +3.3 8.62E-03 
CD3077 phosphosugar-binding transcriptional regulator +3.3 6.84E-03 
CD3616 putative Na+/H+ exchanger +3.3 5.79E-03 
CD2368 hypothetical protein +3.2 3.53E-03 
CD2206 aldehyde dehydrogenase +3.2 4.39E-03 
CD1294 putative membrane-associated peptidase +3.2 6.37E-03 
CD2528 hypothetical protein +3.2 5.76E-03 
CD1326 radical SAM-superfamily protein +3.1 9.51E-03 
CD2171 putative Sodium:dicarboxylate symporter +3.1 5.71E-03 
CD0983 putative hydrolase +3.1 8.37E-03 
CD2103 putative ABC transporter, permease protein +3.1 7.64E-03 
CD2234 cAMP-binding regulatory protein +3.1 6.56E-03 
CD2972 hypothetical protein +3.1 5.79E-03 
CD0321 hypothetical protein +3.1 3.85E-03 
CD3678 putative sporulation membrane protein +3.1 9.32E-03 
CD2253 GntR-family transcriptioanl regulator +3.0 1.81E-03 
CD2782 cell surface protein +3.0 5.71E-03 
CD1625 two-component sensor histidine kinase +3.0 8.33E-03 
CD2057 conserved hypothetical protein +3.0 5.05E-03 
CD0427 putative DNA-binding protein +3.0 5.79E-03 
CD1201 N utilization substance protein B +3.0 9.32E-03 
CD0482 putative lantibiotic resistance two-component sensor kinase +3.0 3.77E-03 
CD1227 putative O-methyltransferase +3.0 5.96E-03 
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CD1504 ABC transporter, ATP-binding protein +3.0 6.42E-03 
CD2100 putative [2Fe-2S]-binding subunit of oxidoreductase +2.9 5.59E-03 
CD1665 cysteine synthase A +2.9 9.30E-03 
CD0481 putative lantibiotic resistance two-component response regulator +2.9 7.73E-03 
CD1806 putative fructokinase +2.8 4.41E-03 
CD1736 putative transcriptional regulator +2.8 5.08E-03 
CD1624 two-component response regulator +2.8 5.71E-03 
CD0676 conserved hypothetical protein +2.8 4.41E-03 
CD2516 putative L-asparaginase +2.8 5.08E-03 
CD1258 putative GTPase +2.8 3.50E-03 
CD3677 SpoIIIJ-associated protein +2.8 8.91E-03 
CD3239 conserved hypothetical protein +2.8 7.92E-03 
CD2450 putative ribosomal protein L11 methyltransferase +2.8 6.36E-03 
CD2049 conserved hypothetical protein +2.8 6.07E-03 
CD2690 putative membrane-associated phosphatase +2.7 5.71E-03 
CD2592 fibronectin-binding protein +2.7 7.02E-03 
CD2766 putative penicillin-binding protein repressor +2.7 5.08E-03 
CD1270 two-component sensor histidine kinase +2.7 4.63E-03 
CD2780 putative phosphomannomutase/phosphoglycerate mutase +2.7 6.36E-03 
CD2015 putative membrane protein +2.7 5.71E-03 
CD2770 putative capsular polysaccharide biosynthesis glycosyl transferase +2.7 6.56E-03 
CD2689 putative lipoprotein +2.7 5.74E-03 
CD1046 peptidase T +2.7 4.84E-03 
CD1314 tRNA pseudouridine synthase B +2.6 9.32E-03 
CD1343 glutamine synthetase +2.6 8.10E-03 
CD2998 putative iron ABC transporter, permease protein +2.6 5.96E-03 
CD2597 lipoprotein signal peptidase +2.6 5.79E-03 
CD3582 putative pseudouridylate synthase +2.5 8.33E-03 
CD1574 conserved hypothetical protein +2.5 6.84E-03 
CD1542 conserved hypothetical protein +2.5 1.81E-03 
CD0521 two-component response regulator +2.5 5.76E-03 
CD1505 putative ABC transporter, permease protein +2.5 7.52E-03 
CD2265 putative membrane protein +2.5 5.96E-03 
CD0696 probable cation transport protein +2.5 5.05E-03 
CD1309 translation initiation factor IF-2 +2.5 9.51E-03 
CD2615 TetR-family trancscriptional regulator +2.5 7.55E-03 
CD0517 putative membrane protein +2.5 9.30E-03 
CD0408A putative membrane protein +2.5 9.75E-03 
CD2050 putative 23S RNA and tRNA pseudouridine synthase +2.4 5.79E-03 
CD2017 putative phage regulatory protein +2.4 7.55E-03 
CD2655 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alan ine ligase +2.4 5.08E-03 
CD1995 putative membrane protein +2.4 9.53E-03 
CD0670 putative regulatory protein +2.4 7.33E-03 
CD0316 putative ABC transporter, permease protein +2.4 7.92E-03 
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CD2806 holliday junction DNA helicase +2.4 5.76E-03 
CD3520 putative cation efflux protein +2.4 7.49E-03 
CD2771 putative UDP-glucose 6-dehydrogenase +2.4 6.81E-03 
CD3647 PTS system, IIa component +2.3 5.79E-03 
CD0569 putative outer membrane lipoprotein +2.3 8.69E-03 
CD0336 ABC transporter, ATP-binding protein +2.3 9.57E-03 
CD0159 putative glyoxalase +2.3 8.43E-03 
CD2097 putative membrane protein +2.3 8.27E-03 
CD2345 LysR-family regulatory protein +2.3 5.79E-03 
CD0566 putative RNA methylase +2.3 6.36E-03 
CD0984 putative membrane protein +2.3 8.82E-03 
CD1281 putative tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase +2.3 5.59E-03 
CD1297 putative membrane protein +2.3 4.41E-03 
CD3220A small acid-soluble spore protein +2.3 8.62E-03 
CD2503 cation-transporting ATPase +2.3 6.56E-03 
CD1946 AraC-family transcriptional regulator +2.2 8.06E-03 
CD0781 penicillin-binding protein +2.2 5.37E-03 
CD3648 PTS system, IIb component +2.2 9.32E-03 
CD0822 putative lantibiotic ABC transporter,ATP-binding protein +2.2 6.46E-03 
CD1388 putative transcriptional regulator (pseudogene) +2.2 5.79E-03 
CD1311 putative RNA-binding protein +2.2 6.42E-03 
CD1041 ATP-dependent nuclease subunit A +2.2 6.71E-03 
CD0891 putative agmatinase +2.2 5.79E-03 
CD1996 AraC-family transcriptional regulator +2.2 5.71E-03 
CD3359 ABC transporter, ATP-binding protein +2.1 2.78E-03 
CD2995 ribonucleoside-diphosphate reductase alpha chain +2.1 8.72E-03 
CD0198 GMP synthase [glutamine-hydrolyzing] +2.1 7.64E-03 
CD0282 putative phosphoesterase +2.1 8.30E-03 
CD1268 ABC transporter, ATP-binding protein +2.1 2.78E-03 
CD2336 putative toxic anion resistance protein +2.1 5.76E-03 
CD0344 metallo-beta-lactamase superfamily protein +2.1 6.71E-03 
CD0796 LacI-family transcriptional regulator +2.1 6.81E-03 
CD2179 putative formate dehydrogenase +2.1 7.92E-03 
CD3055 putative ABC transporter, permease protein +2.1 5.71E-03 
CD2465 amino acid transporter +2.1 6.42E-03 
CD1467 ABC transporter, permease protein +2.1 4.67E-03 
CD1678 putative membrane protein +2.1 5.79E-03 
CD0350 conserved hypothetical protein +2.1 4.84E-03 
CD2359 putative hydrolase +2.1 6.42E-03 
CD1644 putative transcriptional regulator +2.1 6.39E-03 
CD2526 glycogen branching enzyme +2.0 6.98E-03 
CD1394 putative oxidoreductase +2.0 8.62E-03 
CD2994 ribonucleoside-diphosphate reductase beta chain +2.0 5.42E-03 
CD1813 hypothetical protein +2.0 8.33E-03 
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CD2052 putative lipoprotein +2.0 3.99E-03 
CD2183 ATP-dependent RNA helicase +2.0 5.37E-03 
CD0888 arginine decarboxylase +2.0 7.34E-03 
CD2337 putative membrane protein +2.0 8.29E-03 
CD2818 ABC transporter, ATP-binding/permease protein +2.0 5.71E-03 
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Table B2. Genes significantly down-regulated during germination (p ≤ 0.01). 
Systematic Name Gene product Fold change (30 vs 180 min) p-value 
CD2354 glycine reductase complex component B alpha and beta subunits -100.0 4.67E-03 
CD2352 glycine/sarcosine/betaine reductase complex component A -100.0 5.59E-03 
CD2349 glycine/sarcosine/betaine reductase complex component C beta subunit -100.0 5.79E-03 
CD2355 thioredoxin -100.0 6.42E-03 
CD2380 putative indolepyruvate oxidoreductase subunit -88.5 6.16E-03 
CD2356 thioredoxin reductase -86.2 1.81E-03 
CD2351 glycine reductase complex component B gamma subunit -73.5 4.66E-03 
CD2348 glycine/sarcosine/betaine reductase complex component C alpha subunit -64.9 3.74E-03 
CD2357 putative glycine reductase complex component -38.6 6.36E-03 
CD0804 electron transfer flavoprotein beta-subunit -30.0 3.53E-03 
CD2625 putative membrane protein -29.8 5.71E-03 
CD3027 PTS system, glucose-specific IIa component -28.4 4.24E-03 
CD3028 putative phosphosugar isomerase -27.9 5.05E-03 
CD0022 putative translation elongation factor -27.8 4.67E-03 
CD3136 6-phospho-beta-glucosidase -26.5 5.96E-03 
CD3137 PTS system, IIabc component -26.2 9.51E-03 
CD2693 putative sodium:dicarboxylate symporter -25.3 1.87E-03 
CD3029 putative bifunctional protein: repressor/cystathionine beta-lyase -24.2 2.00E-03 
CD3030 PTS system, maltose and glucose-specific IIbc component -23.8 2.78E-03 
CD0179 NAD-specific glutamate dehydrogenase -23.8 7.80E-03 
CD1125 nitroreductase-family protein -23.5 6.56E-03 
CD1692 ArsR-family transcriptional regulator -21.2 3.77E-03 
CD1745A putative ferrous iron transport protein A -18.3 4.67E-03 
CD1693 putative dinitrogenase iron-molybdenum cofactor -17.7 2.81E-03 
CD2342 succinate-semialdehyde dehydrogenase [NAD(P)+] -15.2 3.50E-03 
CD2343 succinyl-CoA:coenzyme A transferase -12.9 4.45E-03 
CD0840 putative hydrolase -12.0 7.98E-03 
CD2339 4-hydroxybutyrate CoA transferase -11.9 2.78E-03 
CD2796 cell surface protein -11.8 1.81E-03 
CD1139 electron transport complex protein -11.4 6.71E-03 
CD0279 conserved hypothetical protein -11.4 5.79E-03 
CD2340 conserved hypothetical protein -11.2 2.78E-03 
CD0399 acyl-CoA dehydrogenase, short-chain specific -11.1 4.66E-03 
CD0855 oligopeptide ABC transporter, substrate-binding lipoprotein -11.0 6.37E-03 
CD0856 oligopeptide ABC transporter, ATP-binding protein -10.5 2.40E-03 
CD2338 NAD-dependent 4-hydroxybutyrate dehydrogenase -10.5 4.76E-03 
CD0142 putative RNA-binding protein -10.4 6.42E-03 
CD2341 gamma-aminobutyrate metabolism dehydratase/isomerase [includes: 4-hydroxybutyryl-coa dehydratase; vinylacetyl-coa-delta-isomerase] -10.2 3.53E-03 
CD0857 oligopeptide ABC transporter, ATP-binding protein (pseudogene) -10.0 6.37E-03 
CD1142 electron transport complex protein -9.9 5.71E-03 
CD2248 conserved hypothetical protein -9.9 5.76E-03 
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CD1138 electron transport complex protein -9.8 3.30E-03 
CD1795 conserved hypothetical protein -9.8 6.42E-03 
CD1807 putative NADPH-dependent FMN reductase -9.7 8.26E-03 
CD2344 putative membrane protein -9.2 6.68E-03 
CD2600 putative carbon starvation -9.1 9.95E-03 
CD1140 electron transport complex protein -9.0 3.70E-03 
CD0398 subunit of oxygen-sensitive 2-hydroxyisocaproyl-CoA dehydratase -8.6 5.71E-03 
CD0718 formate--tetrahydrofolate ligase -8.5 3.85E-03 
CD0854 oligopeptide ABC transporter, permease protein -8.4 2.78E-03 
CD2249 putative ATPase -8.3 9.80E-03 
CD1142A hypothetical protein -8.3 4.67E-03 
CD0397 subunit of oxygen-sensitive 2-hydroxyisocaproyl-CoA dehydratase -8.1 8.43E-03 
CD1137 electron transport complex protein -8.1 8.91E-03 
CD0180 hypothetical protein -7.9 9.27E-03 
CD3419 delta-aminolevulinic acid dehydratase -7.5 5.08E-03 
CD1141 electron transport complex protein -7.2 3.77E-03 
CD3407 putative iron-only hydrogenase, catalytic subunit -7.1 4.41E-03 
CD0396 activator of 2-hydroxyisocaproyl-CoA dehydratase -7.1 7.02E-03 
CD2378 putative membrane protein -7.1 5.71E-03 
CD0866 putative exported protein -7.0 5.34E-03 
CD0174 putative oxidoreductase, acetyl-CoA synthase subunit -7.0 2.81E-03 
CD2797 putative exported protein -7.0 5.18E-03 
CD3421 porphobilinogen deaminase -6.9 5.79E-03 
CD0267 putative exported protein -6.9 8.43E-03 
CD2444 putative sigma 54 modulation protein -6.8 5.05E-03 
CD0050 putative dual-specificity prolyl/cysteinyl-tRNA synthetase -6.8 7.02E-03 
CD2667 PTS system, glucose-specific IIbc component -6.7 2.11E-03 
CD0188 putative ketopantoate reductase -6.7 2.78E-03 
CD0270 putative flagellar motor switch protein -6.7 9.53E-03 
CD0268 flagellar basal-body rod protein FlgG -6.6 7.80E-03 
CD0176 putative oxidoreductase, NAD/FAD binding subunit -6.6 5.14E-03 
CD1897 hypothetical protein -6.5 2.78E-03 
CD1510 conserved hypothetical protein -6.5 3.17E-03 
CD0269 putative flagellar basal-body rod protein -6.5 9.32E-03 
CD0828 putative oxidative stress protein -6.3 2.78E-03 
CD3229 dihydrodipicolinate reductase -6.1 6.98E-03 
CD1896 putative lipoprotein -6.0 5.37E-03 
CD0255 flagellar hook protein -6.0 8.33E-03 
CD0720 putative FolD bifunctional protein [includes: methylenetetrahydrofolate dehydrogenase; methenyltetrahydrofolate cyclohydrolase] -5.9 8.43E-03 
CD3406 putative iron-only hydrogenase,electron-transferring subunit -5.8 4.66E-03 
CD0114 putative ATP/GTP-binding protein -5.6 9.30E-03 
CD2666 PTS system, glucose-specific IIa component -5.5 5.71E-03 
CD0716 putative bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase -5.5 9.30E-03 
CD0853 oligopeptide ABC transporter, permease protein -5.3 5.79E-03 
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CD0588 hypothetical protein -5.3 7.80E-03 
CD0258 flagellar basal body-associated protein -5.3 9.27E-03 
CD1537 putative glutamate synthase [NADPH] small chain -5.1 3.53E-03 
CD2054 aspartokinase -5.1 6.42E-03 
CD2158 4-aminobutyrate aminotransferase -5.1 8.33E-03 
CD1461 putative membrane protein -5.0 9.39E-03 
CD0394 (R)-2-hydroxyisocaproate dehydrogenase -5.0 2.78E-03 
CD0118 putative subunit of oxidoreductase -5.0 4.39E-03 
CD1895 putative membrane protein -5.0 5.96E-03 
CD0177 cyclopropane-fatty-acyl-phospholipid synthase -4.9 3.85E-03 
CD3423 cobalt-precorrin-6a reductase -4.9 6.71E-03 
CD0776 LacI-family transcriptional regulator -4.7 9.47E-03 
CD2511 transcriptional antiterminator -4.7 5.71E-03 
CD3664 putative amino acid aminotransferase -4.7 5.96E-03 
CD0725 putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex, small subunit -4.5 5.71E-03 
CD3669 putative exported protein -4.5 5.79E-03 
CD0296 hypothetical protein -4.5 5.37E-03 
CD2510 PTS system, IIbc component -4.5 5.42E-03 
CD0723 putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex, dihydrolipoyl dehydrogenase subunit -4.5 5.79E-03 
CD2852 D-alanyl transferase -4.5 6.56E-03 
CD0178 putative ATP-binding protein -4.5 8.16E-03 
CD2828 putative aromatic amino acid aminotransferase -4.4 5.91E-03 
CD1365A hypothetical protein -4.2 6.42E-03 
CD2512 PTS system, IIa component -4.1 5.76E-03 
CD3424 cobalt-precorrin-3b c(17)-methyltransferase -4.1 5.98E-03 
CD1333 putative tyrosine recombinase -4.1 2.78E-03 
CD2156 radical SAM-superfamily protein -4.1 4.67E-03 
CD1369 hypothetical protein -4.0 7.41E-03 
CD1953 conserved hypothetical protein -4.0 7.34E-03 
CD0402 sigma-54-dependent transcriptional regulator -3.9 1.65E-03 
CD3316 formate dehydrogenase accessory protein -3.8 9.27E-03 
CD1372 phage protein -3.8 5.79E-03 
CD1462 GntR-family transcriptional regulator -3.8 9.13E-03 
CD3150 conserved hypothetical protein -3.8 5.71E-03 
CD2591 low-specificity L-threonine aldolase -3.8 6.84E-03 
CD1371 phage protein -3.7 9.10E-03 
CD0389 6-phospho-beta-glucosidase -3.7 5.80E-03 
CD1448 conserved hypothetical protein -3.7 5.59E-03 
CD1363 putative phage protein -3.7 9.47E-03 
CD3033 thioredoxin -3.7 3.05E-03 
CD3510 putaive membrane protein -3.7 5.71E-03 
CD3649 conserved hypothetical protein -3.6 4.46E-03 
CD2118 threonine synthase -3.6 6.36E-03 
CD1493 putative 3-methyladenine DNA glycosylase -3.5 5.05E-03 
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CD3315 electron transport protein -3.5 8.33E-03 
CD0727 putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex,methyltransferase subunit -3.5 5.05E-03 
CD0726 putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex, alpha subunit -3.4 3.77E-03 
CD2601 two-component response regulator -3.3 8.92E-03 
CD2377 NUDIX-family protein -3.3 4.45E-03 
CD0559 conserved hypothetical protein -3.3 5.79E-03 
CD3463 alanine racemase -3.3 5.71E-03 
CD3317 formate dehydrogenase H -3.3 6.56E-03 
CD1534 putative gamma-glutamyltranspeptidase -3.2 6.42E-03 
CD0631 conserved hypothetical protein -3.2 4.67E-03 
CD1771 conserved hypothetical protein -3.2 5.59E-03 
CD1261 putative ribonucleotide-diphosphate reductase -3.2 4.21E-03 
CD1082 molybdopterin-guanine dinucleotide biosynthesis protein B -3.2 4.39E-03 
CD1459 putative 5-nitroimidazole reductase -3.2 5.98E-03 
CD2996 hypothetical protein -3.1 8.43E-03 
CD0108 anaerobic ribonucleoside-triphosphate reductase -3.1 9.91E-03 
CD0825 rubrerythrin -3.1 7.33E-03 
CD2626 cinserved hypothetical protein -3.1 7.57E-03 
CD3405 putative iron-only hydrogenase,electron-transferring subunit -3.1 4.41E-03 
CD0834 putative isocitrate/3-isopropylmalate dehydrogenase -3.1 9.00E-03 
CD3464 putative lipoprotein -3.0 6.84E-03 
CD1081 molybdopterin biosynthesis protein -3.0 4.45E-03 
CD3315A hypothetical protein -3.0 9.13E-03 
CD3465 conserved hypothetical protein -3.0 3.89E-03 
CD1262 ribonuclease HII -3.0 9.32E-03 
CD2119 homoserine kinase -3.0 5.91E-03 
CD0813 putative PTS system, IIb component -2.9 5.79E-03 
CD0750 amino acid ABC transporter, substrate-binding protein -2.9 3.53E-03 
CD2245 asparaginyl-tRNA synthetase -2.9 3.77E-03 
CD3512 type IV pilus assembly protein -2.9 9.10E-03 
CD2407 putative multidrug efflux pump, membrane protein -2.9 5.96E-03 
CD2443 conserved hypothetical protein -2.8 9.13E-03 
CD0243 conserved hypothetical protein -2.8 9.80E-03 
CD2376 putative membrane protein -2.8 5.08E-03 
CD1476 putative signaling protein -2.8 5.79E-03 
CD2124 putative transporter -2.8 3.77E-03 
CD2408 putative multidrug efflux pump, outer membrane protein -2.7 5.71E-03 
CD1304 putative mannosyl-glycoprotein endo-beta-N-acetylglucosamidase -2.7 6.58E-03 
CD2298 hypothetical protein -2.7 3.85E-03 
CD0341 conserved hypothetical protein -2.7 4.45E-03 
CD2627 conserved hypothetical protein -2.6 5.71E-03 
CD1969 putative regulatory protein -2.6 5.79E-03 
CD3466 holo-[acyl-carrier protein] synthase -2.6 9.72E-03 
CD3135 putative sugar-bisphosphate aldolase -2.6 4.45E-03 
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CD0633 conserved hypothetical protein -2.6 3.17E-03 
CD0752 amino acid ABC transporter, ATP-binding protein -2.5 5.79E-03 
CD2155 radical SAM-superfamily protein -2.5 5.37E-03 
CD2053 diaminopimelate decarboxylase -2.5 5.98E-03 
CD1702A putative thiamine biosynthesis protein -2.5 5.71E-03 
CD3507 putative type IV pilin -2.5 5.79E-03 
CD0807 hypothetical protein -2.5 7.33E-03 
CD2406 putative lipoprotein -2.5 6.84E-03 
CD3504 putative type IV prepilin leader peptidase -2.4 3.85E-03 
CD0467 putative hydrolase -2.4 4.67E-03 
CD2154 putative ATP/GTP-binding protein -2.4 3.77E-03 
CD1970 putative cyclase -2.4 8.33E-03 
CD2958 V-type sodium ATP synthase subunit E -2.4 5.76E-03 
CD2297 putative phage-related regulatory protein -2.3 3.17E-03 
CD1495 pyrroline-5-carboxylate reductase -2.3 5.55E-03 
CD2481 uracil-DNA glycosylase -2.3 7.80E-03 
CD2027 N-carbamoyl-L-amino acid hydrolase -2.3 7.03E-03 
CD0572 conserved hypothetical protein -2.3 6.69E-03 
CD0731 putative radical SAM superfamily protein -2.2 9.32E-03 
CD2161 putative membrane protein -2.2 5.76E-03 
CD1051 putative ABC transporter, permease protein -2.2 9.80E-03 
CD2061 conserved hypothetical protein -2.2 6.84E-03 
CD2060 conserved hypothetical protein -2.2 5.71E-03 
CD2296 hypothetical protein -2.2 6.55E-03 
CD2216 hypothetical protein -2.2 6.42E-03 
CD2622 conserved hypothetical protein -2.2 6.47E-03 
CD0728 putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex, beta subunit -2.2 7.33E-03 
CD1538 putative signaling protein -2.1 8.60E-03 
CD0275 spore photoproduct lyase -2.1 9.30E-03 
CD2624 putative exported protein -2.1 7.71E-03 
CD2524 nicotinate-nucleotide adenylyltransferase -2.1 7.02E-03 
CD2795 cell surface protein -2.1 6.37E-03 
CD0810 putative flavodoxin -2.0 7.85E-03 
CD0879 putative carbohydrate kinase -2.0 8.84E-03 
CD0756 putative reductase -2.0 9.10E-03 
CD3670 putative selenocysteine lyase -2.0 7.02E-03 
CD0636 putative radical SAM superfamily protein -2.0 9.51E-03 
CD0635 conserved hypothetical protein -2.0 9.32E-03 
CD1135 putative cell wall hydrolase -2.0 8.75E-03 
CD2259 conserved hypothetical protein -2.0 9.35E-03 
CD1413 putative membrane protein -2.0 4.00E-03 
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Table B3. Fifty most abundant transcripts present in the dormant spore (p ≤ 0.01) 
Systematic Name Description Fold change (0 vs 180min) p-value 
CD3249 small acid-soluble spore protein B +595.2 0.00286 
CD1631 putative superoxide dismutase [Mn] +417.6 0.00034 
CD1486 putative lipoprotein +383.2 0.00141 
CD2688 small acid-soluble spore protein A +375.5 0.00141 
CD1463 putative membrane protein +365.3 8.08E-06 
CD0783 putative stage IV sporulation protein +337.3 0.00183 
CD2112 hypothetical protein +267.1 2.01E-05 
CD0214 conserved hypothetical protein +253.8 0.000157 
CD2375 conserved hypothetical protein +252.8 0.000134 
CD0213 putative spore coat protein +214 0.000932 
CD2245A conserved hypothetical protein +177.1 0.000796 
CD2809 conserved hypothetical protein +86.89 0.000896 
CD1880 hypothetical protein +81.49 0.00355 
CD1430 putative exported polysaccharide deacetylase +29.15 0.00166 
CD1290 putative small acid-soluble spore protein +27.67 0.00886 
CD1567 putative manganese-containing catalase +25.05 0.00473 
CD0446 D-ornithine aminomutase E component +22.51 0.0064 
CD1669 ABC transporter, ATP-binding protein +22.28 0.0238 
CD1487 hypothetical protein +21.9 0.00668 
CD3082 PTS system, IIb component +21.28 0.00748 
CD3164 ribonuclease R +20.36 0.00615 
CD2315 putative exported protein +18.1 0.00485 
CD3551A conserved hypothetical protein +17.74 0.0264 
CD0424 putative single-strand binding protein +17.73 0.0219 
CD3258 iron-only hydrogenase +16.2 0.0294 
CD1904 ABC transporter, permease protein +16.05 0.0263 
CD1067 hypothetical protein +15.73 0.000778 
CD3371 conjugative transposon protein +15.73 0.00871 
CD0990 3-isopropylmalate dehydratase large subunit +15.52 0.00628 
CD1581 hypothetical protein +15.37 0.00257 
CD1291 D-alanyl-D-alanine carboxypeptidase +15.15 0.0076 
CD2374 hypothetical protein +14.99 0.00558 
CD3199 putative ABC transporter, permease protein +14.84 0.0179 
CD-16S-rRNA Clostridium difficile 16S ribosomal RNA +14.66 1.96E-23 
CD0312 ArsR-family transcriptional regulator +14.19 0.00459 
CD2425 phosphate butyryltransferase +14.16 0.00559 
CD3446 endoglucanase +14.07 0.026 
CD2000 major intracellular serine protease +14.02 0.0101 
CD3305 ATP-dependent Clp protease proteolytic subunit +13.52 0.00246 
CD0413 putative single-strand binding protein +13.4 0.0499 
CD3130 putative 6-phospho-beta-glucosidase +13.39 0.000731 
CD0420 putative cell surface protein +13.34 0.00137 
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CD1592 potassium-transporting ATPase B chain +13.31 0.00595 
CD0419A hypothetical protein +13.17 0.00694 
CD3177 xanthine dehydrogenase, molybdenum binding and iron-sulfur binding subunits +13.08 0.00974 
CD0445 D-ornithine aminomutase S component +12.87 0.00148 
CD1197 putative stage III sporulation protein AF +12.77 0.0201 
CD0444 putative pyridoxal-phosphate dependent enzyme +12.69 0.00362 
CD1575 putative exported protein +12.54 0.00442 
CD3388 putative conjugative transposon replication initiation factor +12.48 0.00116 
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Table B4. Genes required for sporulation (p ≤ 0.01) 
Systematic name Descriptive name Log fold change p-value 
CD0623 hypothetical protein -7.86 4.09E-11 
CD3473 ATP synthase C chain -6.03 7.95E-80 
CD3475 ATP synthase protein I -5.85 6.30E-89 
CD3272 putative membrane protein -5.54 3.89E-79 
CD0555 signal peptidase I -5.21 4.35E-87 
CD1428A hypothetical protein -4.94 8.65E-53 
CD0714A probable sugar O-acetyltransferase (partial) -4.92 3.36E-10 
CD3490 stage II sporulation protein e -4.78 2.22E-83 
CD0624 putative phage-related regulatory protein -4.26 2.57E-10 
CD0057 RNA polymerase sigma-H factor -3.96 3.18E-55 
CD1138 electron transport complex protein -3.87 2.82E-40 
CD0125 putative cell wall endopeptidase -3.82 8.44E-60 
CD3468 ATP synthase beta chain -3.79 4.57E-55 
CD1471 putative membrane protein (putative phage infection protein) -3.78 7.73E-57 
CD3447 putative transcription antiterminator -3.75 1.93E-59 
CD1653 putative lipoprotein -3.74 4.47E-59 
CD3474 ATP synthase A chain -3.69 4.68E-40 
CD1229 putative penicillin-binding protein -3.61 5.47E-56 
CD3198 multidrug resistance protein -3.60 9.06E-49 
CD3494 conserved hypothetical protein -3.59 5.88E-37 
CD2463 heat-inducible transcription repressor -3.57 8.29E-45 
CD0383 conjugative transposon FtsK/SpoIIIE-related protein -3.57 2.15E-46 
CD1320 putative peptidase -3.47 6.56E-46 
CD1610 putative membrane protein -3.41 4.53E-22 
CD3556 putative membrane protein -3.41 5.37E-32 
CD3303 chromate transport protein -3.40 9.00E-37 
CD1214 stage 0 sporulation protein A -3.40 1.12E-36 
CD2375 conserved hypothetical protein -3.40 1.96E-09 
CD2317 two-component sensor histidine kinase -3.36 1.55E-47 
CD1196 stage III sporulation-related protein -3.36 1.56E-35 
CD1136 putative membrane protein -3.35 1.23E-42 
CD3119 putative glycosyltransferase -3.34 7.33E-46 
CD3533 phosphonate ABC transporter, ATP-binding protein -3.33 1.00E-38 
CD3670 putative selenocysteine lyase -3.32 7.06E-42 
CD1344 putative cell wall biosynthesis protein -3.30 1.86E-41 
CD2644 sporulation sigma-E factor processing peptidase -3.26 8.24E-34 
CD1029 putative cell wall anchored protein -3.25 2.49E-40 
CD1678A hypothetical protein -3.21 4.67E-12 
CD2766 putative penicillin-binding protein repressor -3.19 8.80E-31 
CD1464 two-component response regulator -3.19 2.81E-42 
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CD2419 AraC-family transcriptional regulator -3.12 1.08E-44 
CD0459 ABC transporter, ATP-binding protein -3.11 1.52E-15 
CD0814 GntR-family transcriptional regulator -3.09 4.86E-43 
CD3250 conserved hypothetical protein -3.08 8.29E-25 
CD3302 chromate transport protein -3.08 1.42E-35 
CD0044 putative membrane protein -3.06 3.29E-38 
CD2232 anaerobic sulfite reductase subunit B -3.05 6.12E-33 
CD3276 PTS system, IId component -3.04 1.72E-24 
CD0653 ABC transporter, ATP-binding protein -3.02 3.74E-38 
CD1266 putative ABC transporter, permease protein -3.00 7.40E-33 
CD3441 putative aminotransferas -2.97 4.63E-38 
CD3388 putative conjugative transposon replication initiation factor -2.96 6.62E-20 
CD0637 putative acetyltransferase -2.96 7.95E-17 
CD3567 putative cell wall hydrolase -2.94 1.01E-34 
CD3624 putative ABC transporter, permease protein -2.94 2.05E-31 
CD1267 putative ABC transporter, permease protein -2.91 1.15E-26 
CD0409 putative replication initiation protein -2.91 8.24E-40 
CD2233 anaerobic sulfite reductase subunit A -2.91 1.11E-38 
CD1301 putative membrane protein -2.90 1.01E-30 
CD3225 dihydrodipicolinate synthase -2.90 5.52E-35 
CD0018 recombination protein -2.89 3.99E-29 
CD1631 putative superoxide dismutase [Mn] -2.88 1.36E-08 
CD0384 conjugative transposon protein -2.88 1.91E-07 
CD0867 putative membrane protein -2.87 7.89E-35 
CD1360 putative phage repressor -2.86 1.67E-10 
CD3633 putative membrane protein -2.85 1.24E-21 
CD1068 putative polysaccharide biosynthesis/sporulation protein -2.85 1.23E-25 
CD1128 DNA polymerase I -2.85 3.69E-38 
CD1324 putative DNA translocase -2.84 4.04E-36 
CD0161 putative lantibiotic ABC transporter,ATP-binding protein -2.84 1.21E-35 
CD0585 GntR-family transcriptional regulator -2.79 6.69E-32 
CD2969 putative AMP-binding protein -2.79 7.14E-24 
CD3110 putative phosphofructokinase -2.78 2.63E-30 
CD0618 putative transcriptional regulator -2.77 1.41E-25 
CD3448 putative tagatose-1,6-bisphosphate aldolase -2.77 1.38E-34 
CD3146 pseudogene -2.76 8.14E-26 
CD2496 selenide,water dikinase -2.74 3.00E-27 
CD1961 ABC transporter, ATP-binding protein -2.71 2.34E-14 
CD0440A regulatory protein (partial) -2.70 2.28E-06 
CD2354 glycine reductase complex component B alpha and beta subunits -2.70 1.82E-29 
CD3362 ABC transporter, permease protein -2.66 1.00E-18 
CD0691 putative short chain dehydrogenase -2.66 2.31E-26 
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CD2884 PTS system, lichenan-specific IIb component -2.66 9.49E-22 
CD2051 putative membrane protein -2.64 1.77E-23 
CD3150 conserved hypothetical protein -2.63 5.59E-30 
CD0335 hypothetical protein -2.58 2.75E-14 
CD2561 putative phosphatase -2.57 3.36E-30 
CD2104 putative ABC transporter, permease protein -2.56 3.88E-26 
CD2495 L-seryl-tRNA(Sec) selenium transferase (selenocysteinyl-tRNA(Sec) synthase) -2.55 6.56E-28 
CD3668 putative transcriptional regulator -2.53 2.77E-29 
CD2652 cell division/stage V sporulation protein -2.53 9.76E-22 
CD2493 selenocysteine-specific elongation factor -2.51 1.11E-28 
CD0032 putative beta-glucosidase -2.51 4.20E-25 
CD1170 conserved hypothetical protein -2.48 2.40E-26 
CD3144 putative transcriptional regulator -2.48 3.75E-24 
CD0775 stage V sporulation protein AE -2.47 6.03E-12 
CD2967 dipicolinate synthase, B chain -2.46 1.40E-14 
CD3147 putative DNA-methyltransferase -2.45 2.15E-21 
CD3079 6-phospho-beta-glucosidase -2.43 1.46E-29 
CD1692 ArsR-family transcriptional regulator -2.42 3.75E-26 
CD1311 putative RNA-binding protein -2.42 8.80E-25 
CD0629 putative transcriptional regulator -2.41 7.47E-24 
CD0627A putative ferredoxin -2.40 1.98E-12 
CD0305 putative aminobenzoyl-glutamate utilization protein -2.39 1.02E-22 
CD2839 putative two-component sensor histidine kinase -2.38 3.31E-19 
CD3536 putative phosphonate metabolism protein -2.37 1.46E-26 
CD0619 conserved hypothetical protein -2.37 8.50E-11 
CD3632 putative isochorismatase -2.34 3.19E-24 
CD2021 hypothetical protein -2.33 5.96E-21 
CD3016 putative transcriptional antiterminator -2.32 2.10E-24 
CD3472 ATP synthase B chain -2.31 1.93E-24 
CD3148 hypothetical protein -2.31 2.68E-26 
CD1174 conserved hypothetical protein -2.31 7.69E-21 
CD3352 AraC-family transcriptional regulator -2.30 8.59E-20 
CD3559 cell division protein -2.30 2.12E-24 
CD0767 PTS system, glucitol/sorbitol-specific IIa component -2.30 1.26E-24 
CD1140 electron transport complex protein -2.29 3.71E-13 
CD2959 V-type sodium ATP synthase subunit K -2.26 9.02E-20 
CD3223 dihydrodipicolinate synthase -2.25 8.54E-25 
CD0314 putative membrane protein -2.24 1.09E-10 
CD3005 IclR-family transcriptional regulator -2.23 1.15E-21 
CD3368 putative GTPase -2.21 1.56E-21 
CD2554 transposase-like protein A -2.20 1.37E-05 
CD0210 putative hydrolase -2.19 9.32E-20 
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CD0160 putative two-component response regulator -2.19 4.43E-23 
CD3048 PTS system, IIc component -2.18 3.92E-24 
CD1603 ABC transporter, permease protein -2.17 8.07E-17 
CD3399 putative exported protein -2.16 5.20E-22 
CD3063 putative exported protein -2.15 2.44E-21 
CD0394 (R)-2-hydroxyisocaproate dehydrogenase -2.15 1.33E-19 
CD0593 hypothetical protein -2.14 2.60E-21 
CD3070 PTS system, IIc component -2.14 4.17E-21 
CD2845 rubrerythrin -2.13 3.11E-17 
CD0907A putative phage regulatory protein -2.13 5.28E-09 
CD0124 stage II sporulation protein D -2.12 8.19E-22 
CD0674 putative membrane protein -2.12 8.42E-05 
CD3341 pseudogene -2.12 1.49E-05 
CD3502 peptidyl-tRNA hydrolase -2.11 3.76E-16 
CD3290 putative protein translocase -2.10 4.13E-22 
CD1851 putative conjugal transfer protein (putative single-stranded dna binding protein) -2.10 5.40E-11 
CD0462 two-component response regulator -2.09 9.81E-19 
CD3146A putative transposase (partial) -2.09 7.30E-15 
CD0783 putative stage IV sporulation protein -2.08 2.28E-12 
CD3613 conserved hypothetical protein -2.08 1.45E-14 
CD3617 conserved hypothetical protein -2.07 3.85E-22 
CD1270 two-component sensor histidine kinase -2.07 1.32E-12 
CD3353 GntR-family transcriptional regulator -2.06 1.28E-14 
CD2860 putative membrane protein -2.06 3.73E-13 
CD3255 two-component response regulator -2.06 1.63E-21 
CD3501 transcription-repair coupling factor -2.06 1.32E-21 
CD3469 ATP synthase subunit gamma -2.06 8.16E-16 
CD2996 hypothetical protein -2.06 3.34E-19 
CD1656 putative membrane protein -2.06 8.52E-16 
CD0552 putative spore-cortex-lytic protein -2.05 9.07E-15 
CD0889 S-adenosylmethionine decarboxylase proenzyme -2.05 8.66E-14 
CD0168 putative cyclic nucleotide-binding protein -2.04 7.62E-16 
CD1878 hypothetical protein -2.04 1.16E-05 
CD3266 two-component sensor histidine kinase -2.04 8.74E-17 
CD3470 ATP synthase alpha chain -2.03 3.77E-15 
CD3511 type IV pilus assembly protein -2.03 2.23E-18 
CD0031 AraC-family transcriptional regulator -2.02 5.42E-20 
CD1744 two-component sensor histidine kinase -2.01 8.75E-14 
CD0484 ABC transporter, ATP-binding protein -2.01 9.97E-12 
CD2357 putative glycine reductase complex component -2.00 4.95E-12 
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TableB5. Genes required for germination (p ≤ 0.01) 
Systematic Name Description Log fold change p value 
CD2136A hypothetical protein -7.84 1.49E-09 
CD1424 hypothetical protein -7.41 1.27E-07 
CD2043 putative hydrolase -6.81 1.74E-05 
CD2838 putative two-component response regulator -6.78 1.74E-05 
CD2809 conserved hypothetical protein -6.67 5.00E-05 
CD1699 riboflavin synthase alpha chain -6.30 1.43E-04 
CD1957 two-component response regulator -6.30 1.43E-04 
CD2150 putative endonuclease/exonuclease/phosphatase -6.30 1.43E-04 
CD1283 conserved hypothetical protein -6.25 2.53E-04 
CD2306 hypothetical protein -6.25 2.53E-04 
CD3630 putative PTS system, IIb component -6.04 7.95E-04 
CD1111 putative membrane protein -5.98 1.41E-03 
CD0435A hypothetical protein -5.86 2.50E-03 
CD1256 tRNA (Guanine-n(1)-)-methyltransferase -5.58 7.88E-03 
CD2214 putative regulatory protein -5.11 4.37E-18 
CD1940 putative membrane protein -4.92 2.22E-10 
CD0670 putative regulatory protein -4.77 3.75E-09 
CD1668 putative membrane protein -4.71 5.13E-14 
CD2683 putative propanediol utilization protein -4.30 1.13E-28 
CD1019 conserved hypothetical protein -4.28 5.01E-11 
CD0782 putative exported protein -4.25 4.53E-24 
CD0770 anti-sigma F factor antagonist -4.24 1.49E-10 
CD2294 putative membrane protein -4.23 2.05E-06 
CD2048 RpiR-family transcriptional regulator -4.16 1.29E-30 
CD1322 aspartokinase -4.15 1.07E-36 
CD2808 putative membrane protein -4.14 7.01E-16 
CD2966A putative membrane protein -4.05 1.76E-05 
CD3276 PTS system, IId component -4.01 3.03E-29 
CD1231 site-specific recombinase -4.00 1.24E-48 
CD2483 putative exported protein -3.89 5.15E-35 
CD0106 germination-specific N-acetylmuramoyl-L-alanine amidase -3.82 2.06E-31 
CD3471 ATP synthase subunit delta -3.77 5.52E-21 
CD1244 putative membrane protein -3.72 2.91E-12 
CD0771 anti-sigma F factor -3.72 7.32E-16 
CD2114 two-component system response regulator -3.72 7.32E-16 
CD1321 conserved hypothetical protein -3.68 2.11E-15 
CD3541 spore maturation protein B -3.68 7.50E-12 
CD0695 putative exported peptidase -3.65 1.81E-24 
CD2000 major intracellular serine protease -3.65 1.23E-29 
CD1945 putative glyoxalase -3.59 4.88E-04 
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CD1142 electron transport complex protein -3.56 1.23E-35 
CD2745 adenine phosphoribosyltransferase -3.56 2.05E-12 
CD0101 ABC transporter, ATP-binding protein -3.53 7.75E-19 
CD2800 putative membrane protein -3.53 7.59E-04 
CD2304 putative regulatory protein -3.49 3.48E-10 
CD0382 hypothetical protein -3.46 4.22E-04 
CD0171 putative DNA-binding protein -3.46 6.74E-32 
CD1795 conserved hypothetical protein -3.35 1.05E-07 
CD2410 pyruvate, phosphate dikinase -3.34 4.87E-36 
CD3464 putative lipoprotein -3.34 5.10E-27 
CD1529 putative ABC transporter, permease protein -3.32 1.85E-16 
CD1831A hypothetical protein -3.31 1.07E-03 
CD2411 conserved hypothetical protein -3.30 2.84E-25 
CD2169 iron-sulfur binding protein -3.28 5.70E-16 
CD3551 putative arginine decarboxylase -3.28 2.63E-21 
CD1480 putative exported protein -3.28 1.70E-03 
CD1627 putative D-alanyl-D-alanine carboxypeptidase -3.28 1.70E-03 
CD0696 probable cation transport protein -3.26 1.14E-12 
CD1753 ABC transporter, ATP-binding protein -3.24 5.42E-11 
CD2682 pyruvate-flavodoxin oxidoreductase -3.19 4.94E-31 
CD1139 electron transport complex protein -3.18 1.43E-15 
CD1786 hypothetical protein -3.18 8.39E-05 
CD2636 putative membrane protein -3.15 4.04E-09 
CD3667 conserved hypothetical protein -3.14 5.72E-22 
CD1002 putative regulatory protein -3.13 2.58E-14 
CD1045 putative membrane protein -3.09 5.32E-11 
CD0163 hypothetical protein -3.09 2.64E-25 
CD2446 putative tRNA binding protein -3.09 2.21E-15 
CD0102 ABC transporter, permease protein -3.04 2.30E-16 
CD1962 ABC transporter, permease protein -3.03 2.36E-29 
CD3194 AraC-family transcriptional regulator -2.99 3.78E-12 
CD3271 hypothetical protein -2.98 3.50E-16 
CD0397 subunit of oxygen-sensitive 2-hydroxyisocaproyl-CoA dehydratase -2.97 3.66E-18 
CD1613 hypothetical protein -2.97 1.90E-13 
CD3678 putative sporulation membrane protein -2.97 6.72E-11 
CD3153 putative phage DNA-binding protein -2.96 4.13E-21 
CD1974 HfQ protein -2.96 6.90E-20 
CD0925 hypothetical phage protein -2.96 8.78E-11 
CD1677 putative membrane protein -2.95 6.58E-07 
CD0802 putative CoA-transferase -2.93 3.54E-16 
CD1578 putative membrane-associated ribonuclease -2.93 9.30E-07 
CD1328 RecA protein (recombinase A) -2.92 3.97E-21 
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CD0179 NAD-specific glutamate dehydrogenase -2.92 1.05E-28 
CD1174 conserved hypothetical protein -2.90 5.51E-27 
CD3078 putative membrane protein -2.90 2.24E-05 
CD2019 probable transporter -2.90 1.02E-14 
CD1703 putative thiamine biosynthesis protein -2.89 1.02E-14 
CD0485 two-component sensor histidine kinase -2.89 1.36E-15 
CD1737 putative gluconate permease -2.88 5.61E-25 
CD3294 putative type IV pilin -2.88 2.18E-09 
CD1274 DNA topoisomerase I -2.87 9.37E-31 
CD3476 putative ATP synthase protein -2.86 3.25E-05 
CD2805 holliday junction DNA helicase -2.86 7.89E-20 
CD3445 PTS system, IIa component -2.82 4.31E-08 
CD2392 conserved hypothetical protein -2.79 1.03E-11 
CD1485 conserved hypothetical protein -2.79 6.82E-05 
CD2105 ABC transporter, ATP-binding protein -2.78 1.98E-12 
CD1242 putative membrane protein -2.77 1.30E-11 
CD3379 conjugative transposon protein -2.77 9.87E-05 
CD1564 hypothetical protein -2.76 1.28E-03 
CD0395 isocaprenoyl-CoA:2-hydroxyisocaproateCoA-transferase -2.76 1.97E-19 
CD1617 GntR-family transcriptional regulator -2.75 5.07E-20 
CD1137 electron transport complex protein -2.75 3.37E-19 
CD1532 ABC transporter, ATP-binding protein -2.73 1.91E-03 
CD3492 putative septum formation protein -2.72 1.51E-20 
CD3666 conserved hypothetical protein -2.72 4.35E-11 
CD0979 putative phage regulatory protein -2.72 9.37E-06 
CD0403 putative fructose-bisphosphate aldolase -2.72 1.23E-06 
CD2539 ribonuclease Z -2.69 5.73E-14 
CD0311 hypothetical protein -2.69 4.47E-32 
CD3350 putative glycosyl transferase -2.68 1.24E-14 
CD1470 putative phage shock protein -2.67 7.74E-12 
CD0630 putative drug/sodium antiporter -2.67 4.07E-11 
CD3033 thioredoxin -2.65 6.14E-14 
CD2988 two-component system esponse regulator -2.65 2.25E-13 
CD0543 conserved hypothetical protein -2.64 3.75E-14 
CD3627 putative dihydrodipicolinate synthase -2.64 1.91E-11 
CD2570 two-component sensor histidine kinase -2.63 1.45E-24 
CD0449 Na+/H+ antiporter -2.62 1.96E-15 
CD3353 GntR-family transcriptional regulator -2.62 1.81E-18 
CD2551 hypothetical protein -2.62 1.97E-04 
CD1018 putative ABC transporter, permease/ATP-binding protein -2.60 1.71E-25 
CD1207 1-deoxy-D-xylulose 5-phosphate synthase -2.60 7.00E-16 
CD1767 glyceraldehyde-3-phosphate dehydrogenase 1 -2.59 4.50E-15 
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CD1204 exodeoxyribonuclease VII small subunit -2.58 8.76E-06 
CD3610 putative glyoxalase -2.58 8.76E-06 
CD3631 putative transcription antiterminator -2.58 5.12E-23 
CD2016 hypothetical protein -2.57 2.85E-03 
CD3059 putative membrane protein -2.57 5.42E-05 
CD2824 putative membrane protein -2.57 8.76E-06 
CD0863 PTS system, IIa component -2.57 1.13E-06 
CD2538 putative lipoprotein -2.57 4.20E-15 
CD2356 thioredoxin reductase -2.56 6.09E-14 
CD2656 stage V sporulation protein D (sporulation specific penicillin-binding protein) -2.55 2.83E-19 
CD2566 PTS system, IIa component -2.55 1.55E-06 
CD1537 putative glutamate synthase [NADPH] small chain -2.53 6.17E-13 
CD3262 putative phosphateABC transporter, permease protein -2.53 6.24E-07 
CD1943 conserved hypothetical protein -2.52 3.25E-11 
CD1981 putative transcriptional regulator -2.52 7.67E-05 
CD3477 putative cytidine and deoxycytidylate deaminase -2.51 4.03E-11 
CD1428 putative transcriptional regulator -2.50 4.30E-03 
CD1292 conserved hypothetical protein -2.50 2.89E-06 
CD2482 putative lipoprotein -2.50 1.83E-07 
CD1598 putative endonuclease -2.48 3.94E-06 
CD3312 probable transporter -2.48 3.63E-17 
CD2222 conserved hypothetical protein -2.47 1.57E-05 
CD2229 putative membrane protein -2.45 7.80E-16 
CD1240A putative phage-related DNA-directed RNA polymerase 7 kDa polypeptide -2.45 8.83E-04 
CD1519 putative acetyltransferase -2.45 7.35E-06 
CD3195 putative excinuclease ABC subunit A -2.44 1.35E-20 
CD1422 MerR-family transcriptional regulator -2.44 7.39E-13 
CD2185 hypothetical protein -2.44 1.89E-13 
CD2197 putative subunit of oxidoreductase -2.42 1.00E-05 
CD0460 ABC transporter, permease protein -2.42 1.67E-21 
CD2254 putative amino acid recemase -2.41 1.61E-10 
CD3165 conserved hypothetical protein -2.40 5.64E-08 
CD0429 putative membrane protein -2.39 8.51E-12 
CD1536 putative dehydrogenase, electron transfer subunit -2.39 1.81E-12 
CD3677 SpoIIIJ-associated protein -2.37 2.12E-10 
CD1586 hypothetical protein -2.37 3.70E-12 
CD2358 putative oligoendopeptidase -2.36 3.16E-13 
CD0659 putative transcriptional regulator -2.35 9.63E-03 
CD1254 conserved hypothetical protein -2.35 9.63E-03 
CD3623 putative ABC transporter, ATP-binding protein -2.33 1.54E-10 
CD2807 crossover junction endodeoxyribonuclease RuvC -2.33 6.17E-10 
CD2144 putative membrane protein -2.33 3.30E-17 
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CD0934 hypothetical phage protein -2.32 1.14E-04 
CD1126 AraC-family transcriptional regulator -2.32 8.80E-07 
CD3083 transcription antiterminator -2.31 2.18E-09 
CD1141 electron transport complex protein -2.31 2.17E-06 
CD0572 conserved hypothetical protein -2.30 2.01E-10 
CD2729 putative regulator of the sigma(E) factor -2.30 5.29E-18 
CD1678 putative membrane protein -2.30 4.30E-04 
CD1100 putative conjugative transposon protein -2.29 3.82E-03 
CD1505 putative ABC transporter, permease protein -2.29 2.89E-06 
CD1418A putative integrase (partial) -2.28 8.16E-07 
CD3040 conserved hypothetical protein -2.28 6.81E-20 
CD2859 putative D-aminoacylase -2.26 1.13E-16 
CD3241 proline reductase -2.25 2.06E-14 
CD0398 subunit of oxygen-sensitive 2-hydroxyisocaproyl-CoA dehydratase -2.25 6.60E-13 
CD0336 ABC transporter, ATP-binding protein -2.24 4.36E-16 
CD1539 ABC transporter, ATP-binding protein -2.23 5.46E-03 
CD2097 putative membrane protein -2.23 5.46E-03 
CD2598 putative oligosaccharide deacetylase -2.21 2.41E-10 
CD2159 putative membrane protein -2.20 2.76E-03 
CD0674 putative membrane protein -2.20 4.19E-04 
CD1533 putative ABC transporter, permease protein -2.19 1.76E-10 
CD1312 transposase-like protein B -2.19 2.32E-13 
CD0613 ABC transporter, ATP-binding protein -2.18 2.90E-07 
CD2231 anaerobic sulfite reductase subunit C -2.18 3.09E-17 
CD3489 putative oligopeptidase -2.17 7.58E-19 
CD3197 MerR-family transcriptional regulator -2.16 1.21E-08 
CD0165 putative amino acid transporter -2.16 7.50E-10 
CD2585 peptide deformylase 2 -2.15 2.10E-06 
CD3354 conserved hypothetical protein -2.15 1.43E-12 
CD1725 AraC-family transcriptional regulator -2.15 2.36E-11 
CD0826 putative oxidative stress regulatory protein -2.15 1.59E-04 
CD0315 hypothetical protein -2.15 1.72E-03 
CD1924 putative ethanolamine/propanediol transporter -2.14 3.55E-08 
CD2332 PTS system, mannitol-specific IIa component -2.14 1.88E-20 
CD3102 putative dipeptidase -2.14 2.61E-19 
CD2730 conserved hypothetical protein -2.14 8.66E-12 
CD1078 PTS system, IId component -2.14 4.44E-08 
CD3123 putative nitroreductase -2.13 5.87E-11 
CD0554 signal peptidase I -2.12 1.59E-11 
CD1743 two-component response regulator -2.12 3.44E-09 
CD1759 conserved hypothetical protein -2.11 2.07E-05 
CD2724 probable polysaccharide deacetylase -2.11 2.70E-17 
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CD2287 putative membrane protein -2.11 1.27E-05 
CD3364 ABC transporter, ATP-binding protein -2.10 2.27E-14 
CD1525 putative iron-sulfur protein -2.10 1.88E-07 
CD0765 PTS system, glucitol/sorbitol-specific IIb component -2.10 8.28E-19 
CD2659 prolipoprotein diacylglyceryl transferase -2.10 1.88E-17 
CD2435 DNA repair protein -2.10 2.54E-16 
CD1793 putative membrane protein -2.09 8.68E-05 
CD1330 conserved hypothetical protein -2.09 7.79E-14 
CD2968 dipicolinate synthase, A chain -2.09 1.79E-06 
CD1956 two-component sensor histidine kinase -2.08 2.31E-06 
CD0547 putative penicillin-binding protein repressor -2.08 2.00E-08 
CD0233 conserved hypothetical protein -2.07 3.39E-03 
CD2464 oxygen-independent coproporphyrinogen III oxidase -2.07 1.96E-12 
CD1175 acetate kinase -2.07 3.04E-13 
CD3047 conserved hypothetical protein -2.06 8.12E-10 
CD1350 putative lantibiotic ABC transporter, permease protein -2.06 2.99E-06 
CD2160 putative membrane protein -2.06 1.82E-11 
CD3247 putative electron transfer protein -2.05 5.29E-14 
CD0664A conserved hypothetical protein -2.05 3.03E-08 
CD1237 pseudogene -2.05 8.21E-04 
CD2563 conserved hypothetical protein (partial) -2.05 8.21E-04 
CD2806 holliday junction DNA helicase -2.05 2.41E-11 
CD3245 sigma-54-dependent transcriptional activator -2.04 1.88E-19 
CD2386 conserved hypothetical protein -2.03 7.48E-08 
CD1067 hypothetical protein -2.03 2.07E-10 
CD1039 conserved hypothetical protein -2.03 2.80E-13 
CD1813 hypothetical protein -2.03 2.52E-06 
CD1511 conserved hypothetical protein -2.02 1.93E-07 
CD2276 putative sodium:solute symporter -2.02 1.59E-12 
CD3564 stage II sporulation protein -2.01 2.78E-12 
CD2025 putative ABC transporter, permease protein -2.01 2.45E-11 
CD3568 conserved hypothetical protein -2.00 2.54E-12 
CD1812 putative two-component system response regulator (partial) -2.00 7.11E-07 
CD1754 putative ABC transporter, permease protein -2.00 3.22E-06 
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Abstract
Clostridium difficile is the leading cause of hospital acquired diarrhoea in industrialised countries. Under conditions that are
not favourable for growth, the pathogen produces metabolically dormant endospores via asymmetric cell division. These
are extremely resistant to both chemical and physical stress and provide the mechanism by which C. difficile can evade the
potentially fatal consequences of exposure to heat, oxygen, alcohol, and certain disinfectants. Spores are the primary
infective agent and must germinate to allow for vegetative cell growth and toxin production. While spore germination in
Bacillus is well understood, little is known about C. difficile germination and outgrowth. Here we use genome-wide
transcriptional analysis to elucidate the temporal gene expression patterns in C. difficile 630 endospore germination. We
have optimized methods for large scale production and purification of spores. The germination characteristics of purified
spores have been characterized and RNA extraction protocols have been optimized. Gene expression was highly dynamic
during germination and outgrowth, and was found to involve a large number of genes. Using this genome-wide, microarray
approach we have identified 511 genes that are significantly up- or down-regulated during C. difficile germination (p#0.01).
A number of functional groups of genes appeared to be co-regulated. These included transport, protein synthesis and
secretion, motility and chemotaxis as well as cell wall biogenesis. These data give insight into how C. difficile re-establishes
its metabolism, re-builds the basic structures of the vegetative cell and resumes growth.
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Introduction
Clostridium difficile is a Gram-positive, anaerobic bacterium and a
leading cause of antibiotic-associated diarrhoea in industrialised
countries [1]. Infection typically occurs among hospitalized
patients, whose natural intestinal microflora has been disrupted
by prolonged treatment with broad-spectrum antibiotics, allowing
the pathogen to colonize the compromised gastro-intestinal tract
[2]. The resulting, toxin-mediated disease can range from mild,
self-limiting diarrhoea through severe diarrhoea to the potentially
lethal pseudomembraneus colitis and can progress to toxic
megacolon and sepsis syndrome causing significant morbidity
and mortality [3].
Under conditions that are not favourable for growth, C. difficile
exits the vegetative growth cycle and triggers sporulation,
producing metabolically dormant endospores (spores). These are
thought to be the primary infectious agent as recent studies have
shown that a mutant strain of C. difficile unable to produce SpoOA,
a regulatory protein essential for spore formation, is unable to
efficiently persist and transmit the disease [4]. Due to their multi-
layered structure, spores are extremely robust and resistant to both
chemical and physical insult, providing the mechanism by which
C. difficile can evade the potentially fatal consequences of exposure
to heat, oxygen, alcohol, and certain disinfectants [reviewed in
5,6]. Spores shed in faeces are therefore difficult to eradicate and
can persist in healthcare facilities for extended periods of time
leading to infection or re-infection of individuals through
inadvertent ingestion of contaminated material [7,8].
In order to cause disease, spores need to return to vegetative
growth through a process termed germination. In Bacillus,
Clostridium and related species, spore germination is initiated upon
binding of small molecules called germinants (often nutrients such
as sugars and/or amino acids) to specific germination receptors
(GRs). This triggers a series of irreversible biophysical events that
lead to rehydration of the spore core and degradation of its
protective layers. Once the constraints of spore outer layers are
lifted, the cell enters a period of longitudinal growth, accompanied
by re-establishment of cell metabolism during which DNA, RNA
and protein synthesis resume [reviewed in 9]. While spore
germination in Bacillus is well understood, and genes involved in
this process have recently been identified in Clostridium perfringens
[10–12], little is known about C. difficile germination and
outgrowth. Even though many components of the spore germi-
nation machinery are conserved between spore forming members
of Bacillales and Clostridiales, recent studies have revealed significant
differences both in the proteins and in the signal transduction
pathways involved [reviewed in 13]. Bioinformatic analysis of C.
difficile genome has failed to reveal genes encoding known
germination receptor subunits [14–16] even though a number of
such genes were identified in other Clostridia. Furthermore, while
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the C. difficile 630 spore proteome has recently been described [17],
little homology has been found between C. difficile spore proteins
and those present in other spore-formers. This would suggest that
the aspects of germination in C. difficile are unique, a notion
supported by the limited numbers of studies published so far [18–
21].
We now know that bile salts (cholate, taurocholate, glycocholate
and deoxycholate) stimulate C. difficile spore germination [21].
More recently glycine and histidine were shown to act as a co-
germinants with these cholate derivatives [18,22,23], and kinetic
studies suggest that there are distinct germination receptors for
taurocholate and glycine [24]. Neither of these compounds has
been previously described as a germinant for spores of Bacillus or
Clostridium species, supporting the notion of a novel mode of
germinant recognition in C. difficile spores. Furthermore, cheno-
deoxycholate, another bile salt, has been shown to inhibit C. difficile
spore germination [19], adding a new level of regulation to the
current model of C. difficile colonisation of the gut.
As limited as our insight into the mechanism of germination in
C. difficile might be, even less is known about the events that follow
initiation of germination and while transcriptomic analysis of gene
expression during germination has been carried out in B. subtilis
[25] and more recently C. novyi-NT [26] and C. sporogenes [27], no
such data is available for C. difficile. To address this issue we use a
combination of standard microbiology, microscopy and genome-
wide transcriptome analysis to explore the morphological,
physiological and transcriptional changes that occur during
germination and subsequent outgrowth of C. difficile 630 spores
and try to elucidate some of the processes that occur during the
transformation of a metabolically dormant spore into an actively
growing vegetative cell.
Results and Discussion
Characterization of Germination and Outgrowth
Dynamics
C. difficile 630, an epidemic, virulent and multi-drug-resistant
strain was selected for this analysis, as its complete genome
sequence has been determined [15]. In order to obtain sufficient
quantities of spores, free from vegetative cells and cell debris, a
protocol for producing and purifying spores was developed.
Growth of C. difficile 630 on solid SMC sporulation medium for 7
days ensured the highest sporulation rates (data not shown). Using
these growth conditions, 107 - 108 endospores could be
reproducibly obtained per ml of initial culture. Phase contrast
microscopy confirmed the high purity of the purified spore
suspensions, revealing fully developed, phase-bright endospores,
free of vegetative cells and noticeable cell debris (Figure 1).
To ensure that the purification process does not detrimentally
affect the spores, the viability and germination dynamics of the
isolated spores were assessed. Spore germination is classically
measured as a decrease in optical density (OD) of a spore
suspension occurring concomitantly with the release of dipicolinic
acid (DPA) from the spore core, rehydration of the core, and
degradation of the cortex [9]. This is followed by an increase in
OD600 correlated with outgrowth and cell division as the cells
enter logarithmic growth phase. OD600 measurement of liquid
cultures containing germinating spores combined with colony
forming unit (CFU) counts and microscopy showed that
.99.9999% of spores undergo germination when grown in
nutrient medium (BHIS) supplemented with the germinant,
sodium taurocholate (Tch) as indicated by a rapid decrease in
OD600 (approx. 50% of initial value within 5 minutes of induction)
and a 5-log drop in the number of spore CFUs (Figure 2A, 2B and
2C). Importantly, based on phase contrast and fluorescence
microscopy analysis, spore germination in nutrient medium
supplemented with an excess of Tch was synchronous and
appeared to be complete within 180 min. This would be critical
in subsequent transcriptomic analysis of gene expression during
germination as it ensured that all spores were in the same phase of
germination. Immediately upon induction of germination, the
dormant spores lost their phase-bright appearance becoming
susceptible to Hoechst 33258 DNA staining, presumably due to
Ca2+-DPA release and subsequent rehydration of the spore core
resulting in a gradual increase in spore volume (0 - 30 min). This
was followed by hydrolysis of cortex peptidoglycan and shedding
of spore outer layers (45–60 min). Once these physical constraints
were removed, germinating cells entered a phase of longitudinal
growth which coincided with DNA replication followed by
symmetric cell division (60–180 min) (Figure 3A and 3B). In
contrast, no germination was observed among spores grown in
medium devoid of the germinant as no changes in OD600, spore
CFU count or spore morphology could be observed throughout
the 6 h incubation period (Figure 2A and 2D; Figure 3D). Unlike
in Bacillus, where pre-treating spores with high temperature
increases germination rates, we found that heat activation had
no effect on germination dynamics of the isolated C. difficile
endospores (data not shown). Interestingly, germination was not
observed when liquid cultures were incubated aerobically,
presumably due to the inhibitory presence of oxygen. Even
though a decrease in OD600 and spore CFUs was observed
immediately after induction with Tch and the spores lost their
phase-bright appearance becoming susceptible to DNA staining
(indicative of Ca2+-DPA release and core rehydration), spores
failed to progress fully to outgrowth and eventually were killed as
indicated by the gradual drop in total CFUs (Figure 2A and 2C;
Figure 3C). This is consistent with recent findings [28] and
suggests that oxygen is a negative regulator of C. difficile endospore
germination acting downstream of any signalling events that
induce germination.
Optimization of RNA Extraction
RNA quality is of paramount importance in any transcriptional
analysis of gene expression. It was therefore critical to develop a
method for extracting RNA that would not only provide high
yields, but would also ensure that the integrity of RNA was
maintained. Mechanical disruption with silica beads followed by
acid phenol-based extraction was shown to give the highest quality
RNA. Using this method, between 2 and 10 mg of total RNA
could be reproducibly isolated per 108 spores. The quantity of
extracted RNA depended on the status of the spores and increased
gradually as the spores went from dormancy through germination
to outgrowth (Figure S1A). This could be attributed to the
increasing susceptibility of the spore envelope to lysis during
germination and/or the initiation of RNA synthesis [9]. All
preparations were of high purity and integrity as indicated by a
260/280 nm absorption ratio in the range of 2.05 to 2.18 and
Bioanalyzer electropherograms showing sharp and undegraded
peaks (Figure S1B). Interestingly, we found that the ribosomal
RNA (rRNA) of spores differed from that present in vegetative
cells. In addition to the 16S and 23S rRNA species, two smaller
rRNA species were identified in dormant spores, represented by
small peaks on Bioanalyzer spectra (Figure S1C). These could only
be discerned in dormant spores and reduced in intensity as
germination progressed. A similar phenomenon has previously
been reported in Bacillus [25] as well as the more closely related
Clostridium novyi [26] and Clostridium sporogenes [27], although its
significance remains unknown. These smaller species might
Transcription during C. difficile Germination
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Figure 1. C. difficile spore purification. C. difficile was sporulated on SMC solid medium, washed extensively and purified via density gradient
centrifugation. Samples taken before and after purification were analysed using phase contrast microscopy A) Crude spore preparation before
purification. Phase-bright endospores (white arrow), vegetative cells and significant amount of cell debris (black arrows) are visible. B) Spore
preparation after purification. Phase-bright endospores are visible, free of vegetative cells and cell debris.
doi:10.1371/journal.pone.0064011.g001
Figure 2. Growth characteristics during spore germination and outgrowth. Purified C. difficile 630 endospores were resuspended in BHIS
60.5% sodium taurocholate (Tch) to an OD600 of 0.1 and incubated either aerobically or anaerobically for 6 h at 37uC. Growth was monitored via
OD600 measurements and CFU counts. A) C. difficile 630 germination dynamics growth curve. Spores incubated in the presence of 0.5% Tch showed a
rapid decrease in OD600 immediately after resuspension, in both aerobic and anaerobic conditions. No decrease in OD600 was observed for spores
incubated in the absence of Tch. B) CFU counts for spores germinated anaerobically in BHIS +0.5% Tch. C) CFU counts for spores germinated
aerobically in BHIS +0.5% Tch. D) CFU counts for spores germinated anaerobically in BHIS. Data reported as means and standard deviations from
three independent experiments.
doi:10.1371/journal.pone.0064011.g002
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represent rRNA fragments or be indicative of RNA maturation
within the germinating spore [29].
Microarray Analysis of Temporal Gene Expression during
Spore Germination – General Observations
Total RNA extracted from germinating spores at eight time
points representing dormancy (0 min), germination (15, 30, 45,
60 min) and outgrowth (90, 120, 180 min) was analysed by
competitive RNA/DNA hybridisation using the BmG@S
CDv2.0.1 microarray. Gene expression was highly dynamic
during germination and outgrowth and was found to involve a
large part of the genome. Relatively few transcripts were identified
in dormant spores (see below), consistent with their metabolically
silent state. In contrast, a significant up-regulation of gene
expression was observed immediately after induction of germina-
tion, peaking at 30 min (Figure 4). In order to validate these
results, semi-quantitative RT PCR was used to confirm the
temporal expression pattern for a number of selected genes
showing a wide range of distinct expression profiles being either
significantly up- or down-regulated in the early or late stage of
Figure 3. Morphological changes during spore germination and outgrowth. Purified C. difficile 630 endospores were resuspended in BHIS
60.5% sodium taurocholate (Tch) to an OD600 of 0.1 and incubated either aerobically or anaerobically for 6 h at 37uC. At the given time points
samples were formaldehyde-fixed and analysed using phase contrast microscopy and fluorescence microscopy following DNA staining with Hoechst
33258. A and B) Spores germinated anaerobically in BHIS +0.5% Tch. Upon induction of germination, dormant spores lose their phase-bright
appearance and become susceptible to DNA staining. This is followed by a gradual increase in volume and shedding of spore outer layers which
remain visible as empty ‘shells’. Once the physical constraints of the outer spore layers are removed, the spore enters a phase of longitudinal growth
coinciding with DNA replication followed by symmetric cell division. C) Spores germinated aerobically in BHIS +0.5% Tch. Following induction of
germination, spores lose their phase-bright appearance and become susceptible to DNA staining but fail to progress to outgrowth. D) Spores
germinated anaerobically in BHIS. No changes in spore appearance and no DNA staining could be observed.
doi:10.1371/journal.pone.0064011.g003
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germination. In all cases the expression profiles obtained matched
those seen in the microarray experiment (Figure 5).
We investigated in detail two time points: 30 min and 180 min
post germination. At 30 min all spores are actively germinating in
contrast to 180 min when normal vegetative growth has
commenced. In total, 263 genes were up-regulated and 248 genes
down-regulated at 30 min when compared to the 180 min time
point (p#0.01) (Figure 4A). The magnitude of change of the
statistically up-regulated genes ranged from 1.3-fold to 80-fold,
and that of down-regulated genes ranged from 1.3- to 100-fold.
Many gene clusters encoding enzyme complexes or biochemical
pathways appeared to be co-ordinately regulated. The Kyoto
Encyclopedia of Genes and Genomes (KEGG) database was used
to identify significantly differentially regulated pathways. Selected
examples have been listed below and summarised in Table 1.
Where appropriate, genes that marginally failed the stringent
statistical cut-off (0.01#p#0.05) are also mentioned. Full lists of
genes generated through this experiment are shown in supple-
mentary data (Table S1).
Spore Transcripts
Despite early research hinting at the presence of mRNA in
spores [30,31], for a long time it has been generally assumed that
dormant spores do not contain functional transcripts. This view
Figure 4. Temporal gene expression profiles in germinating C. difficile spores. A) All significantly, differentially regulated genes, B) two-
component systems, C) ABC-transporters, D) phosphotransferase system, E) ribosomal proteins, F) transcriptional regulators, G) flagellar assembly and
chemotaxis, H) type IV pili, I) peptidoglycan biosynthesis, J) secondary cell wall polymer (SCWP) biosynthesis are shown. Microarray gene expression
data represented as normalised intensity with respect to control conditions. Analysed using 1-way ANOVA (A p#0.01, B-J p#0.05) and Benjamini-
Hochberg multiple testing correction. Each line represents data for one gene. All graphs were generated using GeneSpring GX7.3.1.
doi:10.1371/journal.pone.0064011.g004
Figure 5. RT-PCR validation of microarray results. cDNA was prepared from total RNA using reverse transcription. Primers internal to five
selected genes were used to amplify fragments of,150 bp: (CD2782 - cell wall binding protein, CD2796 - cell wall binding protein, CD0663 - toxin A,
CD0660 - toxin B, CD2625 - putative membrane protein). gDNA was used as template in a positive control reaction. 25 reaction cycles were carried
out to ensure non-saturating conditions. A) microarray expression profile (normalised to 180 minutes), B) gel electrophoresis of the PCR amplicons.
doi:10.1371/journal.pone.0064011.g005
Table 1. Numbers of genes differentially regulated during
germination.
Functional group Up-regulated Down-regulated
Two-component systems 26 5
ABC-transporters 71 34
Phosphotransferase system 11 30
Ribosomal proteins 12 1
Transcriptional regulators 45 24
Flagellum and chemotaxis 0 34
Type IV pili 0 7
Peptidoglycan biosynthesis 9 1
Secondary cell wall
polymers
12 0
The total number of genes within specific functional groups up-regulated or
down-regulated at 30 min into germination was determined using microarray
analysis (p#0.05).pone.0064011.g006.tif.
doi:10.1371/journal.pone.0064011.t001
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has now changed as recent studies conducted in B. subtilis [25], C.
novyi-NT [26] and C. sporogenes [27] have shown that mRNA is
abundant in spores and that its composition is dramatically
different from that observed in vegetative cells. A number of
explanations for this phenomenon have been proposed. Spore
transcripts might represent mRNA that has been entrapped during
the late phases of sporulation and is later degraded to act as a
reservoir of nucleotides during germination. Indeed, five out of
fifteen most abundant spore transcripts identified in this study
represented late-sporulation genes such as those encoding small
acid-soluble proteins A and B (CD2688 and CD3249 respectively)
a putative spore coat protein (CD0213) and a stage IV sporulation
protein (CD0783) (Table S2). Alternatively, transcripts might be
stored to equip the spore with proteins that will become necessary
during the transformation into a vegetative cell such as those
involved in growth, protein synthesis, detoxification, metabolism,
transport, secretion etc. Interestingly, the second most abundant
transcript we have identified encodes a putative Mn-superoxide
dismutase (CD1631). Other genes with redox activity whose
transcripts were present at relatively high levels in dormant spores
included two putative oxidoreductase complexes with ferrodoxin
activity (CD2197-CD2199A and CD2427-CD2429A), a NADH
oxidase (CD2540) and a NADH-dependent flavin oxidoreductase
(CD2709). The inclusion of such a large number of redox genes
within the spore transcriptome is intriguing, particularly in the
light of the anaerobic life cycle of C. difficile. While C. difficile spores
are resistant to ambient oxygen concentrations, vegetative cells can
be killed by relatively short exposure to oxygen. It would thus be
tempting to speculate that at least a subset of these genes might
play a role in detoxification by scavenging reactive oxygen species
(ROS). Finally, consistent with previous reports [26], we found
that a large proportion of spore transcripts encode proteins with an
unknown function (nine out of top fifteen hits). This not only
underlines the difference in mRNA composition between spores
and vegetative cells but also the need for more research into the
spore transcriptome of major spore-forming bacteria.
Two-component Signal Transduction Systems
Two-component regulatory systems serve as a basic stimulus-
response coupling mechanism to allow organisms to sense and
respond to changes in many different environmental conditions.
They typically consist of a membrane-bound histidine kinase that
senses a specific environmental stimulus and a corresponding
response regulator that mediates the cellular response, mostly
through differential expression of target genes [reviewed in 32]. C.
difficile 630 has fifty-one two-component sensor histidine kinases
and fifty-four response regulators. Nine kinase genes and seventeen
response regulator genes were up-regulated in germinating spores.
Only five genes (three kinases and two response regulators) were
down-regulated (Figure 4B).
Transport of Metabolites and Sugars
The germinating spore requires a large supply of metabolites
and cofactors to facilitate re-establishment of cell metabolism.
Consistent with this requirement, we found 100 out of 229 ABC-
transporter genes were differentially regulated during germination.
A majority of these (70 genes) were up-regulated during
germination when compared to the vegetative state, including
the entire potABCD locus (spermine/putrescine ABC-transporter).
The spermidine/putrescine transporter is involved in polyamine
trafficking, which in turn plays a crucial role in DNA replication,
cell division and stress response. Interestingly, polyamines have
previously been implicated in the shift from a quiescent to a
proliferating state in bacteria, plants, fungi and other eukaryotic
systems [reviewed in 33,34]. Similarly, the appABC operon
(peptide/nickel ABC-transporter) and the ssuABC operon (sulfo-
nate/nitrate/taurine ABC-transporter) were up-regulated. The
latter is of particular interest as taurine conjugated with cholate
yields taurocholate, the primary germinant for C. difficile spores.
One could speculate that the up-regulation of this transporter
might be a part of a positive feedback loop providing a constant
supply of the germinant and the basis for commitment in
germinating spores. Other ABC-transporters that had at least
one significantly up-regulated gene included maltose/maltodextrin
ABC-transporter (9.5-fold), lactose/L-arabinose ABC-transporter
(13.6-fold) and iron complex ABC-transporter (2.6-fold). In
contrast, two ABC-transporter complexes involved in cobalt and
nickel transport and encoded by the cbiMNOQ operon were down-
regulated (Figure 4C).
The PTS system is a complex phosphate translocation
mechanism involved in the transport of sugars such as glucose,
mannose and mannitol. As such it plays a key role in cell
metabolism driving glycolysis. Unlike ABC-transporters, sugar
transport was largely inactive during germination with the entire
branch of the system responsible for glucose trafficking signifi-
cantly down-regulated (from 1.9- to 23.8-fold) in germinating
spores when compared to vegetative cells, including members of
the pstG-ABC operon. In contrast, a number of genes involved in
fructose and lactose metabolism were up-regulated in germinating
spores. These included fruABC (fructose-specific phosphotransfer-
ase; 75.2-fold), CD2270 (putative 1-phosphofructokinase; 79.8-
fold) and CD1806 (putative fructokinase; 2.8-fold) (Figure 4D).
While this could simply reflect the composition of the culture
medium, it could also indicate the preference for fructose as the
main carbon source in early germination.
Ribosomal Proteins and Transcriptional Regulators
Exit from dormancy requires the bacterium to rebuild most of
the structures found in a vegetative cell, necessitating large
amounts of protein synthesis. It is not surprising then that a
significant up-regulation of genes involved in transport, coincided
with up-regulation of transcription and translation. In general, all
genes encoding ribosomal proteins were up-regulated during
germination. These included three genes encoding 30S subunit
proteins and eight genes encoding 50S subunit proteins (Figure 4E).
Similarly, genes encoding DNA-directed RNA polymerase were
up-regulated, although only the genes encoding the b and b9
subunits of the polymerase had a p value #0.05. Furthermore,
sixty-eight genes encoding transcriptional regulators were up-
regulated (from 1.3- to 10.9-fold) while twenty-four genes were
down-regulated (from 1.3- to 21.2-fold) in germinating spores
(Figure 4F). These included members of the gntR, tetR araC, marR,
merR, rpiR, copR, deoR and lysR gene families. On the whole, genes
encoding tRNA synthetases were down regulated in germinating
spores when compared to a vegetative cell. Similarly, enzymes
involved in amino acid metabolism were largely down-regulated
during germination, possibly reflecting the preferential catabolism
of endogenous nutrients as a means for obtaining the necessary
‘building blocks’ for protein synthesis in early germination.
Secretion and Cell Wall Components
The Sec machinery provides a major pathway of protein
translocation from the cytosol across the cytoplasmic membrane in
bacteria [35]. A number of components of the sec secretory
pathway can be identified in C. difficile 630 including secA1, secA2,
secE and secY [27]. In general, all genes within the secAYEG operon
were up-regulated in germinating spores, although only secA2 (3.4-
fold) and secE (3.8-fold) significantly so. The lipoprotein signal-
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peptidase lspA was also up-regulated (2.6-fold) as was the signal
recognition particle encoded by ffh (4.16-fold) and prolipoprotein
diacylglyceryl transferase encoded by lgt (3-fold).
The C. difficile flagellar assembly is encoded by thirty-five genes
located within a single cluster. A vast majority of flagellar genes
were inactive in germinating spores when compared to vegetative
cells. In addition, five genes encoding components of the bacterial
chemotaxis machinery including motA, motB, cheY, cheD and cheW
were also found to be down-regulated in germinating spores
(Table 2; Figure 4G) as were seven genes within two gene clusters
encoding putative type IV pilus proteins (Table 3; Figure 4H). As
cell motility is typically initiated upon nutrient deprivation in
stationary phase, the overall inactivity of genes involved in motility
during germination is in accordance with expectations, in that
flagellar genes are dormant during germination and are tran-
scribed in vegetative cells.
As a hallmark of cell expansion during germination and
outgrowth, genes involved in cell wall biosynthesis were found to
be significantly up-regulated in germinating spores. Peptidoglycan
is produced from N-acetylglucosamine (GluNAc) and N-acetyle-
muramic acid (MurNAc) in a series of reactions involving
incorporation of D-glutamine and D-alanyl-D-alanine. Genes
encoding the enzymatic components of this pathway are largely
located within the mur-mra cluster. Ten enzymes involved in
peptidoglycan biosynthesis were up-regulated in germinating
spores, including ddl (D-Ala D-Ala ligase B; 7.3-fold) glnA
(glutamine synthase; 2.6-fold) and murF (UDP-MurNAc-pentapep-
tide synthase; 2.4-fold) as well as other members of the mur-mra
cluster: murGDE and mraYW (Table 4; Figure 4I). In addition to
peptidoglycan, the Gram-positive cell wall can also contain
secondary cell wall polymers (SCWP) such as teichoic, teichuronic
acids and lipoteichoic acids which can make up between 10 and
Table 2. List of differentially regulated flagellar assembly and chemotaxis genes.
Systematic name Gene product p-value Fold change
CD0228 flagellar motor switch protein 0.0248 21.9
CD0230 putative flagellar biosynthesis protein 0.0151 23.7
CD0231 putative flagellar hook-associated protein 0.0204 23.6
CD0232 flagellar hook-associated protein 0.0167 25.0
CD0235 flagellar protein FliS 0.0106 23.7
CD0236 flagellar protein 0.0161 24.0
CD0237 flagellar cap protein 0.0165 23.1
CD0239 flagellin subunit 0.0282 22.0
CD0246 flagellar basal-body rod protein 0.0271 23.1
CD0247 flagellar hook-basal body complex protein 0.0117 23.8
CD0248 flagellar M-ring protein 0.0177 23.9
CD0249 flagellar motor switch protein 0.0187 24.8
CD0250 flagellar assembly protein 0.0115 25.6
CD0251 flagellum-specific ATP synthase 0.0139 25.7
CD0252 flagellar protein 0.0172 26.1
CD0253 putative flagellar hook-length control protein 0.0177 25.7
CD0255 flagellar hook protein 0.00833 26.0
CD0255A putative flagellar protein 0.0154 26.2
CD0256 chemotaxis protein 0.0164 26.4
CD0257 chemotaxis protein 0.0236 26.0
CD0258 flagellar basal body-associated protein 0.00927 25.3
CD0259 putative flagellar protein 0.0297 24.9
CD0260 flagellar biosynthetic protein 0.0394 24.4
CD0261 flagellar export protein 0.0393 24.9
CD0262 flagellar export protein 0.0364 25.4
CD0263 flagellar export protein 0.0232 25.5
CD0265 flagellar number regulator 0.0284 26.3
CD0268 flagellar basal-body rod protein FlgG 0.0078 26.6
CD0269 putative flagellar basal-body rod protein 0.00932 26.5
CD0270 putative flagellar motor switch protein 0.00953 26.7
CD0271 putative flagellar motor switch protein 0.0475 24.6
CD0533 chemotaxis protein 0.017 21.8
CD0535 chemotaxis protein 0.0329 21.9
CD0540 chemotaxis protein 0.0257 21.6
doi:10.1371/journal.pone.0064011.t002
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60% of its structure. Although the genes specifying these
components have not been identified in C. difficile, it might be
relevant that a cluster of genes (CD2769-80) specifying glyco-
transferases and related enzymes was found to be significantly up-
regulated in germinating spores (Table 5; Figure 4J).
Toxins
Of central importance in C. difficile is the pathogenicity locus
(PaLoc) containing five genes encoding two large clostridial toxins:
TcdA and TcdB as well as their regulators (tcdC, tcdR) and export
machinery (tcdE) [36]. Both toxin A and B are represented by
multiple probes on the microarray. tcdA was down-regulated
during germination when compared to the vegetative cell. No
transcripts for tcdB could be detected in either state, consistent with
the observation that toxins are expressed in stationary phase.
Concluding Remarks
This study aims to give a genome-wide overview of the temporal
gene expression during germination and outgrowth of C. difficile
spores. We decided to focus on the events that follow initiation of
germination and are critical in the transformation of a metabol-
ically dormant spore into an actively growing vegetative cell. Our
analysis was possible as we initially demonstrated the synchronous
nature of germination in C. difficile. This is intriguing as
germination in Bacillus species and even the more closely related
C. perfringens and C. botulinum has been shown to be heterogenous
[37–40]. While the vast majority of a spore population will enter
germination upon exposure to germinants, a small proportion may
not germinate for many hours or even days. This ‘superdormancy’
has been correlated with a low level of specific germination
receptors in individual spores [41] and is thought to be an example
of ‘bet hedging’, ensuring the survival of a given population in a
rapidly changing environment. Under the conditions tested,
99.9999% of the C. difficile 630 spore population germinated
synchronously. This might be a reflection of the unique
germination mechanism present in C. difficile and/or the fact that
the human gut is a relatively stable environment eliminating the
need for super-dormancy.
Our results will give insight into how a dormant organism re-
establishes its metabolism, re-builds the basic structures of the
vegetative cell and resumes growth. Around 14% of genes (511
genes out of 3679) were found to be significantly differentially
regulated at 30 min of germination when compared to the
vegetative cell and a number of functional groups of genes
appeared to be co-regulated. Further analysis of the genes and
biochemical pathways identified here as important in germination
will enable a more targeted investigation of germination in C.
difficile endospores.
Experimental Procedures
Bacterial Strains and Culture Conditions
C. difficile 630 (tcdA+ tcdB+; epidemic strain isolated in 1985 from
Zurich, Switzerland; PCR ribotype 012) was routinely cultured on
Table 3. List of differentially regulated type IV pilin genes.
Systematic name Gene product p-value Fold change
CD3295 putative type IV pilus-assembly protein 0.0211 +1.3
CD3504 putative type IV prepilin leader peptidase 0.00385 22.4
CD3505 putative type IV pilus retraction protein 0.0186 22.5
CD3507 putative type IV pilin 0.00579 22.5
CD3508 putative type IV pilin 0.0141 22.3
CD3509 putative type IV pilus assembly protein 0.0191 22.3
CD3511 type IV pilus assembly protein 0.0245 23.4
CD3512 type IV pilus assembly protein 0.0091 22.9
doi:10.1371/journal.pone.0064011.t003
Table 4. List of differentially regulated peptidoglycan biosynthesis genes.
Systematic name Gene product p-value Fold change
CD0784 putative N-acetylmuramoyl-L-alanine amidase 0.0195 +2.0
CD1343 glutamine synthetase 0.0081 +2.6
CD1408 D-alanine–D-alanine ligase B 0.00843 +7.3
CD2651 UDP-N-acetylglucosamine–N-acetylmuramyl-(penta peptide) pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase
0.022 +1.4
CD2653 UDP-N-acetylmuramoylalanine–D-glutamate ligase 0.0105 +1.5
CD2654 phospho-N-acetylmuramoyl-pentapeptide-transferase 0.0145 +1.7
CD2655 UDP-N-acetylmuramoyl-tripeptide–D-alanyl-D-alan ine ligase 0.00508 +2.4
CD2664 putative UDP-N-acetylmuramoylalanyl-D-glutamate–2,6-diaminopimelate ligase 0.0344 +2.4
CD3563 putative spore cortex-lytic enzyme 0.0245 +2.2
CD1898 putative phage-related cell wall hydrolase (endolysin) 0.0174 26.1
doi:10.1371/journal.pone.0064011.t004
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blood agar base II (Oxoid) supplemented with 7% horse blood
(TCS Biosciences), brain-heart infusion (BHI) agar (Oxoid) or in
BHI broth (Oxoid). Cultures were grown statically in an anaerobic
cabinet (Don Whitley Scientific) at 37uC in an anaerobic
atmosphere (10% CO2, 10% H2 and 80% N2). The strain has
been fully sequenced [15] and its genome sequence is available at
http://www.sanger.ac.uk/resources/downloads/bacteria/
clostridium-difficile.html).
Genomic DNA Extraction
C. difficile 630 was collected from 10 ml late-log-phase culture by
centrifugation at 5,0006g for 10 min. Genomic DNA was purified
through subsequent incubations with lysozyme (1 h at 37uC),
pronase (1 h at 55uC), 10% N-lauroylsarcosine (1 h at 37uC) and
RNase (1 h at 37uC) followed by phenol/chloroform extraction
and ethanol precipitation.
Sporulation
C. difficile 630 sporulation was induced as described previously
[42]. Briefly, 10 ml of TGY broth (3% tryptic soy broth; 2%
glucose; 1% yeast extract; 0.1% L-cysteine) was inoculated with a
single colony of C. difficile 630 grown on BHIS agar (brain heart
infusion agar supplemented with 0.1% L-cysteine and 5 mg/ml
yeast extract). Following over-night static incubation, bacteria
were sub-cultured 1:10 in SMC broth (9% Bacto peptone, 0.5%
proteose peptone, 0.15% Tris base, 0.1% ammonium sulphate),
incubated until the culture reached OD600 of 0.6 and spread out
on SMC agar plates. After 7 days of anaerobic incubation at 37uC,
spores were harvested in 2 ml of ice-cold sterile water.
Spore Purification
Crude spore suspensions were washed five times with ice-cold
sterile water and vortexed for 10 min in between washes. The
resulting pellets were re-suspended in 500 ml of 20% HistoDenz
(Sigma) and layered over 1 ml of 50% HistoDenz in a 1.5 ml tube.
Tubes were centrifuged at 14,0006g for 15 min. The spore pellet
was recovered and washed three times with ice-cold sterile water
to remove residual HistoDenz. Spore purity was assessed via phase
contrast microscopy. Spore yields in individual preparations were
estimated by counting colony forming units (CFU) on BHI agar
plates supplemented with 0.1% sodium taurocholate (Tch).
Purified spores were stored in water at 4uC until further analysis.
Germination Assay
Purified C. difficile 630 spores were re-suspended to and OD600
of 0.1 in BHIS 60.5% Tch and incubated under aerobic or
anaerobic conditions for 6 h at 37uC. Growth was monitored via
OD600 measurements. CFU enumeration was carried out by
plating 10-fold dilutions of the germinating cultures on BHIS
+0.1% Tch. For spore enumeration, samples were heated at 70uC
for 30 min prior to plating.
Phase Contrast and Fluorescence Microscopy
Samples were spun down (5,0006g; 10 min; 4uC), washed with
1 ml of PBS and fixed with 3.7% formaldehyde for 15 min at RT.
Following fixation, samples were washed with PBS once more and
dried onto glass slides. DNA staining was carried out by adding
Hoechst 33258 dye to the mounting medium to a final concen-
tration of 20 mg/ml. Phase contrast and fluorescence microscopy
were carried out according to standard procedures on an Eclipse
E600 microscope (Nikon) using a 1006oil immersion lens. Images
were captured using a Retiga-400R Charge Coupled Device (Q-
Imaging).
RNA Extraction and RT-PCR
RNA was extracted using the FastRNA Pro Blue Kit (MP
Biosciences). Briefly, 5 ml cultures containing 56109 endospores
(OD600 10) at various stages of germination were mixed with
10 ml of RNA Protect (Qiagen) and incubated for 5 min at RT.
Samples were centrifuged (5,0006g; 10 min; 4uC), resuspended in
1 ml of RNA Pro solution and transferred to a lysing matrix tube
containing 0.1 mm silica beads. Tubes were processed in a
FastPrep-24 instrument (MP Biosciences) (3645 s at 6.5 ms21
with 2 min of cooling on ice between cycles). The efficiency of
spore rupture was evaluated via phase contrast microscopy as well
as by plating spore samples prior to and post processing, indicating
that only 0.0001% of the spore population remains intact.
Following disruption, samples were centrifuged to remove spore
debris and silica beads from suspension (16,0006g; 10 min; 4uC).
Approx. 700 ml of liquid was transferred to an RNase-free tube
and incubated at RT for 5 min. 300 ml of chloroform was added.
The sample was vortexed for 10 s and centrifuged (16,0006g;
15 min; 4uC) to separate the phases. The aqueous phase was
transferred to a fresh tube containing 200 ml of 95% EtOH and
placed on ice. The mixture was transferred to a spin column
Table 5. List of differentially regulated putative secondary cell wall polymer (SCWP) biosynthesis genes.
Systematic name Gene product p-value Fold change
CD2769 capsular polysaccharide biosynthesis protein 0.0201 +2.9
CD2770 putative capsular polysaccharide biosynthesis glycosyl transferase 0.00656 +2.7
CD2771 putative UDP-glucose 6-dehydrogenase 0.00681 +2.4
CD2772 putative teichuronic acid biosynthesis glycosyl transferase 0.016 +2.2
CD2773 putative beta-glycosyltransferase 0.0115 +2.3
CD2774 putative teichuronic acid biosynthesis glycosyl transferase 0.019 +2.2
CD2775 putative minor teichoic acid biosynthesis protein 0.016 +2.3
CD2776 putative glycosyl transferase 0.0408 +2.4
CD2777 putative polysaccharide polymerase 0.0182 +2.5
CD2778 putative polysaccharide biosynthesis protein 0.0311 +2.5
CD2779 putative mannose-1-phosphate guanylyltransferase 0.0116 +2.2
CD2780 putative phosphomannomutase/phosphoglycerate mutase 0.00636 +2.7
doi:10.1371/journal.pone.0064011.t005
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assembly (SV Total RNA isolation system; Promega) and
centrifuged (16,0006g; 1 min). Columns were washed twice with
600 ml and 250 ml of RNA wash solution. RNA was eluted in
45 ml of RNase-free water. DNase treatment was carried out using
the Turbo DNase kit (Ambion) according to manufacturers
protocol. The enzymatic reaction was cleaned-up using the
RNeasy Mini Kit (Qiagen) RNA purity and quantity was
determined by nanodrop UV spectroscopy. RNA integrity was
confirmed on a RNA 6000 nano lab-Chip using a Bioanalyzer
2100 instrument (Agilent). Samples were stored at 280uC until
further analysis.
Reverse Transcriptase PCR
For conventional RT-PCR, first strand cDNA was synthesized
from total RNA using random decamers as primers and the
RETROscript Kit (Ambion) according to manufacturer’s instruc-
tions and then used in standard Taq (Sigma) PCR reactions using
gene specific primers (Table S3).
Microarray Analysis
The microarray was constructed by determining all unique
genes from the predicted coding sequences of C. difficile strains 630,
QCD-32g58, 196, R20291 plasmid pCD630. Multiple optimal
hybridisation 60-mer oligonucleotide sequences were designed
(Oxford Gene Technologies), from which a minimal non-
redundant subset of oligonucleotides were selected with a target
coverage of three 60-mers per gene. Arrays were manufactured on
the Inkjet in situ synthesized platform (Agilent) using the 8615 k
format.
Competitive genomic DNA/RNA hybridizations were carried
out according to standard Agilent protocols. Briefly, 5 mg of total
RNA was labelled with Cy3 via reverse transcription using
SuperScript II (Invitrogen). 1 mg of gDNA was labelled with
Cy5 using Exo-Klenow fragment. Both labelling reactions were
cleaned-up using the PCR Purification MiniElute Kit (Qiagen).
Cy3-labeled cDNA and Cy5-labeled gDNA were mixed with 106
blocking agent and hybridization buffer and incubated for 3 min
at 95uC and 30 min at 37uC. Samples were then applied to a C.
difficile OGT array CDv2.0.1 (BmG@S) and incubated for 24 h in
a hybridization oven set to 65uC. The microarray slide was
washed, fixed in acetonitryl, dried and scanned using an Agilent
G2565CA Scanner. Microarray data extraction was performed
using ImaGene software (BioDiscovery), and further processed
using MAVI Pro software (MWG Biotech). Normalization and
statistical analysis were performed using GeneSpring v7.3.1
software (Agilent Technologies). Briefly, gene specific data was
derived from average intensity of between 1 and 5 oligonucleotide
reporters. Gene values below 0.01 were set to 0.01. Each gene’s
measured intensity was divided by its control channel value in
each sample; if the control channel was below 10 then 10 was used
instead. If the control channel and the signal channel were both
below 10 then no data was reported. Each measurement was
divided by the 50th percentile of all measurements in that sample.
Replicate time points were normalized to the 180 minute time
point: each measurement for each gene was divided by the median
of that gene’s measurements in the corresponding control samples.
Following the initial experiment covering eight time points (09,
159, 309, 459, 609, 909, 1209 and 1809), two additional biological
replicates were carried out for time points 309, 609, 909 and 1809.
Each time point was independently tested versus 180 min using 1-
way ANOVA using Benjamini-Hochberg multiple testing correc-
tion and p= 0.01 or 0.05.
Accession Numbers
The array design (CDv2.0.1) is deposited in BmG@Sbase
(Accession No. A-BUGS-49; http://bugs.sgul.ac.uk/A-BUGS-49)
and ArrayExpress (Accession No. A-BUGS-49). Fully annotated
microarray data have been deposited in BmG@Sbase (accession
number E-BUGS-145; http://bugs.sgul.ac.uk/E-BUGS-145) and
also ArrayExpress (accession number E-BUGS-145).
Supporting Information
Figure S1 RNA quality control. A) Gradual increase in RNA
yield observed during spore germination. B) Bioanalyzer pseudogel
with RNA Integrity (RIN) values C) Bioanalyzer electrophero-
grams showing two distinct peaks corresponding to 16S and 23S
rRNA. In addition, two smaller rRNA species were identified in
dormant spores and in early germination, represented by small
peaks on Bioanalyzer spectra. 5S rRNA peak visible at retention
time 23 seconds.
(DOCX)
Table S1 List of genes up and down regulated during
germination.
(XLS)
Table S2 Abundant spore transcripts.
(XLS)
Table S3 Primers used in this study.
(DOCX)
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